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Abstract		
Copper (Cu) is crucial for cell function and survival and plays important roles in enzyme-
catalyzed metabolic processes, transport of cargo through cellular membranes, and protein 
breakdown. The mitochondria are home to two important Cu-containing enzymes: cytochrome c 
oxidase (COX) and superoxide dismutase 1 (Sod1). Delivery of Cu to COX, the terminal electron 
acceptor in the respiratory chain, is suggested to happen in a bucket brigade fashion via the proteins 
Cox17, Sco1, and Cox11. Sod1, the other major mitochondrial cuproprotein, is thought to obtain Cu 
from its chaperone, Ccs1. Because the mitochondria are a central player in Cu storage and regulation, 
our goal in this study is to analyze how changes in extracellular Cu concentration impact 
mitochondrial function in Saccharomyces cerevisiae. 
Our results showed that Cox17, Sco1, and Cox11 responded differently to excess and limiting 
Cu, suggesting alternate functions for these proteins in mitochondria unrelated to COX assembly. 
During Cu deficient conditions we noticed an interesting redistribution of mitochondrial Cu: retention 
of Cu in mitochondrial Sod1 is accompanied by a complete loss of COX activity. This phenotype 
suggests a regulatory mechanism where Cu is preferentially donated to mitochondrial Sod1 instead of 
COX when Cu is limited. Interestingly, we also find that Cu redistribution in the mitochondria is 
affected when we change the primary carbon source from glucose to galactose. We propose that Cu 
distribution in mitochondria is controlled by an affinity gradient. 
Analysis of cell cycle progression showed that in excess Cu, yeast displayed a cell cycle 
defect while Cu deficient conditions did not affect cell cycle progression. Strikingly, changing the 
primary carbon source to galactose led to a cell cycle defect in the presence of a Cu specific chelator. 
Overall, we suggest that the presence of mitochondrial Sod1 is essential for cell cycle progression.  
The protein machinery responsible for Cu homeostasis has been well characterized, however 
the transport of Cu to cellular compartments and regulatory mechanisms involved in Cu import and 
export are not fully understood. We now demonstrate a novel phenotype that provides insight into 
regulation of Cu within the mitochondria. Additionally, we find that mitochondrial Cu distribution is 
affected by carbon source, and is associated with changes in cell cycle progression. These findings 
further our understanding of Cu homeostasis in yeast, and will likely have implications on Cu-related 
disorders, such as Menkes disease. 
 
 
 
	 v 
Acknowledgements		
First and foremost, I would like to thank my incredible supervisor, Dr. D. Moira Glerum. Moira is 
hard working, knowledgeable, and passionate about her work and I am very grateful that I had the 
opportunity to be part of her lab for almost four years. Moira has inspired to pursue a career in 
research and has immensely helped me develop and mature scientifically and personally. She has 
been an amazing mentor and I will definitely miss working with her.  
 
I would also like to thank NSERC, WIN, ASBMB, and the University of Waterloo for supporting me 
financially during the course of my degree.  
 
To my committee members, Dr. Mungo Marsden and Dr. Andrew Doxey, thank you for asking 
difficult questions and encouraging me through both the ups and downs of this program. I am very 
appreciative of their support.  
 
Thank you to Dr. Liz Meiering for her support on my work with Sod1 and for helping me develop my 
skills as a critical thinker. She constantly provided new insight to me when I presented my ideas and 
was also extremely supportive of my personal struggles. 
 
To the other members of the Glerum lab: Tyler, Renée, Raffaele, and Seville. Thank you for bringing 
me food when I refused to eat lunch, and for listening to my ideas and providing critical insight. I will 
never forget the time we pulled the best April fool’s prank on Moira.  
 
Thank you to Nivetha, who sat with me almost every day to write our theses and pushed me to keep 
going when I told her I wanted to stop working. 
 
Lastly, I would like to thank my family. My parents and my brother have been so loving and 
supportive throughout these years and I feel very fortunate to have such a close family. And thank 
you to Eric, the love of my life, who is one of the best listeners I know. 
 
 
 
	 vi 
Table	of	Contents		
Authors Declaration ......................................................................................................................... ii	
Statement of Contributions .............................................................................................................. iii	
Abstract ........................................................................................................................................... iv	
Acknowledgements .......................................................................................................................... v	
List of Figures ................................................................................................................................. ix	
List of Tables ................................................................................................................................... xi	
List of Abbreviations ...................................................................................................................... xii	
Chapter 1: Introduction ................................................................................................................. 1	
1.1	 Copper (Cu) Homeostasis in Eukaryotes ........................................................................... 1	
1.1.1 Cellular Cu import ........................................................................................................ 2	
1.1.2 Cellular Cu export ......................................................................................................... 3	
1.1.3 Cu chaperones ............................................................................................................... 4	
1.1.4 Cu-responsive transcription factors .............................................................................. 5	
1.2 Cu Related Diseases ............................................................................................................... 6	
1.2.1 Historical context of Cu disorders ................................................................................ 6	
1.2.2 Implications of Cu defects in mitochondrial and neurodegenerative disorders ............ 7	
1.3 Cu and Mitochondrial Function ............................................................................................. 8	
1.3.1 Cytochrome c Oxidase (COX) Function and Assembly ............................................... 9	
1.3.2 Delivery of Cu to Cox1 and Cox2 .............................................................................. 10	
1.3.3 Superoxide Dismutase 1 (Sod1) Function and Assembly ........................................... 12	
1.3.4 Cu delivery to Sod1 in the absence of Ccs1 ............................................................... 13	
1.3.5 Cu delivery to Sod1 in the mitochondria and cytosol ................................................. 14	
1.4 Mitochondrial Cu Import ..................................................................................................... 15	
1.4.1 Cu import via a dually-localized Cu chaperone .......................................................... 15	
1.4.2 Cu is stored in the mitochondrial matrix ..................................................................... 17	
1.4.3 Cu import via glutathione (GSH) ................................................................................ 18	
1.5 Cu Homeostasis and Cell Cycle ........................................................................................... 20	
1.5.1 Yeast cell cycle ........................................................................................................... 20	
1.5.2 Influence of Cu on cell cycle ...................................................................................... 22	
1.5.3 Other pathways connected to Cu homeostasis ............................................................ 23	
1.6 Goals of this study ................................................................................................................ 25 
Chapter 2: Materials and Methods ............................................................................................. 27	
2.1 Yeast strains & Maintenance ................................................................................................ 27	
2.1.1 Mating and Sporulation ............................................................................................... 28	
2.2 Treatment with Cu availability reagents .............................................................................. 28	
2.3 Cell Viability ........................................................................................................................ 29	
	 vii 
2.3.1 Spot Plate Assays ........................................................................................................ 29	
2.3.2 Trypan Blue Staining .................................................................................................. 29	
2.4 Suppressor screen ................................................................................................................. 29	
2.5 Subcellular Fractionations .................................................................................................... 30	
2.5.1 Whole Cell Lysate (WCL) preparation ....................................................................... 30	
2.6.2 Isolation of Mitochondria ........................................................................................... 30	
2.7 RNA Isolations ..................................................................................................................... 31	
2.8 Quantitative PCR (qPCR) .................................................................................................... 31	
2.8.1 Nuclear DNA (nDNA) preparation and primer optimization ..................................... 31	
2.8.2 cDNA synthesis .......................................................................................................... 33	
2.8.3 RT-qPCR ..................................................................................................................... 33	
2.8.4 Analysis & Statistics ................................................................................................... 33	
2.9 Western Blotting .................................................................................................................. 34	
2.9.1 SDS-PAGE and Western blotting ............................................................................... 34	
2.9.2 Analysis ....................................................................................................................... 35	
2.9.3 Oxyblot ....................................................................................................................... 35	
2.10 Enzyme Activity Assays .................................................................................................... 36	
2.10.1 COX activity ............................................................................................................. 36	
2.10.2 SOD activity .............................................................................................................. 36	
2.10.3 Aconitase activity ...................................................................................................... 37	
2.11 Cell Cycle ........................................................................................................................... 37	
2.11.1 Sample preparation ................................................................................................... 37	
2.11.2 Flow cytometry parameters ....................................................................................... 38	
2.11.3 Analysis using FACSDiva software ......................................................................... 38	
Chapter 3: Impacts of Excess Cu ................................................................................................ 39	
3.1 Optimization of Cu availability conditions in S. cerevisiae ................................................. 39	
3.1.1. Determining the appropriate concentrations of CuSO4 and BCS .............................. 39	
3.1.2. Effect of Cu availability on cell viability ................................................................... 41	
3.1.3 Response of MAC1 and CUP2 to extracellular Cu changes ....................................... 42	
3.2 Mitochondrial Cuproproteins in Cu Excess conditions ........................................................ 43	
3.2.1 COX in the face of Cu excess ..................................................................................... 43	
3.2.2 Sod1 in the face of Cu excess ..................................................................................... 48	
3.2.3 Non-Cu related mitochondrial functions in the face in Cu excess .............................. 50	
3.3 Summary of Results ............................................................................................................. 54	
Chapter 4: Analysis of Cu Deficient Conditions ....................................................................... 55	
4.1 Mitochondrial Proteins in Cu Deplete Conditions ............................................................... 55	
4.1.1 COX in the face of Cu deficiency ............................................................................... 55	
4.1.2 Sod1 in the face of Cu deficiency ............................................................................... 61	
4.1.3 Non-Cu related mitochondrial functions in the face in Cu deficiency ....................... 63	
4.2 Examining Cu Deficiency in Mitochondria with Galactose ................................................ 67	
4.2.2 Effect of carbon source on COX during Cu depletion ................................................ 69	
	 viii 
4.2.3 Effect of carbon source on mtSod1 during Cu depletion ............................................ 71	
4.2.4 Effect of carbon source on mitochondrial function during Cu deficiency .................. 71	
4.3 Summary of Results ............................................................................................................. 73	
Chapter 5: Cu Availability and Cell Cycle Progression ........................................................... 75	
5.1 COX Assembly Mutants and Cell Cycle .............................................................................. 75	
5.2 Cu Availability and Cell Cycle Progression ........................................................................ 77	
5.3 Summary of Results ............................................................................................................. 83	
Chapter 6: Discussion .................................................................................................................. 84	
6.1 Existence of a Mitochondrial Matrix Cu Pool ..................................................................... 84	
6.2 Cox17: the outlier among COX assembly factors ................................................................ 86	
6.3 Comparison of behavior of Sco1 and Cox11 ....................................................................... 90	
6.4 Mitochondrial Cu Distribution with Limiting Cu ................................................................ 92	
6.5 Divergent Cell Cycle Phenotypes with Cu Availability ....................................................... 96	
6.6 Conclusions and Future directions ....................................................................................... 98	
References .................................................................................................................................... 101	
Appendix A: qPCR Data with Galactose as a Carbon Source ..................................................... 116	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 ix 
List	of	Figures			
Chapter 1: Introduction 
Figure 1.1 Pathways important in cellular Cu distribution ..................................................................... 2 
Figure 1.2 Proposed pathway for monomeric COX assembly in humans ............................................ 10 
Figure 1.3 Two unique pathways for Sod1 maturation ........................................................................ 13 
Figure 1.4 Depiction of Ccs1 and Sod1 import into mitochondria ....................................................... 15 
Figure 1.5 Proposed model of Cu trafficking in mitochondria based on the CuL ................................ 17 
Figure 1.6 Roles of GSH in the mitochondrial IMS ............................................................................. 19 
Figure 1.7 Monitoring progression of the yeast cell cycle by flow cytometry ..................................... 22 
 
Chapter 2: Materials and Methods 
 
Figure 2.1 Sample qPCR curve ............................................................................................................. 33 
 
Chapter 3: Impacts of Excess Cu 
Figure 3.1 RT-qPCR of CTR1 and CUP1 in Cu excess and Cu deplete conditions ............................. 40 
Figure 3.2 Cell viability analysis with CuSO4 and BCS ....................................................................... 41 
Figure 3.3 RT-qPCR of MAC1 and CUP2 in Cu excess and Cu deplete conditions ............................ 43 
Figure 3.4 RT-qPCR of COX17, SCO1, COX11 and COX4 in Cu excess conditions ......................... 44 
Figure 3.5 Mitochondrial protein levels in Cu excess conditions ......................................................... 46 
Figure 3.6 Cox17 protein levels in Cu excess conditions ..................................................................... 47 
Figure 3.7 COX activities in Cu excess conditions .............................................................................. 48 
Figure 3.8 RT-qPCR of CCS1 and SOD1 in Cu excess conditions ...................................................... 49 
Figure 3.9 Sod1 protein and activity levels in Cu excess conditions ................................................... 50 
Figure 3.10 TCA cycle protein levels and Aco1 activity levels in Cu excess conditions .................... 51 
Figure 3.11 Oxidative damage in Cu excess conditions ....................................................................... 52 
Figure 3.12 Analysis of mitochondrial Lon protease in Cu excess conditions ..................................... 53 
 
Chapter 4: Analysis of Cu Deficient Conditions 
Figure 4.1 RT-qPCR of COX17, SCO1, COX11 and COX4 in Cu depletion conditions ..................... 56 
Figure 4.2 Mitochondrial protein levels in Cu depletion conditions .................................................... 57 
Figure 4.3 Cox17 protein levels in Cu deficiency ................................................................................ 58 
Figure 4.4 COX activities in Cu depletion conditions .......................................................................... 59 
Figure 4.5 Analysis of yeast on non-fermentable carbon source during Cu deficiency ....................... 60 
Figure 4.6 Analysis of suppressors isolated from plates containing EG + 500 µM BCS ..................... 61 
Figure 4.7 RT-qPCR of CCS1 and SOD1 in Cu deplete conditions ..................................................... 62 
Figure 4.8 Sod1 protein and activity levels in Cu deplete conditions .................................................. 63 
	 x 
Figure 4.9 TCA cycle protein levels and Aco1 activity levels in Cu depletion conditions .................. 64 
Figure 4.10 Oxidative damage in Cu depletion conditions .................................................................. 65 
Figure 4.11 Analysis of mitochondrial Lon protease in Cu depletion conditions ................................ 66 
Figure 4.12 RT-qPCR of CTR1, CUP1, MAC1, and CUP2 with galactose as a carbon source ........... 68 
Figure 4.13 Mitochondrial protein levels and COX activities with glucose (Glc) and galactose (Gal) in 
Cu deficient conditions ................................................................................................................. 70 
Figure 4.14 Sod1 protein and activity levels in glucose (Glc) and galactose (Gal) ............................. 71 
Figure 4.15 TCA cycle analysis in glucose (Glc) and galactose (Gal) ................................................. 73 
 
Chapter 5: Cu Availability and Cell Cycle 	
Figure 6.1 Model for Cells in Cu deficiency ........................................................................................ 93 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 xi 
List	of	Tables	
 
Chapter 1: Introduction 
Table 1.1 Known cuproproteins and their functions ............................................................................... 5 
 
Chapter 2: Materials and Methods 
Table 2.1 Yeast Strains used in this study ............................................................................................ 27 
Table 2.2 Media used in this study ....................................................................................................... 27 
Table 2.3 Primers used in this study ..................................................................................................... 32 
Table 2.4 List of antibodies used in this study ..................................................................................... 35 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 xii 
List	of	Abbreviations			
Ace1 Activator of Cup1 expression 
AD Alzheimer disease 
Aif1 Apoptosis inducing factor 1 
ALS Amyotrophic lateral sclerosis 
ANOVA Analysis of variance 
APP Amyloid precursor protein 
ATP Adenosine triphosphate 
ATP7 ATPase copper transporting 7 
Atx1/Atox1 Antioxidant protein 1 
AOX Alternative oxidase 
BCS Bathocuproine disulphate 
Ccc2 Cross-complements Ca2+ phenotype 2 protein 
Ccs1 Copper Chaperone for Sod1 
CDK Cyclin dependent kinase 
cDNA Complementary DNA 
COX Cytochrome c oxidase 
Cox Cytochrome c oxidase protein 
Ctr Copper transporter 
Cu Copper 
CuL Copper ligand 
CuRE Copper responsive element 
CuSO4 Copper sulphate 
Cyc1 Cytochrome c 
dH2O Deionized water 
DMT Divalent metal transporter 
dNTP Nucleoside triphosphate 
DNA Deoxyribonucleic acid 
EG Ethanol glycerol medium 
Erv1 Essential for respiration and viability protein 1 
Fe Iron 
Fet Ferrous transporter 
FeS Iron-sulfur cluster 
FES Free energy surface 
FRE Ferric reductases 
Grx Glutaredoxin 
	 xiii 
GSH Glutathione 
hSod1 Human superoxide dismutase 
HU Hydroxyurea 
IECs Intestinal epithelial cells 
IMM Inner mitochondrial membrane 
IMS Inter membrane space 
KAc Potassium acetate medium 
KD Knockdown 
KO Knockout 
LHON Leber hereditary optic neuropathy 
Mac1 Metal binding activator 1  
MAT Mating type 
Mcm Mini chromosome maintenance 
MD Menadione 
Mia40 Mitochondrial IMS import and assembly 
MICOS Mitochondrial contact site and cristae organizing system 
Mir1 Mitochondrial import receptor 1 protein 
MMS Methyl methanesulfonate 
Mn Manganese 
mtDNA Mitochondrial DNA 
Mtf1 Metal regulatory transcription factor 1 
MRE Metal responsive element 
Mrs Mitochondrial RNA splicing factor 
MTS Mitochondrial targeting signal 
mtSod1 Mitochondrial Sod1 
MW Molecular weight 
OMM Outer mitochondrial membrane 
ND4 NADH dehydrogenase subunit 4 
nDNA Nuclear DNA 
PCR Polymerase chain reaction 
Pic2 Phosphate carrier 2 
PMS Post-mitochondrial supernatant 
PMSF Phenylmethylsulphonyl fluoride 
Por1 Porin 
PQ Paraquat 
Pt Platinum 
qPCR Quantitative polymerase chain reaction 
Rad53 Radiation sensitive protein 53 
	 xiv 
RNA Ribonucleic acid 
RNR Ribonucleotide reductase 
ROS Reactive oxygen species 
RT Room temperature 
Sco Synthesis of cytochrome c oxidase 
Siz1 SAP and MIZ finger domain protein 1 
Sod1 Superoxide dismutase 1 
STEAP Six transmembrane epithelial antigen of prostate 
SUMO Small ubiquitin like modifier 
TMPD N, N, N’, N’-tetramethyl-p-phenylinediamine dihydrochloride 
TOM Translocase of the outer membrane 
TRAF TNF-receptor associated factor 4 
WD Wilson disease 
WO Yeast nitrogen-base medium without amino acids 
WCL Whole cell lysate 
wtSod1 Wild type Sod1 
XIAP X-linked inhibitor of apoptosis 
Yck Yeast casein kinase 
YPD Yeast peptone dextrose medium 
YPGal Yeast peptone galactose medium 
Ysl Yellow-Stripe 1-Like  
Zn Zinc 
 
	 1 
Chapter	1:	Introduction	
1.1 Copper	(Cu)	Homeostasis	in	Eukaryotes	
Copper (Cu) is crucial for cell function and survival, and plays important roles in 
enzyme-catalyzed metabolic processes, transport of cargo through cellular membranes, and 
protein breakdown. Over the past few decades, the proteins and pathways known to regulate 
Cu homeostasis in yeast and mammalian cells have been studied in detail. However, many 
questions related to Cu trafficking in and out of organelles and regulation of cross-talk 
between Cu-dependent pathways remain unanswered. In a healthy cell, intracellular 
concentrations of Cu are approximately 10-18 M (Rae et al, 1999). It is suggested that 
intracellular Cu does not exist as a free radical – instead, it is bound to a cuproprotein (Cu-
containing protein) or a signaling molecule, such as glutathione (GSH) (Maryon et al, 2013). 
Cellular Cu homeostasis is critical since both Cu deficiency and excess are toxic to cells and 
cause a variety of disease phenotypes (discussed in section 1.2). Reduced concentrations of 
Cu result in poor functionality of Cu-dependent proteins and higher than normal Cu levels 
lead to the Fenton reaction, which produces the toxic hydroxyl radical.  
Many known cuproproteins were initially discovered in the model organism 
Saccharomyces cerevisiae. The majority of Cu metabolic and regulatory pathways are 
conserved between S. cerevisiae and higher eukaryotes (Figure 1.1) (Nevitt et al, 2012) and 
studies in yeast continue to shed further light on our understanding of Cu metabolism and 
disease in humans. 
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Figure 1.1 Pathways important in cellular Cu distribution 
Comparison of pathways involved in Cu homeostasis in yeast (left) and mammalian cells (right). Many 
pathways are conserved from yeast to mammalian systems (Nevitt et al, 2012). 
1.1.1	Cellular	Cu	import	
Before Cu enters the cell it must be in a Cu+ (cuprous) state, which is accomplished 
by cell surface reductases. In mammalian systems, the Six Transmembrane Epithelial 
Antigen of Prostate (STEAP) family proteins are known for their roles in extracellular Cu 
and iron (Fe) reduction (Ohgami et al, 2006). Steap2 was discovered first and this was 
followed by discovery of homologs Steap3 and Steap4 (Ohgami et al, 2006). Interestingly, 
some Steap family proteins have been shown to be overexpressed in human cancers and are 
thought to be a viable therapeutic (Gomes et al, 2012).  
In yeast, the Ferric REductases 1 and 2 (Fre1/2), which were originally discovered to 
reduce extracellular Fe (Dancis et al, 1992), were also shown to be able to reduce 
extracellular Cu (Hassett & Kosman, 1995) (Georgatsou et al, 1997). It was also reported that 
Fre1 is transcriptionally upregulated during Cu-deficient conditions in yeast (Gross et al, 
2000).  
Cu enters the cell using Cu-specific transporters on the plasma membrane, the Copper 
TRansporter (Ctr) proteins. Ctr1 was the first Cu specific importer discovered in S. cerevisiae 
(Dancis et al, 1994) and a mammalian ortholog, which serves a similar function, was 
identified soon thereafter (Zhou & Gitschier, 1997). Four Cu+ atoms bind to each monomer 
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of Ctr1 on the extracellular amino terminus of the protein, then are carried across the lipid 
bilayer and handed off to Cu chaperones at the Ctr1 carboxy terminus in the cytosol (Öhrvik 
& Thiele, 2014). Other membrane proteins have also been shown to translocate Cu into the 
cell in yeast; similarly to Ctr1, Ctr3 is also a high-affinity transporter on the plasma 
membrane (Nevitt et al, 2012). On the other hand, Ctr2 is associated with low-affinity Cu 
transport and resides on the vacuolar membrane (Kampfenkel et al, 1995). Additionally, 
FErrous Transporter 4 (Fet4), originally identified as a Fe transporter, can transport Cu across 
the plasma membrane (Nevitt et al, 2012). 
1.1.2	Cellular	Cu	export	
Cu export is very important in human cells, based on Cu circulation around the body, 
and is carried out by two isoforms of the ATPase copper transporting 7 (Atp7) protein: Atp7 
alpha (Atp7a) and Atp7 beta (Atp7b). Dietary Cu is absorbed into the bloodstream via the 
intestine, where Cu is imported into intestinal epithelial cells (IECs) and exported through the 
basement membrane into the blood stream. Atp7a, a protein that lies on the Golgi membrane, 
performs this process by transportation to the basement membrane through vesicular 
trafficking mechanisms (Ohja & Prasad, 2016). Additionally, Atp7a is responsible for 
bringing Cu across the blood-brain barrier (Ohja & Prasad, 2016). In contrast, Atp7b is 
primarily expressed in the liver and functions to excrete excess Cu from the body through the 
bile duct. In cells where both isoforms are present, their trafficking properties differ, 
highlighting their distinct roles in a single cell (Linz & Lutsenko, 2007). 
In yeast, the Cross-Complements Ca2+ phenotype 2 protein (Ccc2) is orthologous to 
human Atp7a and Atp7b. In fact, a yeast Ccc2 knockout (KO) is complemented by both 
Atp7a and Atp7b, demonstrating overlap in their functionalities (Hung et al, 1997) (Payne & 
Gitlin, 1998). Both Cu and Fe can also recover the sick phenotype present in the Ccc2 KO, 
and this observation led to the discovery of the role of Ccc2 in delivery of Cu to Fet3, a cell 
surface Fe transporter (Yuan et al, 1995). 
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1.1.3	Cu	chaperones	
Because Cu is thought not to exist freely in the cell, it travels to its subcellular 
destinations while bound to Cu chaperones. Currently, three Cu chaperone proteins are 
accepted to play major roles in delivery of Cu to its subcellular destinations. In yeast, two of 
these Cu chaperones have been found to interact directly with Ctr1: AnTioXidant protein 1 
(Atx1) and Copper Chaperone for Sod1 (Ccs1) (Nevitt et al, 2012). Cytochrome Oxidase 
protein 17 (Cox17) is the other accepted Cu-chaperone that is responsible for delivery of Cu 
to cytochrome c oxidase (COX), the final electron acceptor in the electron transport chain, 
but it has not been shown to interact with Ctr1. 
Atx1, which was initially shown to suppress the oxidative damage phenotype seen in 
yeast lacking a functional SuperOxide Dismutase 1 gene (SOD1), was later found to deliver 
Cu to Ccc2 (Lin et al, 1997), a trans-Golgi resident protein involved in cellular Cu efflux. In 
humans, Atox1 is the ortholog of Atx1 and delivers Cu to both Atp7a and Atp7b. Ccs1, 
which is found in both yeast and humans, is now the accepted Cu chaperone for Sod1 
(Fetherolf et al, 2017). Sod1 has an important role in antioxidant defense and is dually 
localized to the mitochondria and cytosol (see section 1.3). Ccs1 knockouts in yeast have 
defects in lysine metabolism, and therefore Sod1 and Ccs1 knockouts in yeast are unable to 
growth without supplemented lysine (Culotta et al, 1997).  
Many other potential Cu-chaperones have been discovered but do not have a defined 
delivery pathway or final destination. There are also many cuproproteins that do not have a 
strictly defined Cu-chaperone (Table 1.1), suggesting that there are likely undiscovered Cu-
chaperones or defined Cu-chaperones that are multifunctional. Further research is needed in 
order to understand regulation of the distribution of Cu around the cell. 
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Table 1.1 Known cuproproteins and their functions  
Many of these proteins do not have a defined Cu-chaperone (modified from Turski & Thiele, 2009) 
Protein Function 
Cu, Zn Superoxide Dismutase Superoxide disproportionation; signaling 
Cytochrome c Oxidase Mitochondrial oxidative phosphorylation; ATP 
production 
Tyrosinase/Laccase Melanin synthesis; virulence and pathogenicity in 
fungi; innate immunity 
Peptidylglycine alpha-amidating monooxygenase Peptide amidation/maturation 
Dopamine beta-hydroxylase Noroepinephrine synthesis 
Ceruloplasmin Ferroxidase: Fe loading onto transferrin 
Hephaestin Ferroxidase for ferroprotein-mediated iron efflux 
Lysyl Oxidase Covalent cross-linking of collagens and elastin 
Lysyl Oxidase-like proteins Oxidation of snail transcription factors resulting 
in E-cadherin silencing and promoting EMT 
Coagulation Factors V and VIII Blot clotting 
Nitrous Oxide Reductase Catalyzes reduction of N2O to N2 in 
denitrification pathway of bacteria 
Ethylene Receptor Ethylene signal transduction 
XIAP Inhibitor of apoptosis 
Ace1 S. cerevisiae transcription factor active under 
conditions of high intracellular copper 
Copper Amine Oxidase Deamination of primary amines to aldehyde 	
1.1.4	Cu-responsive	transcription	factors	
Since both Cu excess and Cu deficiency lead to cellular toxicity, the cell quickly 
responds to these circumstances by initiating transcription of proteins that will help mitigate 
the resulting cellular stress. Metal binding activator 1 (Mac1) is a transcription factor in yeast 
that responds to low concentrations of Cu by binding to a Cu responsive element (CuRE) on 
nuclear DNA to promote transcription of Ctr1 and Ctr3 (Nevitt et al, 2012). In contrast, 
Activator of Cup1 expression (Ace1), another Cu-responsive transcription factor in yeast, is 
activated by high concentrations of Cu and promotes transcription of metallothioneins and 
other genes that have roles in antioxidant defense (Nevitt et al, 2012).  
For their activity, Mac1 and Ace1, which are localized to the nucleus, are required to 
bind Cu. Mac1 always has Cu bound and is activated when Cu levels are below a given 
threshold: above the threshold, the enzyme is inactive (Keller et al, 2005). Ace1 behaves 
reciprocally and is activated when Cu levels are high. Metalation of Mac1 and Ace1 and their 
regulation have been shown to be independent of each other (Keller et al, 2005). Even though 
both of these nuclear proteins require Cu for function, no pathway for Cu import into the 
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nucleus has been established and no Cu chaperone for these transcription factors has yet been 
identified. Transcription initiation in response to changing Cu levels in humans is poorly 
understood. A nucleocytoplasmic protein, metal regulatory transcription factor 1 (Mtf1), is 
known to induce transcription of metallothioneins in response to heavy metals and does so by 
binding to a metal responsive element (MRE) on DNA (Saydam et al, 2003).  
1.2	Cu	Related	Diseases		
1.2.1	Historical	context	of	Cu	disorders	
Historically, Cu disorders are classified by an imbalance in cellular Cu concentration. 
Wilson disease (WD) was described by Kinnear Wilson in 1912 and is classified as an 
autosomal recessive disorder (Rodriguez-Castro et al, 2015). WD is caused by a class of 
mutations in Atp7b, the protein responsible for excretion of Cu through the bile duct. 
Minimal function of Atp7b in the liver causes toxic amounts of Cu to build up in both the 
liver and other organs in the body, leading to the disease phenotype.  
Onset of WD happens in early childhood or teenage years and usually presents as a 
liver problem, which is sometimes accompanied by neurological or psychiatric problems. 
The treatment of WD is aimed at chelating Cu so it is no longer toxic, either by induction of 
metallothioneins or with Cu chelating chemicals that aim to prevent Cu absorption into the 
bloodstream (Rodriguez-Castro et al, 2015). In severe cases of WD, liver transplantation may 
be required.  
In contrast to WD, Menkes disease is classified by having a global Cu deficiency in 
the body and is an X-linked recessive disorder caused by mutations in Atp7a. Because Atp7a 
functions to bring Cu from the digestive tract into the bloodstream, mutations lead to poor 
absorption of Cu and result in dysfunction of important cuproproteins (Ohja & Prasad, 2016). 
Menkes disease patients have a life expectancy ranging from 3 months - 3 years; 
disease symptoms usually present between 6 - 8 weeks of life with seizures and neurological 
regression, caused by a Cu deficiency in the brain. Another common symptom of patients is 
kinky hair, which is due to a deficiency in the cuproprotein lysyl oxidase. The most effective 
treatment for these patients is Cu-histidine, which works to get more Cu into the 
bloodstream, but is not always successful as the lifespan of these patients is extremely short 
(Ohja & Prasad, 2016). 
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1.2.2	Implications	of	Cu	defects	in	mitochondrial	and	neurodegenerative	disorders		
More recently, it has been appreciated that imbalance in cellular Cu availability is 
present in a broader scope of diseases. Mutations in Suppressor of Cytochrome Oxidase 
deficiency 1 and 2 (Sco1/2), two inner mitochondrial membrane (IMM) cuproproteins that 
are important for respiratory chain function, have been shown to cause mitochondrial defects, 
and are also correlated with cellular Cu deficiency (Baker et al, 2017b). Because of their role 
in respiration, patients with mutations in Sco1 and Sco2 have severe problems with ATP 
production. While many pedigrees have been mapped to the E140K mutation in Sco2, Sco1 
mutations are more rare and are found throughout the protein sequence (Baker et al, 2017a). 
Interestingly, no mutations in other mitochondrial cuproproteins, such as Cox11 and Cox17, 
have been implicated in mitochondrial diseases. 
Although Sco1 and Sco2 have similar functions, mutations in these proteins lead to 
different clinical phenotypes. Mutations in Sco1 result in hepatopathy, while mutations in 
Sco2 lead to cardiomyopathy, and both types of mutations are associated with 
encephalopathy (Leary et al, 2007). Mitochondrial disease patients are given a mixture of 
non-toxic dietary supplements including coenzyme Q, lipoic acid, and creatine that 
ameliorates symptoms, but there is no definitive evidence of their effectiveness as a treatment 
(Rak et al, 2016). Recently, gene therapy has been more promising for treatment of 
mitochondrial defects. Symptoms of Leber Hereditary Optic Neuropathy (LHON), another 
type of mitochondrial disorder, were reversed in a mouse model by allotropically expressing 
NADH dehydrogenase subunit 4 (ND4) (Cwerman-Thibault et al, 2015). Other treatments for 
mitochondrial disease have been aimed at minimizing oxidative stress, but these are less 
promising as there is no clear evidence that a mitochondrial deficiency is associated with 
increased levels of oxidative stress (Rak et al, 2016). 
Cu homeostasis is also implicated in neurodegenerative disease. Alzheimer’s disease 
(AD) patients have severe memory problems and struggle to complete familiar tasks, which 
is thought to be partially caused by the presence of amyloid beta (aβ) plaques in the brain, 
leading to destruction of nerve connections.  Amyloid precursor protein (APP), which is 
cleaved to form the aβ plaques seen in AD, is important for transport of Cu into the brain 
(Macreadie, 2008). Studies have also shown that changing Cu concentration correlates with 
regulation of aβ folding and regulation (Singh et al, 2013) (Lang et al, 2013). Although many 
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Alzheimer’s drugs have been targeted towards the aβ plaques, none of them have proven to 
be successful in reversal of symptoms. Drug development work for AD is moving towards 
targeting pathways adversely affected in AD brains, such as Cu transport and regulation.  
Similar to AD, amyotropic lateral sclerosis (ALS) is a fatal neurodegenerative disease 
that affects motor neurons in the brain stem, spinal cord, and cortex (Valentine et al, 2005), 
and cells display Cu trafficking defects. While 10% of patients have mutations linked to 
ALS, the other 90% of cases are sporadic. Both familial ALS (FALS) and sporadic ALS 
(SALS) cases have been linked to dysfunction of Sod1, a cuproprotein that plays an 
important role in oxidative stress (Rosen et al, 1993) (Graffmo et al, 2013). More than 150 
mutations in the SOD1 gene have been identified in FALS patients, which all lead to 
presentation of similar clinical phenotypes. These Sod1 mutations are characterized as gain-
of-function because Sod1 KO mouse models did not develop ALS (Reaume et al, 1996) and 
the observation that wild-type Sod1 (wtSod1) on its own can lead to ALS symptoms (Martins 
& English, 2014) (Graffmo et al, 2013). Only one drug, a glutamate antagonist, has been 
approved for ALS treatment and works to extend median survival of ALS patients 
(Georgoulopoulou et al, 2013).  
1.3	Cu	and	Mitochondrial	Function	
The mitochondria are home to two important Cu-containing enzymes: COX and 
Sod1. Therefore, mitochondrial function is greatly influenced by both intracellular and 
extracellular Cu levels. Besides cuproproteins, it is thought that the remaining 70-80% of 
mitochondrial Cu is attached to a non-proteinacious structure, termed the Cu ligand (CuL), 
which exists in the mitochondrial matrix (Cobine et al, 2004). The CuL pool in the matrix 
was shown to be the source of Cu for both COX and mitochondrial Sod1 (mtSod1) (Cobine 
et al, 2006). More recently, work has focused on the impact of mitochondrial cuproproteins 
on broader cellular Cu homeostasis. Overall, it seems that mitochondrial Cu is a central 
signaling point, yet the mechanisms surrounding this hypothesis have yet to be studied in 
detail. 
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1.3.1	Cytochrome	c	Oxidase	(COX)	function	and	assembly	
Located on the IMM, COX is the terminal electron acceptor in the electron transport 
chain and harbours three Cu atoms. COX has two main functions: to reduce molecular 
oxygen and to pump protons into the inter-membrane space (IMS). Oxygen becomes reduced 
as electrons are passed one-by-one from cytochrome c (Cyc1) and proton translocation 
contributes to the mitochondrial electrochemical gradient. The catalytic core of COX is 
extremely hydrophobic and is made of three mitochondrial-encoded subunits (Cox1, Cox2, 
Cox3) that are surrounded by other subunits to form an 11-subunit (yeast) or 13-subunit 
(mammalian) holoenzyme (Timon-Gomez et al, 2018). The catalytic core incorporates two 
Cu centres during the assembly process. The CuA site, located in the Cox2 subunit, contains 
two Cu atoms and is important for accepting electrons from Cyc1. On the other hand, the CuB 
site is incorporated into Cox1 and has a single Cu atom that helps catalyze proton movement 
through the enzyme (Blomberg & Siegbahn, 2014).  
COX assembly is a complex process, with subunits encoded on both genomes and the 
need to coordinate the incorporation of multiple prosthetic groups. More than 40 proteins, 
referred to as assembly factors, are required for generation of the holoenzyme. A big question 
in studying COX assembly has been whether subunits are added in a linear or modular 
fashion. The linear model proposes that subunits are added one-by-one, while the modular 
approach suggests that individual parts are made first and then put together at the end. In 
humans, the most likely scenario according to a recent review is a combination of these two 
theories. Three core entities are assembled individually, each of them containing one of the 
mitochondrial DNA (mtDNA) encoded proteins, and then these are added in a linear fashion 
to create a fully functional COX (Figure 1.2). There is evidence that COX exists as part of a 
respiratory supercomplex and that if a COX monomer were to be incorporated into that 
supercomplex the assembly pathway would change (Timon-Gomez et al, 2018). 	
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Figure 1.2 Proposed pathway for monomeric COX assembly in humans  
Three core entities centered on Cox1, Cox2, and Cox3 are assembled individually and added in a modular 
fashion to form a fully functional COX monomer (Timon-Gomez et al, 2018) 
1.3.2	Delivery	of	Cu	to	Cox1	and	Cox2	
As stated above, COX contains a CuA site in Cox2 that requires two Cu atoms for 
function, and a CuB site in Cox1 that requires one Cu atom for function. The work to 
understand the mechanism of Cu delivery to COX was originally carried out in yeast. Cox17 
was the first protein defined to have a role in Cu delivery to COX due to the finding that a 
Cox17 KO in yeast has a COX defect, which can be rescued with excess Cu (Glerum et al, 
1996a). Cox17 is a small, cysteine-rich protein that is dually localized: 40% exists the 
cytoplasm and the remaining 60% is found in the IMS of mitochondria (Beers et al, 1997). 
Overexpression of either of the homologous transmembrane proteins Sco1 or Sco2 can 
recover the COX deficiency in the yeast Cox17 KO (Glerum et al, 1996b), demonstrating 
that these proteins also play roles in Cu delivery to COX. Additionally, Sco1 and Sco2 are 
able to exchange Cu (Banci et al, 2008) but have non-overlapping functions in COX 
assembly (Glerum et al, 1996b). Thorough characterization of Sco1 led to the hypothesis that 
Sco1 delivers Cu specifically to the CuA site in Cox2 (Beers et al, 2002). The observations 
that Sco1 physically interacts with Cox2 (Lode et al, 2000) and that Sco1 can bind both Cu+ 
and Cu2+ (Timon-Gomez et al, 2018) both provide strong evidence to support this hypothesis.  
Another transmembrane protein, Cox11, was identified to deliver Cu to the CuB site 
in Cox1 based on studying the bacterium Rhodobacter sphaeroides (Hiser et al, 2000). In a 
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R. sphaeroides Cox11 KO, assembly of COX is incomplete because of the lack of CuB, 
indicating that Cox11 is likely responsible for incorporation of this metal centre (Hiser et al, 
2000). Together, Cox17, Sco1, and Cox11 were predicted to transfer Cu in a bucket brigade 
fashion: Cox17 donates Cu to Sco1 and Cox11, which then integrate it into the respective 
sites of COX. This model was justified in vitro when purified Cox17 was able to transfer Cu 
to Sco1 and Cox11 (Horng et al, 2004). The model was also shown to work in the cytoplasm 
of yeast when Sco1 and Cox11 had their mitochondrial targeting signals (MTSs) and 
transmembrane domains removed; they could not obtain Cu unless they were co-expressed 
with Cox17 (Horng et al, 2004).  
The discovery of other COX assembly factors that were suggested to have a role in 
Cu delivery to COX resulted in adjustments to the initial model. Because Cox17 point 
mutants showed a specific loss of Cox2, it was proposed that in the IMS, Cox17 delivered Cu 
to only Sco1 (Punter & Glerum, 2003). More recently, it has been speculated that Cox16 may 
also be involved in delivery of Cu to Cox2 because of its physical interaction with both Sco1 
and Cox2 (Aich et al, 2018). Similar to Cox17, Cox19 and Cox23 also bind Cu and deletion 
of their genes results in an isolated COX deficiency (Nobrega et al, 2002) (Barros et al, 
2004). One proposal is that Cox19 and Cox23 play roles upstream of Cox17 in delivery of Cu 
to COX (Horn & Barrientos, 2008). However, other evidence suggests that Cox19 is only 
involved in delivery to the CuB site because of its redox-based interaction with Cox11 (Bode 
et al, 2015). Alternatively, Cox19 and Cox23 could work together to deliver to the CuB site 
since a mutation in Cox1 rescued the COX deficiency of a Cox23 KO in yeast (Dela Cruz et 
al, 2016). 
Two other proteins, Pet191 and Cmc1, have been thought to have roles in Cu delivery 
to COX due to their ability to bind Cu, their localization to the IMM, and the fact that KO 
strains display a loss in respiratory function. Pet191 is unique because, unlike other 
mitochondrial cuproproteins, it does not use the Mitochondrial IMS import and Assembly 40 
(Mia40) pathway for mitochondrial import (Khalimonchuk et al, 2008). Cmc1 is suggested to 
be involved in regulation of distribution of Cu between COX and Sod1 (Horn et al, 2008). 
There are no clear hypotheses of how they function in conjunction with Sco1, Cox11, Cox17, 
Cox19, and Cox23. 
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1.3.3	Superoxide	dismutase	1	(Sod1)	function	and	assembly	
Sod1 is a 32 kDa homodimeric protein that plays a central role in the management of 
oxidative stress and is dually localized: approximately 10% of Sod1 exists in the IMS of 
mitochondria, with the other 90% existing in the cytosol. The main function of Sod1 is to 
break down superoxide into oxygen and hydrogen peroxide, which reduces cellular oxidative 
stress (Valentine et al, 2005). Breakdown of superoxide by Sod1 has been shown to take 
place in the nucleus, cytosol, mitochondria, and peroxisomes of eukaryotic cells (Wood & 
Thiele, 2009) (Tsang et al, 2014) (Reddi & Culotta, 2013) (Islinger et al, 2009), suggesting 
that Sod1 may also exist in other cellular compartments. Cu lies at the dimer interface of 
Sod1 and is crucial for the catalytic mechanism of dismutating superoxide (Tainer et al, 
1983), participating via a two-step process. In the first step, Cu takes an electron from a 
molecule of superoxide and it becomes oxidized to form molecular oxygen. In the second 
step, Cu donates that electron back to another molecule of superoxide to reduce it to 
hydrogen peroxide (Tainer et al, 1983). Sod1 dimers also contain two zinc (Zn) atoms, which 
were initially thought to be a structural component of this protein, but more recent work 
suggests that Zn is required for Sod1 catalytic activity (Nedd et al, 2014). It is thought that 
the function of mtSod1 is to remove superoxide released by the respiratory chain, although 
this has never been directly demonstrated. Moreover, this is at odds with the fact that Sod2, 
the Mn-Sod located in the mitochondrial matrix, is already well known for this role. Thus, 
the function of mtSod1 continues to be a mystery. 
Folding of Sod1 into the fully metallated homodimer is a complex process due to the 
numerous conformations that immature forms of the protein can exhibit, and it is 
hypothesized that overpopulation of these immature forms leads to formation of the toxic 
aggregates that are observed in ALS (Karch et al, 2009). The fully mature Sod1 homodimer 
(Cu,Zn-Sod1S-S) is extremely stable (Stathopulous et al, 2006) and is formed by non-
metallated (apoSod12SH) molecules maturing through many events that gradually increase 
stability (Furukawa et al, 2004).  A recent report suggests that throughout the maturation 
steps of Cu,Zn-Sod1S-S, the free-energy surfaces (FESs) become smoother, suggesting the 
protein is less likely to aggregate as it matures (Figure 1.3) (Culik et al, 2018). Whether the 
apoSod12SH first binds Zn or makes the intramolecular disulfide bond greatly influences the 
affinity of Ccs1, the Cu chaperone for Sod1, for the dimer. If Zn binds first, the monomers 
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will form a preorganized dimer interface that has a high affinity for Ccs1 binding and Cu 
delivery. However, if the disulfide forms first, the binding with Ccs1 is much weaker. 
Therefore, the protein will preferentially populate the E,Zn-Sod12SH state (addition of Zn 
before formation of disulfide) instead of the apoSod1S-S state (formation of the disulfide 
before addition of Zn) to enhance binding with the Cu chaperone (Culik et al, 2018). In 
addition to helping with the insertion of Cu, there is also evidence that Ccs1 mediates 
intermolecular disulfide bond formation (Fetherolf et al, 2017), however the mechanism for 
this process remains unknown. 
	
Figure 1.3 Two unique pathways for Sod1 maturation 
In the on-pathway, Zn is added to before formation of the disulfide, while the opposite occurs in the off-
pathway (Culik et al, 2018) 
1.3.4	Cu	delivery	to	Sod1	in	the	absence	of	Ccs1	
Although the apoSod1S-S state has a lower affinity for the Ccs1 chaperone, it can still 
be populated by Cu because Sod1 is able to gain the metal independent of Ccs1 (Carroll et al, 
2004) (Sea et al, 2013). A Ccs1-independent pathway was originally discovered for human 
Sod1 (hSod1) and is suggested to happen in a GSH-mediated fashion (Carroll et al, 2004). 
Interestingly, C. elegans has no Ccs1 homolog and must therefore activate Sod1 
independently of Ccs1 (Jensen & Culotta, 2005). S. cerevisiae Sod1 also exhibits a Cu 
acquisition pathway independent of Ccs1, but the mechanism for this remains unclear (Sea et 
al, 2013). Currently, there are no known species in which the activation of Sod1 is 
completely dependent on Ccs1.  
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It is easy to hypothesize that delivery of Cu to Sod1 in the absence of Ccs1 can 
happen via other copper chaperones in the cell, such as Atx1 or Cox17. However, this 
possibility is not likely the case as neither Atx1 nor Cox17 overexpression can rescue the 
Ccs1 knockout phenotype (Carroll et al, 2004). In addition, other COX assembly proteins 
that localize in the mitochondria have not been shown to donate Cu to Sod1 (Kawamata & 
Manfredi, 2008). Two alternate Cu donors that may be involved are GSH, which is suggested 
to be involved in Ccs1-independent activation of hSod1 (Carroll et al, 2004) or the anionic 
Cu ligand in the mitochondrial matrix that is suggested to contain up to 85% of mitochondrial 
Cu (Cobine et al, 2004). This ligand also exists in the cytosol in a mostly non-metallated 
form, but the small proportion that is metallated has potential to donate a copper atom to 
Sod1 (Sea et al, 2013). Overall, the Ccs1-independent pathway for Sod1 intermolecular 
disulfide bond acquisition is poorly understood and requires further investigation. 
1.3.5	Cu	delivery	to	Sod1	in	the	mitochondria	and	cytosol	
The nature of mitochondrial import dictates that proteins entering the mitochondria 
must be unfolded. Therefore, both Ccs1 and Sod1 must enter the mitochondria without Cu, 
since Cu binding requires a protein in its secondary structure. Ccs1 enters mitochondria 
through the translocase of the outer membrane (TOM) and then uses the Mia40/Erv1 import 
relay, where it gains its disulfide bond (Kawamata & Manfredi, 2010). If Sod1 also used the 
Mia40/Erv1 import machinery, then Sod1 would form the disulfide bond before gaining the 
metals, which provides a less effective binding surface for Ccs1 (Culik et al, 2018). 
Alternatively, if Sod1 were to enter mitochondria using TOM and not interact with the 
Mia40/Erv1 system, Ccs1 could mediate both the formation of the disulfide and addition of 
Cu (Figure 1.4). Intracellular partitioning of Ccs1 determines Sod1 distribution between the 
mitochondria and cytosol (Kawamata & Manfredi, 2010), suggesting some Sod1 molecules 
interact with Mia40 and others do not. This is in conjunction with the observation that in a 
Ccs1 KO, Sod1 only enters mitochondria via the Mia40/Erv1 import replay (Varabyova et al, 
2013). The questions still remain: in the absence of Ccs1, how does mtSod1 get Cu? And in 
the presence of Ccs1, how does mitochondrial Ccs1 get its Cu?  
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Figure 1.4 Depiction of Ccs1 and Sod1 import into mitochondria 
In this illustration, Ccs1 mediates formation of the Sod1 disulfide bond, since Sod1 does not interact with the 
Mia40/Erv1 import relay (Kawamata & Manfredi, 2010) 
1.4	Mitochondrial	Cu	Import	
The pathways for Cu delivery to COX and Sod1 have been studied in detail, but the 
starting point for these mechanisms is in the IMS and how Cu is delivered to the IMS is still a 
mystery. With Ctr1 located on the plasma membrane and no free Cu in the cell, there is 
clearly a need for Cu chaperones for delivery of the metal to mitochondria.  
1.4.1	Cu	import	via	a	dually-localized	Cu	chaperone	
Cox17 was first discovered to exist in the cytosol (Glerum et al, 1996a) and was 
proposed to act as a Cu shuttle between the cytosol and IMS (Beers et al, 1997). 
Theoretically, Cox19 and Cox23 can also carry out this role since they are both homologous 
to Cox17. The proposed model is that one of Cox17, Cox19, or Cox23 picks up Cu in the 
cytosol, crosses the outer mitochondrial membrane (OMM), and then delivers Cu to COX via 
Sco1 and Cox11. This also suggests that one of these COX assembly factors is the starting 
point of Cu delivery to Sod1 in the IMS, and can deliver Cu to newly folded Ccs1 once it 
crosses the OMM. 
Once piece of evidence that supports this theory is the fact that Cox17 is thought to be 
involved in cisplatin delivery to mitochondria (Zhao et al, 2014). Cisplatin is a platinum (Pt) 
drug that is used to treat cancer, and is known to cause DNA damage in cancer cells. 
Specifically, the cisplatin mode of action involves its delivery to mitochondria and mutation 
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of mtDNA to induce apoptosis (Wisnovsky et al, 2013). Overexpression of Cox17 with 
cisplatin led to increased apoptosis in cells, suggesting that Cox17 was mediating cisplatin 
deliver to mitochondria. On the other hand, knockdown (KD) of Cox17 led to cisplatin being 
less effective at promoting apoptosis (Zhao et al, 2014). These results are also in conjunction 
with results from the Glerum lab suggesting that Cox17 exhibits pro-apoptotic properties in 
yeast (Dubinski, unpublished). Additionally, cisplatin is found to bind Cox17 at the same site 
in which it binds Cu (Zhao et al, 2014). Taken together, these results support the pathway 
that Cox17 shuttles Cu into the mitochondria. 
If Cox17 did deliver Cu to the mitochondria, then its affinity for Cu should be higher 
in the cytosol than in the IMS. Cox17 carries approximately 0.2 – 0.3 mol of Cu per mol of 
protein, but how this differs between the cytosol and IMS is unknown (Beers et al, 1997).  
Unfortunately, purification of Cox17 is difficult because tagging the protein interferes with 
both its location and its function.  
In 2004, Maxfield et al performed an experiment in which they tethered Cox17 to the 
IMM by fusing the protein to the transmembrane domain of Sco2. Therefore, all Cox17 in 
cells was trapped in the mitochondria. Overexpression of the Sco2/Cox17 fusion protein in a 
Cox17 KO in yeast resulted in complete rescue of COX function, suggesting that Cox17 is 
not needed for delivery of Cu from the cytosol into the mitochondria (Maxfield et al, 2004). 
However, these experiments did not consider that either Cox19 or Cox23 could also be 
compensating for loss of Cox17 function. 
The biggest flaw in the hypothesis that Cox17 shuttles Cu into mitochondria is that 
folded proteins cannot cross the OMM. Cox17, Cox19, and Cox23 are 8 kDa, 11 kDa, and 17 
kDa respectively. In order for them to carry Cu, they must be in a folded state, but there is no 
entry point to the mitochondria that is able to transport folded proteins from the OMM into 
the IMS. Porin 1 (Por1), a β-barrel protein residing in the OMM, is able to transport ions and 
small metabolites. Unless another channel that could transport proteins across the outer 
membrane is discovered, it seems very unlikely that one of these small cuproproteins can 
mediate Cu entry into mitochondria. 
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1.4.2	Cu	is	stored	in	the	mitochondrial	matrix	
The discovery of CuL, which resides mainly in the mitochondrial matrix, led to 
another proposed model by which Cu enters the mitochondria. CuL is thought to contain up 
to 85% of mitochondrial Cu (Cobine et al, 2004) and has been shown to be the source of Cu 
for both mtSod1 and COX (Cobine et al, 2006). In 2013, Phosphate Carrier 2 (Pic2) was 
suggested to be one of the proteins responsible for transport into the mitochondrial matrix 
from the IMS (Vest et al, 2013). A few years later, Mitochondrial RNA splicing factor 3 
(Mrs3), which is also a Fe transporter, was shown to work together with Pic2 to transport Cu 
into the matrix (Vest et al, 2016). In yeast, a double KO of Pic2 and Mrs3 leads to almost 
complete loss of COX activity, suggesting that these proteins have overlapping roles in Cu 
transport (Vest et al, 2016). In humans, SLC25A3 was shown to be orthologous to Pic2, and 
have a redundant role in transporting Cu from the IMS into the matrix (Boulet et al, 2017). 
Therefore, this model of mitochondrial Cu import proposes that Cu entering the mitochondria 
first travels to the mitochondrial matrix with help from Pic2 and Mrs3, and is then pumped 
back into the IMS where it is delivered to Ccs1 and Cox17 for incorporation into mtSod1 and 
COX (Figure 1.5). No method of import from the cytosol into the IMS or from the matrix 
back into the IMS has been proposed to date.  	
	
Figure 1.5 Proposed model of Cu trafficking in mitochondria based on the CuL 
Cu is transported from the cytosol into the matrix with help from the SLC25A3 transporter in mammalian 
systems. In yeast, Pic2 is analogous to SLC25A3 (Baker et al, 2017a). 
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Since the important mitochondrial cuproproteins are located in the IMS and no known 
cuproproteins are known to exist in the matrix, it is difficult to imagine the matrix as a 
storage space for mitochondrial Cu. The big difference between the matrix and the IMS is 
that the mitochondrial matrix has a higher pH, which could be a reason that Cu would be 
stored in the matrix. If this were the case, there would also need to be a mechanism to 
prevent Cox17 and Ccs1 from binding to Cu that is destined for the mitochondrial matrix as 
it travels through the IMS. 
The work surrounding this model of Cu import began with the finding of CuL 
(Cobine et al, 2004). Although an isolation protocol of CuL from cells is defined (Cobine et 
al, 2006), the structure of this non-proteinacious ligand remains unknown. Because CuL 
exists in both the cytosol and mitochondria, it seems likely that Cu will travel through both 
membranes when attached to the CuL.  
Pic2 was initially defined to be a phosphate carrier that transports inorganic 
phosphate (Pi) into the matrix to be used by ATP synthase (Hamel et al, 2004). In fact, the 
discovery of the function of Pic2 was based on its redundancy with the Mitochondrial Import 
Receptor 1 protein (Mir1), which was the first known IMM mitochondrial Pi transporter. 
However, the work defining Pic2 as having a secondary function in Cu transport does not 
investigate whether Mir1 exhibits a similar function (Vest et al, 2013), even though Mir1 is 
the main Pi carrier in the IMM (Hamel et al, 2004). In the same article, the authors defined a 
Pic2 KO to have a minor respiratory defect. Since Pic2 is a phosphate transporter, the 
respiratory defect may be a consequence of a dysfunctional ATP synthase and not necessarily 
a Cu transport problem. Additionally, the Pic2/Mrs3 double KO still displays some COX 
activity, indicative of other Cu transport pathways (Vest et al, 2016).  
1.4.3	Cu	import	via	glutathione	(GSH)	
To enter the mitochondria, Cu must cross the OMM and this could happen via a small 
molecule such as glutathione (GSH). GSH is a three amino acid peptide (Glu-Cys-Gly) and is 
able to bind Cu through the thiol group on its cysteine residue. GSH cannot be synthesized or 
degraded in the mitochondria, since the mitochondrial proteome does not consist of any of 
the enzymes in these pathways (Calabrese et al, 2017). The most likely method of GSH entry 
into mitochondria is through Por1 and Por2, since the net negative charge on GSH restricts 
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passage through lipid bilayers (Calabrese et al, 2017). In the IMS, GSH is known to break 
down hydrogen peroxide to water by a reaction in which GSH becomes oxidized to GSSG, a 
structure in which the thiol groups on two molecules of GSH form a disulfide bond. GSH 
also modulates the Mia40/Erv1 pathway through an interaction with glutaredoxin 2 (Grx2) 
(Kojer et al, 2012) (Figure 1.6). Another important factor is that the GSH to GSSG ratio in 
the cytosol and the IMS is similar, meaning most GSH exists in a reduced state - the state that 
is more likely to bind Cu. The proposed mechanism for this Cu import pathway is as follows: 
(1) GSH is synthesized in the cytosol and obtains Cu from Ctr1 (2) Por1 and Por2 mediate 
GSH-Cu import into mitochondria (3) GSH-Cu located in the IMS transfers Cu to Cox17 and 
Ccs1 as they are imported and folded through the Mia40/Erv1 relay.  	
	
Figure 1.6 Roles of GSH in the mitochondrial IMS  
GSH travels into mitochondria using OMM resident Por1 and is involved with various pathways in the IMS 
(Calabrese et al, 2017). 
 
It has been shown previously that GSH has a large role in Cu entry into the cell 
through Ctr1 (Maryon et al, 2013). Specifically, GSH is though to be an intermediary step 
between Ctr1 and the Cu chaperones Ccs1 and Atox1, strongly suggesting that a GSH-Cu 
complex forms in the cytosol and theoretically could travel into mitochondria. Because GSH 
is thought to enter mitochondria through Por1 and Por2 and a GSH-Cu complex could be the 
source of Cu for mtSod1 and COX, a Por1/Por2 double KO should negatively impact both 
mtSod1 and COX activity. In fact, during the first characterization of Por2 the authors 
reported that a Por1/Por2 double KO does not grow on glycerol, a non-fermentable carbon 
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source, suggesting the strain may have a COX defect (Blachly-Dyson et al, 1997). 
Additionally, our lab has demonstrated that a COX defect is not necessarily associated with 
increased oxidative stress (Dubinski et al, 2018), and the Por1 KO in yeast is associated with 
decreased oxidative stress (Magri et al, 2016). One explanation for the decreased oxidative 
stress in the Por1 KO could be the loss of COX activity, which is caused by limited Cu 
transport into the mitochondria. 
If the GSH-Cu complex does enter mitochondria, it must lose Cu to other 
cuproproteins. Using in vitro affinity measures, it was demonstrated that both Cox17 and 
Ccs1 have much higher affinities for Cu than GSH (Banci et al, 2010), meaning Cu transfer 
from GSH to these cuproproteins is feasible. Another report demonstrated delivery of Pt from 
GSH to Cox17 (Zhao et al, 2015), further supporting that Cu transfer between these proteins 
is possible. However, the mechanism for transfer of Cu from GSH to Cox17 and Ccs1 must 
be preferred in the IMS and not the cytosol. This model proposes a feasible pathway for Cu 
import but there is no direct experimental evidence demonstrating its functionality in vivo. 
1.5	Cu	Homeostasis	and	Cell	Cycle	
1.5.1	Yeast	cell	cycle		
Actively dividing cells undergo the cell cycle, which consists of two important stages: 
DNA replication and cell division. To prepare for these, cells have growth and development 
phases, the Gap1 (G1) and Gap2 (G2) phases (Barnum & O’Connell, 2014). Before 
replication, cells obtain mass and integrate growth signals in the G1 phase, while in the G2 
phase cells organize a newly replicated genome and prepare for chromosome segregation. 
The cyclin dependent kinases (CDKs) are an important protein family that play a central role 
in cell cycle control and are regulated by phosphorylation. On average, it has been recorded 
that a S. cerevisiae cell takes 125 ± 9 minutes to complete one cell cycle (Shaw et al, 1998). 
Progression of the cell cycle is monitored by a series of checkpoints, which are 
activated and interrupt normal progression if cells are unfit. Many of the proteins known to 
be involved in checkpoint activation were originally identified in yeast. One of the central 
players in the S-phase checkpoint pathway in yeast is RADiation sensitive protein 53 
(Rad53), which has functions in both ceasing DNA replication and influencing levels of 
dNTP pools (Jossen & Bermejo, 2013). Rad53 is an effector kinase, which begins a 
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phosphorylation cascade that ends with prevention of the Mini Chromosome Maintenance 2-
7 helicase complex (Mcm 2-7) from unwinding DNA at origins of replication. Rad53 also 
activates ribonucleotide reductase (RNR) after it phosphorylates Crt1, a repressor of the RNR 
complex. Therefore, activation of Rad53 results in halting DNA replication and increasing 
cellular concentrations of dNTPs (Jossen & Bermejo, 2013). In mammalian systems, faulty 
checkpoint pathways can lead to uncontrolled cell growth. p53, which is known for its high 
mutation rates in cancer, plays an important role in checkpoint control; it is a transcription 
factor that activates transcription of the CDK inhibitor p21, which arrests cell cycle 
progression until DNA damage is repaired (Kastan et al, 1992). This explains why mutations 
in p53 promote replication and division in damaged cells and lead to tumor growth.  
Flow cytometry is commonly used to measure cell cycle progression. In this 
approach, cells are arrested in the G1 phase and then released so they all enter the cell cycle 
in a synchronous fashion. Cells are then collected at specific time points and stained with a 
DNA-specific dye, so fluorescence intensity can be measured per cell using a flow cytometer 
(Monje-Casas & Walker, 2017). The intensity for cells that have been synchronized to G1 
phase is considered to be 1N copies of DNA, and cells displaying double the intensity (2N) 
are assumed to be finished replication and preparing for mitosis (Haase & Reed, 2002). By 
reading samples over time, these two peaks will shift and cell cycle progression can be 
monitored (Figure 1.7).  
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Figure 1.7 Monitoring progression of the yeast cell cycle by flow cytometry 
S. cerevisiae cells expressing GFP-Tub1 as a mitotic spindle marker and the flow cytometry profiles expected at 
each phase of the cell cycle (Monje-Casas & Walker, 2017). 
1.5.2	Influence	of	Cu	on	cell	cycle	
If free Cu exists in the cell, the Fenton reaction will lead to formation of reactive 
oxygen species (ROS), which will cause DNA damage. DNA damage is one of the major 
reasons cells will halt reproduction. A recent report shows that loss of function of the 
cuproproteins Sod1, COX, hemocyanin, and plastocyanin all affect the cell response to DNA 
damage, and thereby displaying a biological connection between Cu and cell cycle (Zhang et 
al, 2016).  
Rad53 (yeast) and p53 (mammalian cells) are two important proteins that play central 
roles in DNA damage checkpoints in these eukaryotic organisms, and have previously been 
connected to Cu homeostasis. In yeast, Rad53 is thought to regulate Cu responsive genes 
while other cell cycle proteins such as Mec1, Dun1, and Crt1 are not (Dong et al, 2013). The 
authors describe a novel regulatory relationship between Cu and DNA-damage that also 
involves Sod1 activity. In the presence of DNA damaging agents methyl methanesulfonate 
(MMS) and hydroxyurea (HU), Cu import genes are induced and metallothioneins are 
repressed, suggesting a need for Cu in the presence of DNA damage. Under these conditions, 
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Rad53 senses DNA damage and responds by interacting with active Sod1 to upregulate CTR1 
and other import genes (Dong et al, 2013). This paper proposes a connection between Cu 
homeostasis and cell cycle regulation. 
Similar to yeast Rad53, mammalian p53 is an important protein for regulation of cell 
cycle and when activated, can either activate DNA repair proteins or initiate the apoptotic 
cascade. A relationship was found between p53 and Sco2, a mitochondrial cuproprotein 
required for COX assembly (Turski et al, 2009). There is a canonical p53 binding site on the 
Sco2 promoter, suggesting that Sco2 is produced under stress conditions in healthy cells. 
This fits with the finding that Sco2 is downregulated in some cancers, because p53 is 
normally dysregulated in cancerous cells (Turski et al, 2009).  
Other work has found direct links between cuproproteins and cell cycle progression. 
Atx1 is responsible for Cu transport to the Golgi apparatus in yeast. Interestingly, many cell 
cycle genes were differentially regulated in a transcriptomic analysis of Atx1 KO cells, 
suggesting that Atx1 has a potential role in cell cycle control (Cankorur-Cetinkaya et al, 
2016). Our lab has also found that losing COX assembly factors related to Cu delivery 
correlates with a cell cycle defect, suggesting a relationship between Cu deficiency and cell 
cycle (Camasta, unpublished). 
1.5.3	Other	pathways	connected	to	Cu	homeostasis	
Fe Transport: Interplay between Cu and Fe was first suspected in the 1800s through study 
of hypochromic anemia in Italy and France. Hypochromic anemia patients have lower 
hemoglobin levels, which correspond to a Fe deficiency. However, women working in Cu 
factories did not contract the disease, suggesting that high Cu could compensate for having a 
Fe deficiency (Gulec & Collins, 2014). Mechanistically, Cu is required for hemoglobin 
synthesis in erythrocytes but the process of where this happens and the regulation remain 
unknown (Gulec & Collins, 2014).  
One example of a well-characterized protein that links Fe and Cu metabolism is 
ceruloplasmin, which binds many Cu atoms and is a ferroxidase in serum that helps with 
mobilization of Fe from storage tissues (Sharp, 2004). Low ceruloplasmin activity leads to 
anemia that is recovered by dietary Cu, but not Fe. Hephaestin, a homolog of ceruloplasmin, 
is intracellular and plays a role in Fe efflux from enterocytes and loads Fe onto transferrin, 
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the major Fe transport protein in the body (Sharp, 2004). In humans, dietary Cu and Fe are 
absorbed into the bloodstream through intestinal epithelial cells (IECs) in the duodenum. 
Atp7a, which is involved with transcytosis of Cu, is strongly induced during Fe deficiency 
(Gulec & Collins, 2014). Divalent metal trasporter 1 (DMT1), initially classified for uptake 
of Fe, is also able to take up Cu (Illing et al, 2012). Many questions about DMT1 still 
remain: How does Cu uptake influence the interaction between DMT1 and Fe; does Cu 
uptake only happen during Fe deficiency; and is Cu transport through DMT1 physiologically 
relevant?  
In yeast, Mrs3, a Fe transporter on the IMM, has been described to transport Cu to the 
matrix (Vest et al, 2016). Interestingly, Mrs4, another Fe transporter, does not have the same 
phenotype, meaning that not all Fe transporters can also transport Cu, outside a select few. 
Many other Fe and Cu interactions have been described in yeast and humans but these are 
outside the scope of this overview. 
SUMOylation: Small ubiquitin-like modifiers (SUMO) are a family of proteins that act in 
post-translational modification and covalent linkage to other proteins in order to modify their 
functions. The pathways involved in SUMOylation of proteins are similar to those of 
ubiquitination; however, SUMOylated proteins are not always targets for degradation 
(Lumpkin et al, 2017).  
Addition of the SUMO modification to target proteins requires the E3 ligase class of 
enzymes. One of these enzymes, SAP and mIZ finger domain protein 1 (Siz1), is thought to 
connect Cu homeostasis to SUMOylation (Chen et al, 2011). In Arabidopsis thaliana, Siz1 
KO plants are hypersensitive to excess Cu and display decreased amounts of SUMOylated 
proteins compared to a healthy plant. This led to the finding that the Yellow-Stripe 1-Like 
(YSL) genes YSL1 and YSL3 genes are involved in Cu-induced SUMOylation, and the Siz1 
KO displays lower levels of SUMO because it is unable to downregulate these genes (Chen 
et al, 2011).  
At a protein level, some cuproproteins are also SUMOylated and have alternate 
functions. The Cu chaperone Atox1 is translocated to the nucleus when it is SUMOylated and 
is thought to act as a transcription factor (Itoh et al, 2008). SUMOylation of Atox1 is also 
necessary for its interaction with TNF-receptor associated factor 4 (TRAF4), which relies on 
Cu (Das et al, 2016 conference proceeding). Sod1 is also thought to be SUMOylated on 
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Lys75 and this modification is thought to play a role in stability and aggregation in ALS (Fei 
et al, 2006). 
A recent study of SUMOylation in the yeast mitochondrial proteome revealed that 
many COX subunits and assembly factors, which rely on Cu for function, are SUMOylated 
(Paasch et al, 2018). Additionally, the authors found that Mia40, a protein responsible for 
import of several cuproproteins, is also SUMOylated. Because depleting proteasomal 
function led to an increase in SUMOylated mitochondrial proteins, the authors predicted that 
the SUMO modification on this subset of mitochondrial proteins is likely a marker of non-
functional proteins and may result in their degradation (Paasch et al, 2018). 
 
Apoptosis: Cu binding directly influences activity of X-linked inhibitor of apoptosis (XIAP), 
an anti-apoptotic protein (Mufti et al, 2007). Specifically, activated XIAP binds to and 
inhibits pro-apoptotic caspases; Cu binding inactivates the protein (Mufti et al, 2007). Since 
XIAP helps to promote apoptosis in conditions of excess Cu and exhibits different affinities 
for Cu+ and Cu2+ (Liang et al, 2014), it has been proposed to act as a Cu sensor. In 
conjunction with this, XIAP helps regulate ubiquitination and degradation of Copper 
Metabolism Domain Containing protein 1 (COMMD1), known to increase Cu efflux from 
the cell (Mufti et al, 2007).  
It has also been proposed that XIAP gains its Cu from Ccs1, and interaction that was 
found by looking at the E3 ubiquitin ligase activity of XIAP (Brady et al, 2010). 
Interestingly, when XIAP ubiquitinates Ccs1, the Cu chaperone for Sod1, Cu delivery from 
Ccs1 to Sod1 becomes more efficient (Brady et al, 2010). Although XIAP is a direct 
connection between Cu and apoptosis in humans, there is no XIAP ortholog in yeast 
(Carmona-Guterriez et al, 2012). 
1.6	Goals	of	this	Study	
Even though mitochondria are well known for their role in energy production, it is 
now appreciated that they also are a central point for many other pathways. For example, 
they are an important part of a signaling cascade in apoptosis when cytochrome c is released 
into the cytosol and are responsible for synthesis of Fe-S clusters, which are an important 
structural motif in a large subset of proteins (Alberts et al, 2015).  
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Mitochondrial cuproproteins have also been thoroughly studied and have recently 
been found to have ancillary roles in other cellular pathways. In 2005, when the crystal 
structure of Sco1 revealed a thioredoxin-like fold, hypotheses pointed to a potential 
secondary role of Sco1 and Cox11 in redox metabolism (Williams et al, 2005). There is no 
defined function for the 40% of Cox17 that resides in the cytosol, since it is unlikely a Cu 
shuttle between the cytosol and mitochondria. Finally, although Sod1 is known to break 
down superoxide, it is known that only 2% of Sod1 molecules in the cell are carrying out this 
role (Corson et al, 1998), posing the question for how the other 98% of Sod1 molecules are 
functioning.  
In the past years, our lab has described a cell cycle defect in yeast strains missing 
Cox17, Sco1, or Cox11, and we think this problem is related to a Cu imbalance. Therefore, 
we undertook this study to more closely investigate how Cu availability impacts 
mitochondrial function. We hypothesize that mitochondrial cuproprotein pools are affected 
by changes in Cu availability and this leads to cell cycle defects. To approach this, we 
studied how mitochondrial cuproproteins respond to differences in levels of extracellular Cu 
and examined if and how a generalized Cu problem impacts cell cycle progression. We find 
that mitochondrial cuproprotein pools are majorly impacted by changes in Cu availability but 
this does not always correlate with a cell cycle defect.  
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Chapter	2:	Materials	and	Methods		
2.1	Yeast	Strains	&	Maintenance	
Table 2.1 Yeast Strains used in this study. 
Strain Genotype Source 
W303 MAT a, ade2-1, his3-1,15, leu2-3,112, trp1-1, ura3-1 Glerum lab 
W303Δcox17 MAT a, ade2-1, his3-1,15, leu2-3,112, trp1-1, ura3-1, COX17::TRP1 Glerum lab 
W303Δsco1 MAT a, ade2-1, his3-1,15, leu2-3,112, trp1-1, ura3-1 SCO1::URA3 Glerum lab 
W303Δcox11 MAT a, ade2-1, his3-1,15, leu2-3,112, trp1-1, ura3-1 COX11::HIS3 Glerum lab 
W303Δcox4 MAT a, ade2-1, his3-1,15, leu2-3,112, trp1-1, ura3-1 COX4::URA3 Glerum lab 
W303Δcox15 MAT a, ade2-1, his3-1,15, leu2-3,112, trp1-1, ura3-1 COX15::HIS3 Glerum lab 
W303 ρ° MAT a, ade2-1, his3-1,15, leu2-3,112, trp1-1, ura3-1 Glerum lab 
KL14 ρ° MAT α, met-6 Glerum lab 
CB11 ρ° MAT a, ade-1 Glerum lab 
EG103 MAT α, his3-1,15, leu2-3,112, trp1-1, ura3-1, gal+ Edith Gralla & Joan Valentine 
EG103 MAT a, his3-1,15, leu2-3,112, trp1-1, ura3-1, gal+ This study 
EG118 MAT α, his3-1,15, leu2-3,112, trp1-1, ura3-1, SOD1::URA3 Edith Gralla & Joan Valentine 
EG118 MAT a, his3-1,15, leu2-3,112, trp1-1, ura3-1, SOD1::URA3 This study 
BY4741 MAT a, his3Δ0, leu2Δ0, met15Δ0, ura3Δ0 Glerum lab 
 
Table 2.2 Media used in this study. 
Media Components Application 
YPD 1% yeast extract, 2% peptone, 2% dextrose 
General S. cerevisiae growth medium 
YPGal 1% yeast extract, 2% peptone, 2% galactose 
General S. cerevisiae growth medium 
EG 1% yeast extract, 2% peptone, 2% ethanol, 2% glycerol 
Medium containing non-fermentable carbon 
sources, for testing mitochondrial defects 
WO 0.67% nitrogen base without amino acids + (NH4)2SO4 , 2% glucose 
Minimal growth media, for strain verification 
KAc 1% potassium acetate, 0.05% glucose Sporulation media 
 2% agar added to any media to make plates 
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Every 4 months, frozen yeast strains were patched onto YPD plates from an -80°C 
stock and then restreaked onto a fresh YPD plate. Replica plating was performed on WO 
media to confirm strains had the correct auxotrophies (0.5 mg of each amino acid per plate), 
and strains were also mated with either KL14 or CB11 to confirm colonies were ρ+. Strains 
were stored on YPD plates at 4°C for up to 4 weeks and then restreaked on new plates. Note: 
The EG118 strain requires methionine and lysine supplementation to grow on minimal media 
(Liu et al, 1992). 
2.1.1	Mating	and	sporulation	
EG103 and EG118 (MAT α) were mated with W303 (MAT a) to form diploid patches 
on YPD. Auxotrophies of diploid patches were verified by replica plating onto WO, then 
diploids were replica plated onto KAc and incubated at RT until tetrads were visible under 
the microscope (7 days). Glusulase (15 µL) was added to 1 mL of sterile dH2O containing a 
loopful of spores and incubated at RT for 15 mins, followed by washing twice in sterile dH2O 
and resuspension in 1 mL of dH2O. 50 µL of spores (1:100 dilution) were plated onto WO 
plates to select for colonies with the correct genotype. After this, 150 colonies with the 
correct genotype were patched onto YPD and verified for mating type (MAT a) by replica 
plating onto WO + 200 µL of an overnight KL14 culture (for EG118, also added 0.5 mg of 
Met). Colonies with the correct mating type and genotype were further verified for ρ° status 
and frozen down at -80°C. 
2.2	Treatment	with	Cu	Availability	Reagents			
Yeast strains from YPD plates were inoculated into 10 mL or 100 mL of YPD or 
YPGal and grown overnight at 30°C and 230 rpm. The next day, cultures were checked for 
contamination and optical density was measured at 600 nm (OD600). For our experiments, we 
assumed that an OD600 of 1.0 corresponded to 1 x 107 cells/mL. All cultures were diluted in 
fresh YPD or YPGal to a density of 1 x 106 cells/mL followed by addition of Cu availability 
reagents. Copper sulphate (CuSO4) was diluted from a filter-sterilized 10% stock solution 
and bathrocuproine disulphate (BCS) was made fresh every experiment as a 50 mM stock 
and filter sterilized. After addition of Cu availability reagents, cells were incubated in the 
dark for 18 hours and then collected for subsequent analyses.  
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2.3	Cell	Viability	
2.3.1	Spot	plate	assays	
Overnight cultures of yeast strains were adjusted to a cell concentration of 107 
cells/mL and then serially diluted (100 – 10-4) in sterile dH2O. Dilutions (5 µL) were spotted 
onto YPD plates and incubated at 30°C for 1 day. Patches were replica plated onto either 
YPD or EG plates with CuSO4 (0.01 – 0.4 %), BCS (10 µM – 5mM), or HU (50 – 100 mM) 
and incubated in the dark at 30°C for 2 days then scored for growth. 
2.3.2	Trypan	blue	staining		
W303 cultures were treated with Cu availability reagents as described above (Section 
2.2). Cells were then diluted (1:1) with 0.4 % Trypan blue solution (Sigma-Aldrich, Oakville, 
Canada) and visualized and counted under the microscope with a hemacytometer. At least 10 
of the 25 sections on the hemacytometer were counted for each condition, and cells were 
classified as viable for their ability to exclude Trypan blue. Viability was scored as a 
percentage by dividing the number of viable cells by the total cells counted. 
2.4	Suppressor	Screen	
The suppressor screen was performed to isolate mutants that were able to grow on a 
non-fermentable carbon source (EG) with 500 µM BCS (Figure 4.6). 105, 106, or 107 cells of 
an overnight W303 culture were plated onto EG plates containing 500 µM BCS and 
incubated in the dark at RT for 15 days. Four colonies were classified as suppressors: they 
were patched onto YPD plates and then restreaked onto YPD to isolate single colonies. 
Colonies were checked for the correct auxotrophies and stored at -80°C.  
To verify colonies were able to grow on EG + BCS, the W303 strain and the 
suppressors were streaked onto YPD, and then replica plated onto EG with BCS 
concentrations ranging from 10 µM – 1 mM. EG plates were incubated for 2 days at 30°C in 
the dark and growth of suppressors was compared to the W303 strain. 
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2.5	Subcellular	Fractionations	
For subcellular fractionations, protein concentrations were determined using the 
Folin-Ciocalteu reagent (Lowry et al, 1951). Before concentration determination, whole cell 
lysate samples were diluted 1:40, post-mitochondrial supernatant (PMS) samples were 
diluted 1:50, and mitochondrial samples were diluted between 1:100-1:120.  
2.5.1	Whole	cell	lysate	(WCL)	preparation	
Mitochondrial mutants and the W303 strain were grown in the presence or absence of 
Cu availability reagents as described above (Section 2.2). Cells (40 mL) were harvested and 
resuspended in lysis buffer (10 mM Tris-HCl pH 8.0, 1% Triton-X-100, 1 mM EDTA, 1 x 
Protease inhibitor cocktail, 1 mM PMSF, 140 mM NaCl) at a ratio of 0.8 g of cells to 1 mL 
of lysis buffer. Cell suspensions were transferred to tubes containing 0.5 mm glass beads 
(beads made up 25% of tube volume) and lysed using the BioSpec Mini-Beadbeater-24 
(ThermoFisher Scientific, Mississauga, Canada). Lysing consisted of 8 cycles of 30 seconds 
in the bead beater and 30 seconds on ice. After lysis, homogenates were incubated on ice for 
5 minutes and then centrifuged at 16,000g (1 minute, RT). The supernatant (whole cell 
lysate) was aliquoted and stored at -80°C.  
2.6.2	Isolation	of	mitochondria		
Mitochondria and PMS (cytosolic) fractions were prepared using differential 
centrifugation as described previously (Banting & Glerum, 2006). Cells were collected from 
800 mL of media and incubated in digestion buffer (1.2 M sorbitol, 75 mM NaPi pH 7.5, 1 
mM EDTA, 1% β-mercaptoethanol, 9.9U/mL zymolyase) for 160 minutes (untreated) or 120 
minutes (Cu-treated) followed by washing in 1.2 M sorbitol and resuspension in 4 mL STE 
(0.5 M sorbitol, 20 mM Tris pH 7.5, 0.5 mM EDTA) per gram of wet weight. 
Homogenization of cells was done using a Waring blender (20 seconds) or Dounce 
homogenizer (35 strokes) and homogenates were treated with 1 mM PMSF. Differential 
centrifugation was carried out by a low speed spin at 1500g (10 minutes, 4°C) and high-
speed spin at 17,000g (15 minutes, 4°C). After the first high-speed spin 5mL of supernatant 
were collected and saved as the cytosolic fraction. Mitochondrial pellets were then washed 
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twice (20,000g, 15 min, 4°C) with 40 mL STE and resuspended in 200 µL of 10 mM Tris pH 
7.5. Mitochondrial and PMS fractions were aliquoted and stored at -80°C. 
2.7	RNA	Isolations	
RNA was isolated using the Geneaid Yeast Total RNA Kit (Geneaid Biotech, Taipei, 
Taiwan). After treatment with Cu availability reagents (Section 2.2), 1.5 mL of culture was 
transferred to a 1.5 mL RNase-free tube and digested for 30 minutes with 200 U of 
zymolyase. Cells were lysed and transferred to a column where they were treated 
immediately with DNAse according to the manufacturer’s instructions. Columns were 
washed once in wash buffer and twice in 70% ethanol before RNA was eluted into 50 µL of 
RNAse free water. All RNA samples were measured with a Nanodrop 3300 (Thermo Fisher, 
MA, USA) to determine their concentrations. 
RNA Gels: RNA was run on agarose gels before cDNA synthesis to determine integrity. All 
glassware and lab materials used were treated with 0.1% DEPC for 12 hours and then 
autoclaved. Gel electrophoresis equipment was soaked in 3% hydrogen peroxide overnight. 1 
µL of ethidium bromide (1 mg/mL) was added to 500 ng of RNA (diluted in RNase-free 
dH2O to a final volume of 10 µL) and loaded onto a 1% agarose gel in 1X MOPS buffer 
(0.2M MOPS, 0.05M sodium acetate, 0.01M EDTA). Gels were run for 90 minutes at 80V 
then visualized with UV light.  
2.8	Quantitative	PCR	(qPCR)	
2.8.1	Nuclear	DNA	(nDNA)	preparation	and	primer	optimization		
Optimization of primers was performed by running PCR on nuclear DNA (nDNA) 
and confirming the presence of a single product at the correct molecular weight. nDNA was 
isolated with the QIAGEN Genomic DNA Kit (QIAGEN, Hilden, Germany). 20 mL of 
W303 cells were harvested (5,000g, 5 min, RT) and digested with zymolyase (250 U), lysed, 
and treated with RNase A (100 mg/mL stock) and Proteinase K (20 mg/mL stock) before 
being transferred to a column according to the manufacturers instructions. Columns were 
washed twice and DNA was eluted into 5 mL of the Qiagen elution buffer. DNA was 
collected by addition of 3.5 mL isopropanol and centrifugation (10,000g, 15 min, 4°C) and 
resuspended in 50 µL dH2O. DNA was precipated by addition of 100% ethanol (7 volumes) 
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and sodium acetate (3M stock, 40 µL) and incubated at -20°C for 30 minutes. DNA was 
collected by centrifugation (16,000 g, 1 min, RT) and excess ethanol was removed using a 
speed vacuum. The final DNA pellet was resuspended in 50 µL TE (10 mM Tris pH 7.5, 1 
mM EDTA) and measured with the Nanodrop 3300 (Thermo Fisher, MA, USA). 
Primers were designed using NCBI PrimerBLAST. nDNA (50 – 500 ng) was subject 
to PCR using 13 sets of primers (Table 2.3) on the PTC-200 machine (GMI Laboratory 
Solutions, MN, USA) to confirm the correct product and to optimize annealing temperature. 
The PCR mixture contained primers (200 nM each), Taq polymerase (0.125 µL, Invitrogen), 
dNTPs (200 nM), 10X PCR buffer (Invitrogen), and MgCl2 (1.5 mM) PCR cycles were as 
follows: (1) 95°C, 4 minutes (2) 95°C, 20 s (3) 53 – 60°C, 30 s (4) 68°C, 2 minutes (5) Go to 
2, 39X (6) 68°C, 2 minutes. PCR products (2 – 5 µl) were run on 1% agarose gel in 1X TBE 
buffer (tris, boric acid, EDTA) for 60 minutes at 100V then visualized with UV light. 
 
Table 2.3 Primers used in this study 
Sequences are listed from 5’ to 3’. 
Target Primer Sequences Product Length 
ACT1 CTGCCGGTATTGACCAAACT CGGTGATTTCCTTTTGCATT 144 bp 
CCS1 TGACCACGAACGATACATAC CACGCTCATTATTTGTTGCT 143 bp 
COX4 ATTGGTCCTGGTGCTAAAGAGGG CCCTCCCTGGACGAATCTAATGG 135 bp 
COX11 CCTGAGATGAATGCAGATGA TGAGTTGTCTTTCCTTGTGT 90 bp 
COX17 GAGTGCGAGGACAAACCTAAGCC CGAAGCCATAACCCTTCATGCAC 160 bp 
CTR1 GCAGCATGAATATGGACGCC TTGACGACATAGTCGACGCC 177 bp 
CUP1 CATGTAGCTGCCCAACGG CATTTCCCAGAGCAGCATG 94 bp 
CUP2 CAATCTTGATTTGGCTTCCC TATATGCGCTTCCTGTTTCA 92 bp 
MAC1 AACACTCTCCCAAAGCTCCG ATAGGCTCCTGTTGAAGCCG 106 bp 
PIM1 CATCCAGTCGATCGGATTCT AATAAGGGCCGTCTGGCTAT 112 bp 
SCO1 CTGAAGTTGTCAAGAAGTGC CTGCTTAATGGTTTCTTGCC 146 bp 
SOD1 AACGTGGGTTCCACATTCAT CACCATTTTCGTCCGTCTTT 156 bp 
TDH2 CCATGGGCTTCTCTAAACA GCGTTGGAAACAATCTTCAA 194 bp 
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2.8.2	cDNA	synthesis		
Synthesis of cDNA from total RNA was performed using the SensiFAST cDNA 
synthesis Kit (Froggabio, Toronto, Canada). RNA (1 µg), 5X TransAmp buffer (4 µL), and 
reverse transcriptase (1 µL) were used to synthesize cDNA on the CFX96 Real-Time PCR 
Detection System (BioRad Laboratories, Mississauga, Canada) with the following cycles: (1) 
25°C, 10 minutes (2) 42°C, 15 minutes (3) 85°C, 5 minutes.  
2.8.3	RT-qPCR	
All qPCR reactions were performed with the Ssofast EvaGreen Supermix (BioRad 
Laboratories, Mississauga, Canada). Reactions consisted of cDNA (50 ng), primers (50 nM), 
and the 2X EvaGreen master mix. Each reaction was done in technical triplicate and for 
every set of primers a negative control without cDNA was also run in technical triplicate. 
qPCR cyc;es were as follows: (1) 95°C, 30 s (2) 95°C, 5 s (3) 60°C, 5 s (4) 55°C – 57°C, 15 s 
(5) Plate read (6) Go to 2, 39X, (7) 65°C – 95°C 0.5s/cycle, plate read. Reactions were 
monitored on the CFX96 Real-Time PCR Detection System and Cq values were obtained 
using the CFX Manager Software (BioRad Laboratories, Missisauga, Canada). Data was 
omitted if the Cq value of the negative control was below 35 cycles. An example qPCR curve 
is shown in Figure 2.1. 	
	
Figure 2.1 Sample qPCR curve 
The blue lines represent the amplification curves for a gene of interest. Y-axis is the relative fluorescence units 
(RFU) and the x-axis is the cycle number. 
2.8.4	Analysis	&	Statistics	
All qPCR data is presented as the relative fold change (ΔΔCq) of the gene of interest 
compared to the ACT1 control gene. To obtain the ΔΔCq value, the differences of Cq values 
	 34 
between the gene of interest and the ACT1 control in the no treatment condition and the 
treatment condition (i.e 0.1% Cu) were calculated and further analyzed according to the 
method by Livak & Schmittgen (2001). The ΔΔCq values for treatment conditions were 
compared to the wild type value using a one-way ANOVA (Microsoft Excel). Statistically 
significant values were further tested through performing a Tukey HSD test to determine 
which treatment conditions were significant from the no treatment control. 
2.9	Western	Blotting	
2.9.1	SDS-PAGE	and	Western	blotting	
Protein samples (mitos: 25 µg, cytosol: 25 µg, WCL: 60 µg) were diluted in Tris (10 
mM pH 6.8) and 1 µL of 100 mM PMSF was added immediately. Samples were then 
solubilized in 4X loading buffer (4% SDS, 4% β-metcaptoethanol, 40% glycerol, 200 mM 
Tris pH 6.8, 0.08% bromophenol blue) and loaded into a gel (10% gel for Rad53 blots, 12% 
gel for all others). Samples were not boiled if the following Western blot was for detection of 
a membrane protein. All other samples were boiled at 95°C for 5 minutes and loaded 
immediately. Gels were run for 70 minutes at 150V.  
The Transblot Turbo transfer system (BioRad Laboratories, Mississauga, Canada) 
was used to transfer proteins onto nitrocellulose membranes. Prior to transfer, membranes 
and gels were soaked in transfer buffer (20% Transblot turbo buffer, 20% ethanol) for 30 
seconds. If the size of the protein of interest was below 50 kDa, the Low MW setting (5 
minutes) was used; otherwise the high MW setting was used (10 minutes).  
Membranes were stained with Ponceau S (2% Ponceau S, 30% TCA, 30% 
sulfosalicylic acid) for 5 minutes on the rocker (Setting 4), rinsed with dH2O and imaged to 
ensure equal loading. Membranes were incubated with blocking buffer (10 mM Tris pH 8, 1 
mM EDTA, 150 mM NaCl, 0.1% Triton-X-100, 1.5% milk) for 1 hour (RT) then treated with 
primary antibodies diluted with blocking buffer (see Table 2.4) for 1 hour (RT). Following 
this, membranes were washed three times in blocking buffer without milk (10 minute 
washes), and treated with secondary antibodies diluted in blocking buffer (see Table 2.4) for 
1 hour (RT). Membranes were then washed three times with secondary wash solution (10 
mM Tris pH 8, 1 mM EDTA, 1 M NaCl, 0.1% Triton-X-100) and rinsed in dH2O before 
imaging. Immediately prior to imaging, membranes were incubated with 500 µL ClarityTM 
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(BioRad Laboratories, Mississauga, Canada) in the dark for 2 minutes. Imaging was done 
using a ChemiDoc MP (BioRad Laboratories, Mississauga, Canada). 	
Table 2.4 List of antibodies used in this study 
Primary Antibodies 
Antigen Host Clonality Dilution Source 
α-Aco1 Rabbit Polyclonal 1:1000 Bulteau lab 
α-Act1 Mouse Monoclonal 1:1000 Thermo Fisher 
α-Cox2 Mouse Monoclonal 1:1000 Abcam  
α-Cox4 Mouse Monoclonal 1:1000 Abcam  
α-Cox11 Rabbit Polyclonal 1:500 Glerum lab 
α-Cox17 Rabbit Polyclonal 1:500 Glerum lab 
α-Cyc1 Rabbit Polyclonal 1:400 Promokine 
α-DNP Rabbit Monoclonal 1:150 Thermo (Oxyblot)  
α-Lon Rabbit Polyclonal 1:1000 Suzuki lab 
α-Por1 Mouse Monoclonal 1:10,000 Molecular Probes 
α-Rad53 Rabbit Polyclonal 1:1000 Abcam 
α-Rnr3 Rabbit Polyclonal 1:500 Antibodies online 
α-Sco1 Rabbit Polyclonal 1:500 Glerum lab 
α-Sdh2 Rabbit Polyclonal 1:1000 Lemire Lab 
α-Sod1 Rabbit Polyclonal 1:500 Antibodies online 
Secondary Antibodies 
α-mouse IgG Goat Polyclonal 1:5000 - 1:10,000 Thermo Fisher 
α-rabbit IgG Goat Polyclonal 1:300 -1:10,000 Abcam  	
2.9.2	Analysis	
Raw data from Western blots was processed and analyzed using the ImageLab 
software Version 5.2.1. Densitometry was performed on Western blots where the signal for 
the no treatment control was clear. For the analysis, the relative intensity of the control was 
compared to the intensity of the bands for the treatment conditions. If the protein of interest 
was more different from the no treatment sample than the control protein (Por1 for mitos, 
Act1 for cytosol and WCL), the protein of interest was considered to be significantly 
different in that treatment condition.  
2.9.3	Oxyblot	
To assess oxidative modification of proteins, the EMD Millipore Oxyblot Protein 
Oxidation Detection Kit (Fisher Scientific, NH, USA) was used according to the 
manufacturer’s protocol. Protein samples (mitos & cytosol: 25 µg, WCL: 20 µg) were diluted 
in 10 mM Tris pH 7 (5 µL final volume) in duplicate and denatured with SDS (6%). 
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Carbonyl groups were modified after addition of derivitization solution (10 µL) and 
incubation at RT for exactly 15 minutes. The derivitization control solution (10 µL) was 
added to the second tube and treated in the same manner. After derivitization, neutralization 
solution (7.5 µL) and 4X loading buffer (9.2 µL) were mixed with protein samples and the 
solution was loaded into a 12% polyacrylamide gel. Gels were run at 100V for 120 minutes 
and transferred onto nitrocellulose using the Transblot Turbo System (described above) using 
the High MW setting (10 minutes). Blocking and antibody incubation were performed as 
described above, except the blocking buffer (1X PBS, 0.05% Tween, 1% BSA) and rinse 
buffer (1X PBS, 0.05% Tween) were different. Blots were imaged as described above using 
the ChemiDoc MP (BioRad Laboratories, Mississauga, Canada). 
2.10	Enzyme	Activity	Assays	
2.10.1	COX	activity		
COX activity was measured qualitatively using TMPD and quantitatively using a 
spectrophotometric assay. For the qualitative method, colonies from agar plates were 
permeabilized onto Whatman filter paper and briefly soaked in potassium phosphate buffer 
(0.04 M KPi pH 6.7, 0.05% Tween-20). Rewetted filter paper was treated with 1 mL of 
TMPD solution (1% TMPD in DMSO) for 5 minutes and colonies with COX activity formed 
a purple precipitate (McEwen et al, 1985). 
COX activity was measured spectrophotometrically by recording the decrease of 
reduced cytochrome c at 550 nm for 60 seconds (Tzagoloff et al, 1975). Cytochrome c was 
reduced using a few crystals of sodium dithionite. Immediately prior to reading absorbance, 
10 µL of mitochondrial protein was solubilized with 1% deoxycholate (DOC) for 20 seconds 
and added to a cuvette containing 0.92 mL KPi buffer  (20 mM KPi pH 7) and 80 µL reduced 
cytochrome c (10 mg/mL in 20 mM Tris pH 7.5). To calculate specific activity, Beer’s law 
was used with the reduced cytochrome c extinction coefficient (28 mM-1 cm-1). Significance 
was calculated by using a one-way ANOVA followed by a Tukey HSD test. 
2.10.2	SOD	activity		
SOD activity was measured in mitochondrial (24 µg protein) and cytosolic (48 µg 
protein) fractions using zymographic analysis as described previously (Beauchamp & 
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Fridovich, 1971). Protein fractions were diluted to 12 µL in Tris buffer (200 mM Tris pH 
6.8), treated with 1 µL PMSF (100 mM) and 6 µL loading dye (250 mM Tris pH 6.8, 50% 
glycerol, 0.02% bromophenol blue), and run on a 10% non-denaturing polyacrylamide gel. 
Gels were incubated in the dark with NBT solution (2% nitroblue tetrazolium in 50 mM KPi 
pH 7) and riboflavin solution (0.02% riboflavin in 36 mM KPi pH 7) followed by 
development in the light for 1 hour. Imaging was done using white light in a BioRad 
ChemiDoc MP (Bio-Rad Laboratories, Mississauga, ON, Canada), and quantification was 
performed on the ImageLab 6.0.1 software (Bio-Rad Laboratories, Mississauga, ON, 
Canada) by comparing relative abundance of bands. 
2.10.3	Aconitase	activity	
Aconitase activity was assayed as described by Bulteau et al (2005). Mitochondria 
(10 µL) were solubilized with 25 mM KH2PO4 pH 7.5 containing 0.05% Triton X-100 (10 
µL) and added to 990 µL of assay buffer (10 mM KPi pH 7.5, 1 mM trisodium citrate, 0.6 
mM MnCl2, 0.5 mM NADP+, 0.05% Triton-X-100). Activity was measured by observing 
NADP+
 
reduction at 340 nm for 2 minutes after addition of isocitrate dehydrogenase (1.0 
U/reaction). Specific enzyme activity was calculated using the NADPH extinction 
coefficienct (6.2 mM-1 cm-1). Significance was calculated by using a one-way ANOVA 
followed by a Tukey HSD test. 
2.11	Cell	Cycle	
2.11.1	Sample	preparation	
Cultures were treated with Cu availability reagents as described above (Section 2.2). 
2 x 107 cells were harvested (2,000g, 3 minutes, RT), washed in sterile dH2O, and 
resuspended in fresh YPD (20mL). Alpha factor (10 µg/mL) and Cu availability reagents 
were added and cultures were incubated for 3 hours in the dark (30°C, 230 rpm). Visualizing 
cells under the microscope and seeing the “schmoo” morphology ensured successful arrest. 
Cells were harvested (2,000g, 5 minutes, RT), washed twice in pre-warmed YPD (20 mL), 
and resuspended in YPD (20 mL) with pronase (10 µg/mL) and Cu availability reagents. 
Cells were then incubated (30°C, 230 rpm) so they would enter the cell cycle synchronously. 
At 0, 40, 80, and 120 minutes after release cells (1.5 mL) were collected; at the 0 minute time 
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point two aliquots were collected and one served as the negative control. At each time point, 
cells were immediately washed in 1mL dH2O (20,000g, 1 minute, RT), fixed in 1 mL of 70% 
ice cold ethanol, and stored at 4°C overnight. 
Fixed cells were harvested (20,000g, 1 minute, RT), washed in dH2O (500 µL), 
resuspended in 500 µL RNase A solution (0.80 µg/mL RNase A in 50 mM Tris pH 8) and 
incubated for 3 hours at 37°C. This was followed by an incubation with 500 µL Proteinase K 
solution (0.25 mg/mL Proteinase K in 50 mM Tris pH 7.5) at 50°C. Cells were collected 
(20,000g, 1 minute, RT), resuspended in 500 µL of the flow cytometry buffer (200 mM Tris 
pH 7.5, 200 mM NaCl, 78 mM MgCl2, 1 µM SYTOX green), and transferred to BD Falcon 
tubes (BD Biosciences, Mississauga, Canada). For each sample, a negative control was 
prepared in the same buffer without SYTOX green. 
2.11.2	Flow	cytometry	parameters	
DNA content analysis was performed using the BD FACS Aria Fusion flow 
cytometer (BD Biosciences, Mississauga, Canada). Immediately prior to analysis, samples 
were vortexed for 10 seconds. The wild type negative control (unstained) and 0-minute time 
point sample (SyTOX stained) were used to set up parameters on the 488 nm laser, which 
were kept consistent for the remainder of the experiment. 20,000 events were collected per 
sample at a maximum flow rate of 1000 events per second. 
2.11.3	Analysis	using	FACSDiva	software	
The FACSDiva 8.0.1 software was used for DNA content analysis. All events 
collected by the flow cytometer were included in the analysis. Chromatograms shown in this 
thesis are distributions of florescence intensity of the SyTOX green stain. For each sample 
(consisting of all time points), the 0-minute time point was used to determine the relative 
fluorescence intensity of the 1N and 2N peaks and the 40, 80, and 120-minute time points 
were analyzed according to those parameters. There were lots of events that displayed 
fluorescence intensities greater than the 2N peak; these were assumed to consist of clumps of 
cells and were omitted from the analysis. 	
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Chapter	3:	Impacts	of	Excess	Cu		
The mitochondrial Cu pool is thought to play an important role in control of Cu 
homeostasis in the cell (Baker et al, 2017a). However, the mechanisms by which 
mitochondria regulate Cu homeostasis and how mitochondrial dysfunction impacts non-
mitochondrial cuproproteins remain under investigation. Many studies have looked at how 
changes in Cu levels impact cellular function. A recent large-scale screen in yeast concluded 
that Cu imbalance is associated with defective Fe homeostasis, NAD+ imbalance, and 
dysfunctions in arginine metabolism, glucose transport, and the pyridoxal phosphate pathway 
(Cankorur-Centinkaya et al, 2013). Our goal in this study was to evaluate how changes in 
extracellular Cu availability adversely impact mitochondria.  
Specifically, we ensured that our cells are physiologically responding to changes in 
extracellular Cu, and we studied how excess Cu affects mitochondrial function. In a Wilson 
disease mouse model, Cu excess has been shown to result in upregulation of cell cycle 
proteins but lead to no change in oxidative stress proteins (Huster et al, 2007). 
3.1	Optimization	of	Cu	availability	conditions	in	S.	cerevisiae	
3.1.1.	Determining	the	appropriate	concentrations	of	CuSO4	and	BCS	
Before investigating whether mitochondrial cuproproteins are affected by changes in 
extracellular Cu levels, we wanted to ensure that the yeast cultures were physiologically 
responding to their changing extracellular environments. To mimic conditions of excess 
extracellular Cu we supplemented media with copper sulphate (CuSO4), and for Cu deplete 
conditions we used bathrocuproine disulfate (BCS), which is a specific Cu chelator and will 
not bind other divalent cations. To optimize concentrations of CuSO4, we considered the 
observation that 0.1% Cu is able to rescue a Ctr1 KO strain (Glerum et al, 1996a) and chose 
the concentrations 0.01% Cu and 0.1% Cu. For BCS, we chose concentrations ranging from 
10 µM to 500 µM based on a previous report that had shown a physiological response in 
yeast to BCS in the range of 10 µM – 100 µM (Wood & Thiele, 2009). 
To measure the cellular response to these chemicals, we looked at transcript levels for 
CTR1 and CUP1. CTR1 encodes a high affinity Cu transporter located on the plasma 
membrane and is transcriptionally upregulated in response to reduced cellular Cu (Wood & 
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Thiele, 2009). In contrast, the CUP1 gene encodes the main metallothionein and is 
transcriptionally upregulated in response to Cu excess conditions. After yeast cultures were 
exposed to either CuSO4 or BCS for 18 hours, RNA was isolated, and used for cDNA 
synthesis and qPCR analysis with primers specific for CTR1 and CUP1 genes (Figure 3.1). 
Transcript levels of CTR1 and CUP1 were normalized to ACT1 transcript levels, which were 
used as a baseline. As expected, CTR1 transcript levels significantly increased with 
increasing concentrations of BCS, and decreased with increasing concentrations of CuSO4. 
CUP1 transcript levels changed in the opposite way: they significantly increased in response 
to increasing CuSO4 and decreased in response to BCS. The response of CTR1 and CUP1 
transcript levels to 0.01% - 0.1% CuSO4 and 10 µM – 500 µM BCS confirmed that the cells 
were physiologically responding to changing Cu concentrations in the extracellular 
environment, in keeping with current understanding. 	
	
Figure 3.1 RT-qPCR of CTR1 and CUP1 in Cu excess and Cu deplete conditions  
(A) Graphical representation of relative abundance of CTR1 and CUP1 compared to no treatment controls. 
RNA was isolated from yeast cells grown for 18 hours in the Cu condition stated. PCR was performed using 
cDNA on both the gene of interest and ACT1 as a control. Values are representative of ΔΔCq values. Three 
biological replicates were performed for each treatment condition. A one-way ANOVA was done to determine 
statistical significance: not significant = n.s, p < 0.05 = *, p < 0.01 = **. Error bars represent ± SEM. (B) Raw 
ΔΔCq values, representing the fold-change in each condition relative to ACT1. 
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3.1.2.	Effect	of	Cu	availability	on	cell	viability	
To ensure that Cu excess or Cu deplete conditions did not lead to a major growth defect, 
we took a two-pronged approach to test cell viability in the presence of Cu excess and 
depletion conditions. First, a spot plate assay was performed on plates with different 
concentrations of the chemicals to identify any growth defects (Figure 3.2-A). These results 
clearly demonstrate that the presence of either 500 µM BCS or 0.15% Cu does not result in a 
growth defect in wild type yeast. In a second approach, wild type yeast were grown in liquid 
media in the presence or absence of BCS or Cu for 18 hours and the numbers of viable and 
non-viable cells were analyzed using the Trypan blue staining method (Figure 3.2-B). The 
difference in this alternative approach is that cells are not required to replicate in order to be 
considered viable. Therefore, counting viable cells using the Trypan blue approach will 
account for live cells that are unable to replicate. Our results displayed that at concentrations 
up to 5 mM BCS and 0.2% Cu, over 85% of cells are still viable. Taken together, these data 
indicated that the concentration range of Cu excess and depletion used are sufficient to 
initiate a physiological response but do not affect cell viability. 	
	
Figure 3.2 Cell viability analysis with CuSO4 and BCS 
(A) Ten-fold dilution series of WT yeast on YPD media with added chemicals. Cells were spotted onto plates 
and incubated for 48 hours at 30oC. (B) Viability analysis with the Trypan blue stain. Liquid cultures of yeast 
were grown for 18 hours with either CuSO4 or BCS and cells were counted using a hemacytometer. A minimum 
of 500 cells was counted for at least two biological replicates for each treatment. Percentages are representative 
of unstained, viable cells (Hilker, unpublished). 
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3.1.3	Response	of	MAC1	and	CUP2	to	extracellular	Cu	changes	
Mac1 and Ace1, Cu-responsive transcription factors in yeast, have activities 
dependent on the concentration of Cu bound to them (Keller et al, 2005). Measurement of 
Mac1 and Ace1 activity is normally performed indirectly by measuring transcript levels of 
CTR1 and CUP1, two of their gene products (Nevitt et al, 2012). From the results in Figure 
3.1, we saw changes in CTR1 and CUP1 transcript levels in both Cu excess and Cu deplete 
conditions, suggesting that activity levels of Mac1 and Ace1 are also affected by Cu 
availability conditions.  
In an attempt to identify a relationship between transcript levels and activity, we analyzed 
whether MAC1 and CUP2 (Ace1) transcript levels changed in response to Cu excess or 
depletion conditions (Figure 3.3). MAC1 transcript levels significantly increased with 0.1% 
CuSO4 but did not significantly change with BCS. The increase of MAC1 transcript levels 
corresponded to a decrease of CTR1 transcription levels in 0.1% Cu, suggesting a disconnect 
between transcript and activity levels. We have seen a similar phenomenon in our studies of 
the yeast stationary phase (Dubinski et al, 2018). A likely explanation is that Mac1 binds 
high levels of Cu when it is inactive; in Cu excess conditions, the cell will transcribe high 
levels of MAC1 so that it can bind free Cu, acting like a Cu sink, but the Mac1 protein will 
remain inactive. Therefore, the increase of MAC1 transcript levels in Cu excess conditions is 
not surprising. CUP2 transcript levels significantly increased with excess Cu and 
significantly decreased with increasing BCS (Figure 3.3), mirroring the changes we saw in 
CUP1 transcript levels. Ace1 is activated when it binds high concentrations of Cu atoms 
(Keller et al, 2005), suggesting that transcript levels of CUP2 are directly correlated with 
Ace1 activity levels. Overall, both MAC1 and CUP2 transcript levels change in response to 
Cu excess, but only CUP2 responds to Cu depletion. 	
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Figure 3.3 RT-qPCR of MAC1 and CUP2 in Cu excess and Cu deplete conditions 
(A) Graphical representation of relative abundance of MAC1 and CUP2 compared to no treatment controls. 
RNA was isolated from yeast cells grown for 18 hours in the Cu condition stated. PCR was performed using 
cDNA on both the gene of interest and ACT1 as a control. Values are representative of ΔΔCq values. Three 
biological replicates were performed for each treatment condition. A one-way ANOVA was performed to 
determine statistical significance: not significant = n.s, p < 0.05 = *, p < 0.01 = **. Error bars represent ± SEM. 
(B) Raw ΔΔCq values, representing the fold-change in each condition relative to ACT1. 
3.2	Mitochondrial	Cuproproteins	in	Cu	Excess	conditions	
3.2.1	COX	in	the	face	of	Cu	excess	
For our analyses of COX in Cu excess conditions, we compared how COX assembly 
factors and subunits responded to CuSO4 transcriptionally, how their protein levels are 
affected, and if this led to changes in activity of the holoenzyme. We began by looking at 
transcript levels of COX17, SCO1, and COX11, which are the three assembly factors with a 
well-defined role in Cu delivery to COX. To do this, we isolated RNA after treatment of wild 
type cells with CuSO4 for 18 hours, followed by cDNA synthesis and qPCR analysis. 
Interestingly, we found no significant difference in the transcript levels of these genes after 
treatment with either 0.01% or 0.1% Cu after 18 hours (Figure 3.4), suggesting that 
regulation of these genes is not affected by Cu. The result that COX17 transcript levels do not 
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change with changing Cu is in agreement with a large-scale screen that was done in attempt 
to identify genes important in Wilson disease (Cankorur-Centinkaya et al, 2013). We also 
investigated transcript levels for one of the nuclear-encoded subunits, COX4, as a means to 
control for a general COX assembly defect unrelated to Cu (Figure 3.4). Similarly to the 
COX assembly factors, increased extracellular Cu did not significantly affect COX4 
transcript levels. These results suggest that there are not likely to be Cu-responsive elements 
in the promoters of COX17, SCO1, COX11 and COX4. 	
	
Figure 3.4 RT-qPCR of COX17, SCO1, COX11 and COX4 in Cu excess conditions 
(A) Graphical representation of relative abundance of COX17, SCO1, COX11 and COX4. RNA was isolated 
from yeast cells grown for 18 hours in YPD + CuSO4. PCR was performed using cDNA on both the gene of 
interest and ACT1 as a control. Values are representative of ΔΔCq values. Three biological replicates were 
performed for each concentration. A one-way ANOVA was performed to determine statistical significance: not 
significant = n.s. Error bars represent ± SEM. (B) Raw ΔΔCq values, representing the fold-change in each 
condition relative to ACT1. 	
We next investigated how the protein levels of COX assembly factors and subunits 
responded to increases in extracellular Cu levels. Mitochondria were isolated by subcellular 
fractionation and 25 µg of mitochondrial protein were separated by SDS-PAGE, transferred 
to nitrocellulose membranes and Western blotted with antibodies against COX assembly 
factors and subunits (Figure 3.5). As a control, we used Por1, a mitochondrial OMM protein 
that is commonly used to verify equal loading. To quantify the Western blots, we compared 
the relative intensity of the band representing the no treatment control to each treatment 
condition. From three biological replicates, we found that Por1 decreased by 20% in response 
to increased extracellular Cu (Figure 3.5). Therefore, we considered proteins that increased or 
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decreased more than 20% (lower than 0.8X or higher than 1.2X) to be affected by excess Cu. 
If protein levels changed by less than 20%, we defined them to be unaffected by increased Cu 
since they were similarly varied compared to our control. 
In the presence of either 0.01% or 0.1% Cu, Cox17 protein levels are affected 
similarly, increasing by about 1.70X compared to the not treatment control. Sco1 protein 
levels are unaffected at 0.01% Cu when compared to the Por1 control, but are slightly 
affected at 0.1% Cu, increasing 32% relative to the no treatment control.  Unexpectedly, 
Cox11 protein levels remained unchanged in the presence of excess Cu since they are vary to 
the same extent as the Por1 control, even though Cox11 plays a role in Cu delivery to Cox1, 
one of the core subunits. The divergent changes of these COX assembly factors to excess Cu 
are unexpected, as they are involved in the same pathway of Cu delivery to COX.  
Investigation of both an mtDNA-encoded subunit and a nuclear-encoded subunit 
revealed differences in how these proteins respond to excess Cu levels. Cox2 is slightly 
increased in 0.1% Cu; however, Cox4 is substantially increased, with 3.65X more protein 
after treatment. It is likely that excess Cu has a stabilizing effect on Cox4 protein, since 
COX4 transcript levels do not change in response to excess Cu. Although Cox4 does not bind 
Cu, the crystal structure reveals a zinc (Zn) atom (Coyne et al, 2007), suggesting that excess 
Cu may stabilize Zn-binding proteins. The electron donor cytochrome c (Cyc1) also increases 
in excess Cu conditions, which supports the increase we see in both Cu-related COX 
assembly factors and subunits and is logical since Cyc1 is an electron donor in the respiratory 
chain. 		
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Figure 3.5 Mitochondrial protein levels in Cu excess conditions 
(A) Representative Western blots of mitochondrial protein samples (25 µg protein) using antibodies to proteins 
involved in COX assembly (Cox17, Sco1, Cox11), COX subunits (Cox2, Cox4), or other mitochondrial protein 
(Cyc1, Por1). All blots were stained with Ponceau S prior to immunoblotting to ensure equal loading across all 
lanes of the gel. (B) Quantification of protein levels on Western blots relative to the no treatment control. Por1 
was used as the loading control. Using the changes in Por1 levels, any quantification above 1.2X or below 0.8X 
was considered to be significant. Quantification is the average of at least two separate subcellular fractionations. 	
Although Cox17 has a well-defined role in the mitochondria, approximately 40% of 
the protein is found in the cytosol (Beers et al, 1997). Therefore, we wanted to compare 
changes of Cox17 protein levels in the mitochondria to those in the cytosol and in the cell as 
a whole. Interestingly, we found that Cox17 protein levels decreased in the cytosolic fraction 
in response to excess Cu, and this is accompanied by a decrease of Cox17 protein in cell 
lysates (Figure 3.6). Specifically, Cox17 protein levels decreased by 38% in the cytosol and 
69% in cell lysates, in contrast to increasing 70% in the mitochondria. The fact that similar 
COX17 transcript levels correlated with an decrease in total cellular Cox17 protein levels in 
Cu excess suggests that Cu might have an overall destabilizing effect on Cox17, but a 
stabilizing effect on the mitochondrial pool of the protein. Because the cell is exposed to 
excess Cu, we hypothesize that only the mitochondrial pool of Cox17 is binding Cu, 
explaining the stabilizing effect that is unique to the mitochondria. 	
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Figure 3.6 Cox17 protein levels in Cu excess conditions 
(A) Representative Western blots of cytosolic protein samples (25 µg protein) and cell lysate protein samples 
(60 µg protein) using antibodies to Cox17 or Act1. All blots were stained with Ponceau S prior to 
immunoblotting to ensure equal loading across all lanes of the gel. (B) Quantification of protein levels on 
Western blots relative to the no treatment control. Act1 was used as the loading control. Using the changes in 
Act1 levels, any quantification above 1.21X or below 0.79X in cell lysates and above 1.05X or below 0.95X in 
the cytosol was considered to be significant. Quantification is the average of at least two separate subcellular 
fractionations. 	
To understand how changes in protein levels reflected in activity, we measured COX 
activity on isolated mitochondria after CuSO4 treatment by recording the oxidation of 
cytochrome c at 550 nm. We found that the specific activity of COX significantly increased 
in response to excess Cu (Figure 3.7). Interestingly, COX activity was similar with 0.01% Cu 
and 0.1% Cu, indicating that a 10-fold difference in Cu does not have an effect on activity. 
This suggests that there may be a threshold of COX activity in the presence of excess Cu that 
is already met in an environment containing 0.01% Cu. Overall, the increase in COX activity 
is in agreement with our Western blots, which displayed increases in protein levels of Cox17, 
Sco1, Cox2, Cox4, and Cyc1, proteins that are all important for a fully functional COX. 
Contrary to our expectations, Cox11 protein levels were similar in excess Cu conditions 
compared to no treatment controls, even though other COX assembly factor protein levels 
and COX activity were increased. 	
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Figure 3.7 COX activities in Cu excess conditions 
Mitochondrial fractions were tested for COX activity by measuring the oxidation of reduced cytochrome c at 
550 nm for 60 seconds. The Student’s T-Test was used between the WT and each treatment to determine 
statistical significance: p < 0.01 = **. Error bars represent ± SEM of technical duplicates on three different 
biological replicates. 
3.2.2	Sod1	in	the	face	of	Cu	excess	
We next investigated how Cu,Zn-Sod1 responds to excess extracellular Cu. Similarly 
to COX assembly factors and subunits, we started by assessing how Sod1 transcript levels 
changed in response to excess Cu. We also looked at CCS1 transcript levels, given its role as 
Cu chaperone for Sod1 in yeast. We found that, after treatment with 0.1% Cu for 18 hours, 
transcript levels of both CCS1 and SOD1 were significantly increased by 3.24X and 2.54X, 
respectively (Figure 3.8). In contrast, treatment with 0.01% Cu revealed no significant 
changes in CCS1 and SOD1 transcript levels. The increase of SOD1 transcript levels with 
0.1% Cu is consistent with the finding that Ace1 activity results in upregulation of SOD1 
transcription (Nevitt et al, 2012). Because we know that CCS1 is functionally related to 
SOD1, it is not surprising that CCS1 transcript levels correlated with SOD1 transcript levels. 
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Figure 3.8 RT-qPCR of CCS1 and SOD1 in Cu excess conditions 
(A) Graphical representation of relative abundance of CCS1 and SOD1. RNA was isolated from yeast cells 
grown for 18 hours in YPD + CuSO4. PCR was performed using cDNA on both the gene of interest and ACT1 
as a control. Values are representative of ΔΔCq values. Three biological replicates were performed for each 
concentration. A one-way ANOVA was done to determine statistical significance: not significant = n.s, p < 0.05 
= *, p < 0.01 = **. Error bars represent ± SEM (B) Raw ΔΔCq values, representing the fold-change in each 
condition relative to ACT1. 	
To evaluate if Sod1 responded to excess Cu at the protein and activity levels, we 
considered the Sod1 pools in both the mitochondria and the cytoplasm. Similarly to Cox17, 
Sod1 is dually localized to the mitochondria and cytosol; approximately 90% of Sod1 protein 
resides in the cytosol and the other 10% is found in the IMS of mitochondria (Valentine et al, 
2005). Western blotting analysis of Sod1 in both mitochondrial and cytosolic fractions 
revealed an increase in protein levels after treatment of either 0.01% or 0.1% Cu (Figure 3.9). 
We used Por1 protein levels (Figure 3.5) as a loading control for mitochondria, and Act1 
protein levels (Figure 3.6) as a loading control for the cytosol. Interestingly, at 0.01% Cu, the 
unchanged SOD1 transcript levels did not correspond to the increase we observed in Sod1 
protein levels, again suggesting altered protein stability. 
Analysis of SOD activity in mitochondrial and cytosolic fractions was performed by 
running protein fractions on a non-denaturing gel followed by exposure to nitroblue 
tetrazolium (NBT) and riboflavin, which form superoxide (Beauchamp and Fridovich, 1971). 
The presence of active Sod1 or Sod2 will appear as a clear band on the gel that can be 
quantified after imaging. As seen in Figure 3.9, SOD activity increased with excess Cu 
treatment, which corresponded to the increased protein levels. Mitochondrial SOD activity 
consists of both Sod1 and Sod2 activity, and is increased 1.61X and 2.19X with treatment of 
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0.01% and 0.1% Cu respectively. Cytosolic SOD activity, which only consists of Sod1, 
increased by 1.51X and 1.80X with the two Cu treatment conditions. Overall, Sod1 protein 
and activity levels are increased in both compartments with excess extracellular Cu. 	
	
Figure 3.9 Sod1 protein and activity levels in Cu excess conditions  
(A) Representative Sod1 Western blot (25 µg protein) and SOD activity gel (48 µg protein in mitochondria, 24 
µg protein in cytosol) using mitochondrial and cytosolic protein samples. SOD activity was measured in-gel 
using a well-established method (Beauchamp & Fridovich, 1971). (B) Quantification of protein and activity 
levels relative to the no treatment control. Por1 was used as the loading control for the Sod1 Western blot in the 
mitochondria, and Act1 for the cytosol. Using the changes in Por1 levels (Figure 3.5) or Act1 levels (Figure 
3.6), we defined significant changes in levels of Sod1. Quantification of protein and activity levels is the 
average of at least two separate subcellular fractionations. 
3.2.3	Non-Cu	related	mitochondrial	functions	in	the	face	in	Cu	excess	
Although COX and Sod1 are the main sources of mitochondrial Cu, we wanted to 
investigate if excess Cu affected other mitochondrial functions, unrelated to Cu. The increase 
we saw in COX activity suggests that there may be more flux through the respiratory chain. 
Therefore, we asked whether TCA cycle proteins Sdh2 and Aco1 are affected by treatment 
with excess Cu. Western blotting analysis revealed that Sdh2 protein levels increase at 0.01% 
Cu but remain constant at 0.1% Cu, while Aco1 protein levels are increased with both 
treatment conditions (Figure 3.10-A, 3.10-B). Sdh2 protein levels increasing at 0.01% Cu but 
not 0.1% Cu could suggest a dose-dependent response of the protein to CuSO4, but more 
experiments would be needed to confirm this hypothesis. 
Because of the differential response between Sdh2 and Aco1 protein levels, we 
cannot conclusively state how the TCA cycle behaves in response to excess Cu conditions. 
To further analyze flux through the TCA cycle, we measured mitochondrial Aco1 activity 
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using an indirect approach (Bulteau et al, 2005). We found that with Cu excess treatment 
conditions, regardless of concentration, Aco1 activity significantly increased (Figure 3.10-C), 
which is consistent with the increased protein levels. In contrast to Sdh2, Aco1 protein and 
activity levels responded similarly to both concentrations of Cu. Taken together, it is likely 
that TCA cycle flux is increased with excess Cu treatment, consistent with the increased flux 
we observed in the respiratory chain. 	
	
Figure 3.10 TCA cycle protein levels and Aco1 activity levels in Cu excess conditions 
(A) Representative Western blots of mitochondrial protein samples (25 µg protein) using antibodies to proteins 
in the TCA cycle (Sdh2, Aco1). Blots were stained with Ponceau S prior to immunoblotting to ensure equal 
loading across all lanes of the gel. (B) Quantification of protein levels on Western blots relative to the no 
treatment control. Por1 (Figure 3.5) was used as the loading control. Using the changes in Por1 levels, any 
quantification above 1.2X or below 0.8X was considered to be significant. Quantification is the average of at 
least two separate subcellular fractionations. (C) Aconitase activity was assayed from mitochondrial fractions 
using citrate as the substrate. NADPH production was measured over 60 seconds at 340 nm (Bulteau et al, 
2003). Error bars represent ± SEM of duplicates of three separate mitochondrial isolations. 	
In addition to being part of the TCA cycle, Aco1 activity is also regarded as a marker 
of oxidative stress in the mitochondria (Bulteau et al, 2005). Aco1 contains an iron-sulfur 
(FeS) centre that is extremely sensitive to oxidative damage. To define whether our increased 
Aco1 activity correlated with decreased oxidative stress, we used an Oxyblot, which allows 
visualization of oxidative damage by detection of protein carbonylation. Our results from cell 
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lysates displayed that, when treated with 0.1% Cu, there is less protein carbonylation relative 
to a no treatment control (Figure 3.11). However, both the cytosolic and mitochondrial 
fractions revealed increased protein carbonylation after exposure to excess Cu. This suggests 
that other cellular compartments, such as the nucleus, have decreased oxidative damage in 
excess Cu conditions. Taken together, we concluded that the increased Aco1 activity we see 
in the 0.1% Cu treatment is related to increased flux through the TCA cycle, and not a 
reflection of a decrease in oxidative damage. 	
	
Figure 3.11 Oxidative damage in Cu excess conditions  
Carbonylation of proteins, a common form of oxidative damage, was measured in cell lysates (20 µg), 
mitochondria (25 µg) and cytosolic (25 µg) fractions after 18 hours of treatment with 0.1% CuSO4, using the 
Millipore OxyBlot Kit. Oxidized proteins were conjugated with 2,4-dintrophenylhydrazine (DNP) and then 
visualized by Western blotting using an anti-DNP antibody. Blots were done on two separate biological 
replicates (Soule, unpublished) 	
Because we saw increased levels of oxidative damage in the mitochondria in the 
Oxyblot, we wondered whether they were associated with changes in mitochondrial 
proteasomal machinery. Therefore, our final test of mitochondrial function was measurement 
of transcript and protein levels of the PIM1 (Lon) gene, an abundant mitochondrial protease 
that degrades proteins that reside in the mitochondrial matrix or the IMM. Assessment of 
PIM1 transcript levels was identical to measurement of other transcripts; qPCR was 
performed on cDNA using primers specific to the PIM1 gene, and ΔΔCq values were 
obtained by comparing PIM1 gene expression to ACT1 gene expression with increasing Cu 
concentration. We found that at a concentration of 0.01% Cu, PIM1 expression is not 
significantly changed, but at 0.1% Cu, PIM1 transcript levels significantly increased 3.35X 
compared to a no treatment control (Figure 3.12-A, 3.12-B). This indicated that exposure to 
0.1% Cu does affect PIM1 gene expression. 
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We next looked at Lon protein levels to identify if the increase in PIM1 transcript 
levels were consistent with levels of the protein product. When compared to the Por1 control, 
we observed no significant changes in Lon protein levels after treatment with excess Cu. 
Specifically, Lon protein levels were 14% increased with 0.01% Cu and 3% decreased with 
0.1% Cu, relative to the no treatment control (Figure 3.12-C). As a result, we concluded that 
the increased transcript levels of PIM1 did not correlate with increased Lon protein levels. 
These preliminary results suggest that in response to excess Cu, the mitochondria do not 
greatly modify their protein degradation machinery. 	
	
Figure 3.12 Analysis of mitochondrial Lon protease in Cu excess conditions  
(A) Graphical representation of RT-qPCR data of PIM1 in Cu excess conditions. RNA was isolated from yeast 
cells grown for 18 hours in YPD + CuSO4. PCR was performed using cDNA on both the gene of interest and 
ACT1 as a control. Values are representative of ΔΔCq values. Three biological replicates were performed for 
each concentration. A one-way ANOVA was done to determine statistical significance: not significant = n.s, p < 
0.01 = **. Error bars represent ± SEM (B) Raw ΔΔCq values, representing the fold-change in each condition 
relative to ACT1. (C) Representative Western blot of mitochondrial protein samples (25 µg protein) using 
antibody to Lon. Blots were stained with Ponceau S prior to immunoblotting to ensure equal loading across all 
lanes of the gel. (D) Quantification of protein levels on Western blots relative to the no treatment control. Por1 
(Figure 3.5) was used as the loading control. Using the changes in Por1 levels, any quantification above 1.2X or 
below 0.8X was considered to be significant. Quantification is the average of at least two separate subcellular 
fractionations.  
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3.3	Summary	of	Results		
In order to study the impact of Cu availability on mitochondrial function, we 
established concentrations of CuSO4 (0.01% and 0.1%) and BCS (10, 100, and 500 µM) that 
physiologically impacted the cell but did not cause a growth defect. 
In Cu excess conditions, we saw a generalized increase in protein levels of COX 
subunits and COX assembly factors, as well as COX activity, but not transcript levels. One 
exception was Cox11 protein levels, which did not significantly increase with either 0.01% or 
0.1% Cu treatment. Although Cox17 protein levels increased in the mitochondria with 
increasing concentrations of Cu, they decreased in both the cytosolic fraction and the whole 
cell lysate, suggesting that the mitochondrial pool of Cox17 is most important under Cu 
excess conditions.  
At 0.1% Cu, both CCS1 and SOD1 genes were upregulated, which corresponded to 
the increase we observed in Sod1 protein levels and SOD activity compared to the no 
treatment control. Our analyses also revealed an increase in flux through the TCA cycle, 
higher mitochondrial oxidative damage, and upregulation of PIM1 in Cu excess conditions. 
Interestingly, the upregulation of PIM1 did not correspond to an increase in Lon protein 
levels in the mitochondria. Taken together, our results suggest that excess extracellular Cu 
leads to increased mitochondrial cuproprotein levels and flux through the respiratory chain, 
which is consistent with increased oxidative damage. 
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Chapter	4:	Analysis	of	Cu	Deficient	Conditions		
Similar to having too much Cu, deficiencies of the metal also have negative impacts 
on cellular and mitochondrial function. When Cu is depleted, cells must alter their regulation 
of Cu distribution, and cuproproteins will not be fully functional. Patient cells with mutations 
in certain proteins related to COX assembly can be rescued by Cu supplementation, 
suggesting that the defect results in Cu deficiency (Jaksch et al, 2001) (Ghosh et al, 2014). 
Therefore, we studied how partitioning of mitochondrial Cu changes under conditions in 
which the metal is limited or restricted. 
Previous literature has reported that in Chlamydomonas during Cu deficiency, cells 
will down-regulate the Cu-containing plastocyanin and a Fe-containing protein, cytochrome 
c6, will take over its native function (Kropat et al, 2015). Similarly, in the pathogenic yeast 
Candida albicans, Cu deficiency results in repression of the SOD1 gene in order to restore 
COX activity in the mitochondria (Broxton & Culotta, 2016). Taken together, these results 
suggest that in the absence of adequate levels of Cu, cells will actively downregulate other 
cuproproteins to lessen the negative effect on mitochondria. In this chapter, we examined 
how Cu deficiency impacts mitochondrial protein levels and function in Saccharomyces 
cerevisiae.  
4.1	Mitochondrial	Proteins	in	Cu	Deplete	Conditions	
4.1.1	COX	in	the	face	of	Cu	deficiency	
We were interested in how mitochondria responded to a generalized Cu deficiency 
since both COX and Sod1 rely on Cu for their functions. To analyze the impact of Cu 
deficiency on mitochondrial cuproproteins, we took a similar approach to our analysis of Cu 
excess conditions. We started by looking at COX and Sod1 pools, and then looked at the 
impacts of Cu deficiency on more generalized mitochondrial function. As described in 
section 3.1, for inducing extracellular Cu-specific deficiency we treated our cultures with 10 
µM, 100 µM, or 500 µM BCS, a Cu chelator. These concentrations of BCS were shown to 
induce a physiological response and yet have minimal negative impact on cell viability. 
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Analysis of transcript levels of COX17, SCO1, and COX11 revealed no significant 
changes with cells treated with BCS compared to the control (Figure 4.1), as seen for Cu 
excess, further suggesting that these genes do not contain any Cu-responsive elements. We 
used transcript levels of COX4 as a control, and observed an unexpected decrease in COX4 
transcript levels by 35% after exposure to 100 µM and 500 µM BCS for 18 hours, but they 
were not significantly different at 10 µM BCS exposure. Our observation of down-regulation 
of one of the COX subunits may indicate a dysfunctional COX or defective COX assembly at 
higher concentrations of BCS.  
	
Figure 4.1 RT-qPCR of COX17, SCO1, COX11 and COX4 in Cu depletion conditions  
(A) Graphical representation of relative abundance of COX17, SCO1, COX11 and COX4. RNA was isolated 
from yeast cells grown for 18 hours in YPD + BCS. PCR was performed using cDNA on both the gene of 
interest and ACT1 as a control. Values are representative of ΔΔCq values. Three biological replicates were 
performed for each concentration. A one-way ANOVA was performed to determine statistical significance: not 
significant = n.s, p < 0.01 = **. Error bars represent ± SEM. (B) Raw ΔΔCq values, representing the fold-
change in each condition relative to ACT1. 
 
We next looked at how protein levels of COX assembly factors and subunits changed 
in response to Cu deficiency. As in Chapter 3, if protein levels of the protein of interest 
changed more than Por1 protein levels, we considered the change to be significant. At 500 
µM BCS, Cox17 protein levels increased while Sco1 and Cox11 protein levels decreased 
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compared to the control (Figure 4.2). However, after exposure to 10 µM and 100 µM BCS, 
Sco1 protein levels were unaffected while Cox11 protein levels decreased by 16%-57%. The 
differences seen with protein levels of Sco1 and Cox11 further supports differentiating 
behaviors of these two proteins, even though they have similar functions. The increase in 
Cox17 protein levels while cells experience a decrease in Sco1 and Cox11 protein levels at 
500 µM BCS, suggests that during Cu deficiency, the mitochondrial pool of Cox17 may have 
a secondary function. 
In agreement with the decrease we observed in COX4 transcript levels, the Cox4 
protein was barely detectable at 500 µM BCS. Specifically, Western blotting using antibodies 
against Cox4 revealed a 77% or 94% decrease in protein levels with 100 µM BCS and 500 
µM BCS, respectively. Cox2, our representative mitochondrial subunit, also significantly 
decreased with increasing BCS concentrations. The decrease in Cox2 and Cox4 protein levels 
is consistent with a decreased level of Cyc1, the COX electron donor, which we also 
observed at 500 µM BCS. Taken together, the loss of both nuclear and mitochondrial-
encoded COX subunits suggests a loss of assembled COX in Cu deficient conditions. 
	
Figure 4.2 Mitochondrial protein levels in Cu depletion conditions  
(A) Representative Western blots of mitochondrial protein samples (25 µg protein) using antibodies to proteins 
involved in COX assembly (Cox17, Sco1, Cox11), COX subunits (Cox2, Cox4), or other mitochondrial protein 
(Cyc1, Por1). All blots were stained with Ponceau S prior to immunoblotting to ensure equal loading across all 
lanes of the gel. (B) Quantification of protein levels on Western blots relative to the no treatment control. Por1 
was used as the loading control. Using the changes in Por1 levels, any quantification above 1.28X or below 
0.72X was considered to be significant. Quantification is the average of at least two separate subcellular 
fractionations. 
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Similarly to what we saw with excess Cu, Cox17 protein levels increased in the 
mitochondria from cells with Cu deficiency. We also performed Western blotting on whole 
cell lysate and cytosolic protein fractions to investigate whether total cell Cox17 pools or 
cytosolic protein levels changed in response to Cu depletion. In whole cell lysates, we 
observed a slight increase in protein levels at 10 µM and 100 µM BCS compared to the Act1 
control, while after exposure to 500 µM BCS the Cox17 protein level was virtually identical 
to the no treatment control (Figure 4.3). From three separate subcellular fractionations, we 
saw that cytosolic Cox17 protein levels were unchanged between the control and all of the 
BCS treatments. Overall, our results suggest that levels of Cox17 in the whole cell are 
unchanged in response to increasing concentrations of BCS. However, we observe a 
redistribution of Cox17; more Cox17 is transported into the mitochondria while the cytosolic 
pool remains constant.  
	
Figure 4.3 Cox17 protein levels in Cu deficiency  
(A) Representative Western blots of cell lysate protein samples (60 µg protein) and cytosolic protein samples 
(25 µg protein) using antibodies to Cox17 or Act1. All blots were stained with Ponceau S prior to 
immunoblotting to ensure equal loading across all lanes of the gel. (B) Quantification of protein levels on 
Western blots relative to the no treatment control. Act1 was used as the loading control. Using the changes in 
Act1 levels, any quantification above 1.10X or below 0.90X in the cell lysates and above 1.21X or below 0.79X 
in the cytosol was considered to be significant. Quantification is the average of at least two separate subcellular 
fractionations. 	
Western blotting data on COX assembly factors and subunits showed that during Cu 
deficiency, we appeared to have a loss of assembled COX. Therefore, we hypothesized that 
increasing concentrations of BCS would correlate with a decrease in COX activity. After 18 
hours of exposure to BCS, we isolated mitochondria and analyzed COX activities by 
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measuring the reduction of reduced cytochrome c over time (Figure 4.4). At 10 µM BCS, we 
did not observe any significant change in COX activity compared to the no treatment control, 
agreeing with the similar protein levels of Cox2 and Cox4 we saw between the no treatment 
sample and 10 µM BCS sample. At 100 µM BCS and 500 µM BCS, we observed a large 
decrease in COX activity, which was confirmed to be significant after performing the 
Student’s T-test. Specifically, COX activity decreased from 470.7 nmol mg-1 min-1 with no 
treatment to 179.3 nmol mg-1 min-1 with 100 µM BCS and to 70.7 nmol mg-1 min-1 with 500 
µM BCS. This low rate of cytochrome c oxidation is likely due to auto-oxidation and 
therefore is not representative of COX activity. Therefore, we concluded that when subjected 
to Cu deficient conditions, COX is no longer assembled or functional. This contradicts results 
from the yeast C. albicans, where it is thought that during Cu deficiency, the cell restores 
COX activity with the minimal mitochondrial Cu present (Broxton & Culotta, 2016).  
	
Figure 4.4 COX activities in Cu depletion conditions 
Mitochondrial fractions were tested for COX activity by measuring the oxidation of reduced cytochrome c at 
550 nm for 60 seconds. The Student’s T-Test was used between the WT and each treatment to determine 
statistical significance: not significant = n.s, p < 0.05 = *, p < 0.01 = **. Error bars represent ± SEM of 
technical duplicates on three different biological replicates. 	
The significant decrease in COX activity with increasing BCS concentration is not 
lethal in S. cerevisiae, as it is able to survive solely by glycolysis. This led us to ask whether 
we could recover COX function in a low Cu environment, if we forced the cells to use 
oxidative phosphorylation by growing the yeast on a non-fermentable carbon source. 
Strikingly, we observed that on EG medium with 500 µM BCS, wild type yeast could not 
survive. This demonstrated that even when forced to undergo mitochondrial respiration, 
Saccharomyces cannot shift its metabolism and therefore the carbon source change is lethal. 
For confirmation of the loss of COX activity when cultures grown in glucose are exposed to 
BCS, we also tested our spot plates for COX activity using a qualitative assay (McEwen et 
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al, 1985). Colonies were permeabilized onto Whatman filter paper and incubated with N, N, 
N’, N’-tetramethyl-p-phenylinediamine dihydrochloride (TMPD). Specifically, oxidation of 
TMPD increases the rate of reaction between cytochrome c and COX, and this results in a 
blue precipitate visible on the filter paper. As expected, we observed COX activity using this 
method in our no treatment control, and the absence of COX activity when cells were 
exposed to BCS. 
	
Figure 4.5 Analysis of yeast on non-fermentable carbon source during Cu deficiency  
Spot plates of WT yeast were grown YPD and EG media in the absence and presence of 500 µM BCS for 2 
days at 30°C. The COX activity was performed on colonies dried onto Whatman filter paper using 1% TMPD 
(McEwan et al, 1985). 	
As a first step towards identifying genes involved in the pathway that regulates 
cellular Cu distribution during low Cu conditions, we screened for suppressors that could 
grow on the non-fermentable carbon source. Overnight cultures of wild type yeast were 
plated onto EG + 500 µM BCS and left to grow until mutants arose. After 15 days, 4 mutants 
colonies were observed. They were streaked onto YPD and replica plated onto EG with 
different concentrations of BCS to confirm the suppressor phenotype (Figure 4.6). These 
patches were tested for COX activity by using the qualitative assay described above. We 
observed that after 2 days of growth at 30oC, suppressors grown on 100 µM BCS had 
increased COX activity compared to the wild type strain, which displayed minimal COX 
activity. At 500 µM BCS, neither the suppressors nor the wild type showed any growth, and 
therefore no COX activity. Genomic DNA preparation and sequencing of the suppressors 
should provide insights into the proteins that regulate mitochondrial Cu distribution in yeast. 
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Figure 4.6 Analysis of suppressors isolated from plates containing EG + 500 μM BCS  
Colonies were isolated after growth on EG + 500 µM BCS for 15 days at RT, patched onto YPD, strain verified, 
and then restreaked. COX activity assay was performed as described (Figure 4.5).  
4.1.2	Sod1	in	the	face	of	Cu	deficiency	
Since we observed that COX became inactive during increasing Cu depletion, we 
wondered if this also applied to the mitochondrial and cytosolic pools of Sod1. The 
distribution of SOD activity between these two compartments might provide insight into 
mitochondrial Cu import in Cu deficient conditions. Our initial analysis of CCS1 and SOD1 
transcript levels in Cu deplete conditions revealed an increase in CCS1 transcript at 500 µM 
BCS, but no significant changes in SOD1 transcript levels with any treatment of BCS (Figure 
4.7). Specifically, CCS1 transcript levels increased by 89% with 500 µM BCS treatment 
while SOD1 transcript levels increased by 3%, a non-significant change. Because CCS1 
transcript levels significantly changed with treatment of either excess Cu or BCS suggests 
that there is a Cu-responsive element on the gene. 
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Figure 4.7 RT-qPCR of CCS1 and SOD1 in Cu deplete conditions 
(A) Graphical representation of relative abundance of CCS1 and SOD1. RNA was isolated from yeast cells 
grown for 18 hours in YPD + BCS. PCR was performed using cDNA on both the gene of interest and ACT1 as a 
control. Values are representative of ΔΔCq values. Three biological replicates were performed for each 
concentration. A one-way ANOVA was done to determine statistical significance: not significant = n.s, p < 0.05 
= * Error bars represent ± SEM (B) Raw ΔΔCq values, representing the fold-change in each condition relative 
to ACT1. 	
We next analyzed how protein and activity levels of Sod1 changed at different 
concentrations of BCS. In the mitochondria, we observed that Sod1 protein levels were 
similar in the 500 µM BCS sample and the control (Figure 4.8). Interestingly, Sod1 protein 
levels at 100 µM were increased 3.03X compared to the control, suggesting that the response 
of mitochondrial Sod1 protein levels to BCS is dose-dependent. We had previously reported 
that Sod1 protein levels are not consistent with activity levels in mitochondrial mutants 
(Dubinski et al, 2018), so we asked whether mitochondrial Sod1 was active at 500 µM BCS. 
Because Sod1 requires Cu to function, we assumed that the presence of Sod1 activity would 
be indicative of Cu being present at the active site. Surprisingly, SOD activity gels revealed 
consistency between protein and activity levels in the mitochondria, indicating that at 500 
µM BCS, our mitochondrial pool of Sod1 was present and active. Taken together, the loss of 
COX activity and retention of Sod1 activity after treatment with 500 µM BCS strongly 
suggests a preferential distribution of Cu to Sod1 in mitochondria. 
Compared to the no treatment sample, cytosolic Sod1 protein and activity levels are 
similar at 10 µM BCS and gradually decrease at 100 µM BCS (Figure 4.8). In contrast to the 
mitochondrial fraction, both Sod1 protein and activity levels were barely detectable in the 
cytoplasm at 500 µM BCS. Since the cytosolic Sod1 pool consists of approximately 90% of 
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the protein, the similar transcript levels of SOD1 likely correspond to a decrease in protein 
level, which suggests that cytosolic Sod1 protein is less stable when Cu is depleted. These 
results suggest that limiting Cu is only donated to the mitochondrial pool of Sod1 and not the 
cytosolic pool. Because we also observed loss of COX activity at 500 µM BCS (Figure 4.4), 
our data suggest that during Cu deficiency, mitochondrial Sod1 activity is essential. 
 
	
Figure 4.8 Sod1 protein and activity levels in Cu deplete conditions  
(A) Representative Sod1 Western blot (25 µg protein) and SOD activity gel (48 µg protein for mitochondria, 24 
µg protein for cytosol) using mitochondrial and cytosolic protein samples. SOD activity was measured in-gel 
using a well-established method (Beauchamp & Fridovich, 1971). (B) Quantification of protein and activity 
levels relative to the no treatment control. Using the changes in Por1 levels (Figure 4.2) or Act1 levels (Figure 
4.3), we defined significant changes in levels of Sod1. Quantification of protein and activity levels is the 
average of at least two separate subcellular fractionations. 
4.1.3	Non-Cu	related	mitochondrial	functions	in	the	face	in	Cu	deficiency	
The lack of COX activity we observed at high concentrations of BCS led us to 
investigate how the TCA cycle behaved in these conditions. We performed the same analyses 
as for Cu excess conditions, which included protein levels of Sdh2 and Aco1 and measuring 
Aco1 activity. Using the Por1 protein levels changes as our control (Figure 4.3), we 
determined that the protein levels of both Sdh2 and Aco1 did not significantly change with 
any BCS treatment. On the other hand, Aco1 activity levels were higher at 100 µM and 500 
µM BCS compared to the control, but remained similar after treatment with 10 µM BCS. 
Interestingly, the Aco1 activity at 100 µM BCS was higher than measured activity at 500 µM 
BCS, which suggests a dose-dependent response to BCS and is reminiscent the pattern we 
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saw with Sod1 protein and activity levels with BCS. At 100 µM BCS, increased levels of 
Sod1 protein and activity suggest a decrease in mitochondrial ROS, which is in agreement 
with increased Aco1 protein levels, since they are sensitive to oxidative damage. Overall, the 
pattern we observed in TCA cycle protein levels and activity did not correlate with the 
significant decrease in COX activity. These preliminary data suggest that the loss of COX 
activity in Cu deficient conditions does not greatly influence flux through the TCA cycle. 
	
Figure 4.9 TCA cycle protein levels and Aco1 activity levels in Cu depletion conditions  
(A) Representative Western blots of mitochondrial protein samples (25 µg protein) using antibodies to proteins 
in the TCA cycle (Sdh2, Aco1). Blots were stained with Ponceau S prior to immunoblotting to ensure equal 
loading across all lanes of the gel. (B) Quantification of protein levels on Western blots relative to the no 
treatment control. Por1 (Figure 3.5) was used as the loading control. Using the changes in Por1 levels, any 
quantification above 1.28X or below 0.72X was considered to be significant. Quantification is the average of at 
least two separate subcellular fractionations. (C) Aconitase activity was assayed from mitochondrial fractions 
using citrate as the substrate. NADPH production was measured over 60 seconds at 340 nm (Bulteau et al, 
2003). Error bars represent ± SEM of duplicates of three separate mitochondrial isolations. 
 
Since increased Aco1 activity could imply either an increased flux through the TCA 
cycle or a decrease in oxidative stress, we asked if oxidative damage in mitochondria was 
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affected by treatment with 500 µM BCS. We performed the Oxyblot with samples exposed to 
500 µM BCS for 18 hours and compared the status of oxidative damage to the no treatment 
control. In the mitochondria, we saw less oxidative damage in the 500 µM BCS sample 
compared to the untreated sample (Figure 4.10). However, the whole cell lysates showed 
similar oxidative damage between the treated and untreated samples, and the cytosolic 
sample showed that the BCS-treated sample had increased oxidative damage compared to the 
control. In the mitochondria, the decrease in oxidative damage is in agreement with the 
increased Aco1 activity levels we observed. The retention of Sod1 activity in the 
mitochondria, but not in the cytosol, at 500 µM BCS is also consistent with the differing 
levels of oxidative damage we observe in the two compartments. Overall, our Oxyblot 
analyses revealed that in the presence of BCS, oxidative damage is variable between 
compartments but is similar in the whole cell compared to the untreated control. 	
	
Figure 4.10 Oxidative damage in Cu depletion conditions  
Carbonylation of proteins, a common form of oxidative damage, was measured in cell lysates (20 µg), 
mitochondria (25 µg) and cytosolic (25 µg) fractions after 18 hours of treatment with 500 µM BCS, using the 
Millipore OxyBlot Kit. Oxidized proteins were conjugated with 2,4-dintrophenylhydrazine (DNP) and then 
visualized by Western blotting using an anti-DNP antibody. Blots were done on two separate biological 
replicates (Soule, unpublished). 	
In keeping with analyses in Cu excess conditions, our final assay in Cu deficient 
conditions was analyzing transcript and protein levels of PIM1 (Lon), an important player in 
the mitochondrial proteasomal machinery. PIM1 has an essential role in the degradation of 
Cox2, which we observed to have almost undetectable protein levels at 500 µM BCS, and 
decreased protein levels at lower BCS concentrations. Therefore, we hypothesized that PIM1 
transcript levels and Lon protein levels are increased after BCS treatment compared to an 
untreated control. As expected, analysis of PIM1 transcript levels revealed a significant 
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increase at 500 µM BCS, but no changes at the lower BCS concentrations (Figure 4.11-A, 
4.11-B). The increase in transcript levels at 500 µM BCS was associated with no change in 
Lon protein levels, compared to the untreated sample. At 100 µM BCS, the unchanged PIM1 
transcript levels represented a slight decrease in Lon protein levels. At 10 µM BCS, the 
unchanged transcript levels were consistent with unchanged Lon protein levels. Overall, 
these results suggest that there is no obvious pattern between PIM1 transcript levels and Lon 
protein levels in the face of Cu deficiency. One possibility is that the decrease we saw in 
Cox2, a mitochondrial-encoded subunit of COX, is likely due to decrease transcription of the 
COX2 gene and not protein degradation, although we did not analyze other mitochondrial 
proteases. 
	
Figure 4.11 Analysis of mitochondrial Lon protease in Cu depletion conditions  
(A) Graphical representation of RT-qPCR data of PIM1 in Cu depletion conditions. RNA was isolated from 
yeast cells grown for 18 hours in YPD + BCS. PCR was performed using cDNA on both the gene of interest 
and ACT1 as a control. Values are representative of ΔΔCq values. Three biological replicates were performed 
for each concentration. A one-way ANOVA was done to determine statistical significance: not significant = n.s, 
p < 0.05 = *. Error bars represent ± SEM (B) Raw ΔΔCq values, representing the fold-change in each condition 
relative to ACT1. (C) Representative Western blot of mitochondrial protein samples (25 µg protein) using 
antibody to Lon. Blots were stained with Ponceau S prior to immunoblotting to ensure equal loading across all 
lanes of the gel. (D) Quantification of protein levels on Western blots relative to the no treatment control. Por1 
(Figure 3.5) was used as the loading control. Using the changes in Por1 levels, any quantification above 1.28X 
or below 0.72X was considered to be significant. Quantification is the average of at least two separate 
subcellular fractionations. 
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4.2	Examining	Cu	Deficiency	in	Mitochondria	with	Galactose	
The phenomenon of glucose repression in yeast occurs when glucose is used as the 
primary energy source, and results in repression of respiration and gluconeogenesis (Kayikci 
& Nielson, 2015). When using galactose as a carbon source, S. cerevisiae must convert it to 
glucose before it can enter glycolysis, and this process requires energy. Recent studies have 
proposed that Sod1 has a role in glucose repression in yeast through its interaction with yeast 
casein kinase 1 (Yck1), which is required for respiratory repression (Reddi & Culotta, 2013). 
Furthermore, Yck1 has been found to localize to the plasma membrane but translocates to the 
mitochondrial membrane during glucose repression and is dynamically tethered there by 
protein palmitoylation (Matic et al, 2018). We wondered if the preferential donation of Cu to 
mitochondrial Sod1 during Cu deficient conditions was related to glucose repression. 
Therefore, we asked if and how mitochondrial function was altered in Cu excess and Cu 
deficient conditions with galactose as the primary carbon source. 
Before investigating changes in respiratory function with galactose in Cu deficient 
conditions, we wanted to confirm that altering Cu availability affected the cellular 
physiological response, similar to what we did in section 3.1. To measure the response, we 
incubated cells with galactose and CuSO4 or BCS for 18 hours and then isolated RNA from 
cells. We found that CTR1 and CUP1 transcript levels, our controls that are expected to 
change with altered Cu availability, were significantly affected (Figure 4.12). CTR1 
transcript levels significantly decreased with excess Cu and increased with Cu deficiency, 
confirming that cells were transcriptionally responding to the changing Cu environment. In 
contrast, CUP1 transcript levels significantly increased with excess Cu and decreased with 
limiting Cu. Interestingly, the changes in CTR1 transcript levels were more pronounced with 
galactose, but the differences we observed in CUP1 transcript levels were less obvious in 
galactose when compared to glucose (Figure 3.1). Overall, the differences detected in CTR1 
and CUP1 transcript levels with changing Cu availability confirmed that cells were 
appropriately responding when they were grown in galactose as the primary carbon source.	
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Figure 4.12 RT-qPCR of CTR1, CUP1, MAC1, and CUP2 with galactose as a carbon source  
(A) Graphical representation of relative abundance of CTR1 and CUP1 compared to no treatment controls. 
RNA was isolated from yeast cells grown for 18 hours in the Cu condition stated. PCR was performed using 
cDNA on both the gene of interest and ACT1 as a control. Values are representative of ΔΔCq values. Three 
biological replicates were performed for each treatment condition. A one-way ANOVA was done to determine 
statistical significance: not significant = n.s, p < 0.05 = *, p < 0.01 = **. Error bars represent ± SEM. (B) 
Graphical representation of relative abundance of MAC1 and CUP2 compared to no treatment controls. RT-
qPCR and statistics were performed exactly as described in A. (C) Raw ΔΔCq values, representing the fold-
change in each condition relative to ACT1. 	
We also evaluated transcript levels of MAC1 and CUP2, the Cu-responsive 
transcription factors in yeast. With galactose and excess Cu, qPCR analysis revealed a 
significant decrease in both MAC1 and CUP2 transcript levels (Figure 4.12). In glucose, we 
observed a significant increase in transcript levels of MAC1 and CUP2 with excess Cu 
(Figure 3.3), which was the first indication that cells respond differently to excess Cu based 
on carbon source. In galactose, we had observed a significant decrease in both MAC1 and 
CUP2 transcript levels in Cu deficient conditions, resembling the pattern we saw when using 
glucose. However, the small decrease we saw in MAC1 transcript levels with glucose was not 
significant, even though it was significant in galactose. Taken together, these results highlight 
transcriptional differences in excess Cu conditions but suggest that transcript levels of MAC1 
and CUP2 are not significantly altered by differing carbon sources during Cu deficiency. 
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In addition to examining the transcript levels depicted in Figure 4.12, we also 
measured transcript levels for TDH2, COX17, SCO1, COX11, COX4, CCS1, SOD1, and 
PIM1. These results are presented in Appendix A, as they were not immediately relevant to 
the main theme of this chapter. 
4.2.2	Effect	of	carbon	source	on	COX	during	Cu	depletion	
Our comparison between COX and Sod1 activity in glucose during Cu deficient 
conditions suggested that with limiting Cu, mitochondrial Sod1 is first in line for acquiring 
Cu. Since Sod1 has been proposed to have a role in glucose repression, we were curious 
whether Cu distribution during Cu deficiency changed with galactose as the primary energy 
source. Therefore, we performed a side-by-side analysis with a no treatment and 500 µM 
BCS treated sample in glucose and galactose. For our analysis, we investigated COX 
assembly factor and subunit protein levels, COX activity levels, Sod1 protein and activity 
levels, and Lon, Sdh2, and Aco1 protein levels and Aco1 activity levels as described earlier.  
The increase in Cox17 protein levels after treatment with 500 µM BCS was similar 
between carbon sources, but exaggerated in galactose, as Cox17 protein levels increased 
7.58X compared to the untreated sample. The trends between Sco1 and Cox11 protein levels 
were less noticeable: Sco1 protein levels were slightly decreased in glucose but similar in 
galactose, and Cox11 protein levels decreased in both carbon sources after BCS treatment. 
The two COX subunits, Cox4 and Cox2, were both barely detectable in either carbon source 
at 500 µM BCS compared to the no treatment control. Lastly, Cyc1 protein levels slightly 
increased in glucose and were down by 51% in galactose following BCS exposure. 
Biological replicates of Cyc1 blots done in section 4.1 suggested that protein levels in 
glucose decrease at 500 µM BCS, while these results suggest they slightly increase. Overall, 
it is likely that Cyc1 levels are not significantly changed at 500 µM BCS as the changes we 
observed were minor.  
As expected, our measurements of COX activities revealed more activity in the 
galactose control compared to the glucose control (Figure 4.13-C). This is due to glucose 
repression, which decreases mitochondrial respiration. However, after BCS exposure, COX 
activity was severely reduced in both carbon sources. In glucose, COX activity dropped 75% 
after treatment with BCS, while a 90% decrease in COX activity was found when galactose 
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was the carbon source. Taken together, the loss of COX subunit protein levels and the lack of 
COX activity we observed after treatment with 500 µM BCS occurs independent of carbon 
source. 
	
Figure 4.13 Mitochondrial protein levels and COX activities with glucose (Glc) and galactose (Gal) in Cu 
deficient conditions  
(A) Representative Western blots of mitochondrial protein samples (25 µg protein) using antibodies to proteins 
involved in COX assembly (Cox17, Sco1, Cox11), COX subunits (Cox2, Cox4), or other mitochondrial protein 
(Cyc1, Por1). All blots were stained with Ponceau S prior to immunoblotting to ensure equal loading across all 
lanes of the gel. (B) Quantification of protein levels on Western blots relative to the no treatment control. Por1 
was used as the loading control. Using the changes in Por1 levels, any quantification above 1.02X or below 
0.98X for glucose and above 1.30X or below 0.7X of was considered to be significant. (C) Mitochondrial 
fractions were tested for COX activity by measuring the oxidation of reduced cytochrome c at 550 nm for 60 
seconds. Each sample was run in duplicate and the error bars represent the range between replicates. All results 
in this figure are from one subcellular fractionation. 
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4.2.3	Effect	of	carbon	source	on	mtSod1	during	Cu	depletion	
Although we did not observe a major difference between carbon sources with respect 
to COX protein levels and activity, we sought to clarify whether Sod1 behaved similarly. We 
performed Western blotting and SOD activity assays on mitochondrial protein fractions in 
glucose and galactose, with and without treatment of 500 µM BCS. The retention of Sod1 
protein and activity levels with glucose was reproducible between the no treatment ant 500 
µM BCS samples (Figure 4.14). Strikingly, the protein and activity levels of mtSod1 in cells 
grown in galactose were almost undetectable at 500 µM BCS compared to the no treatment 
control. Specifically, Sod1 protein levels went down to 10% of control and activity levels 
went down by 65%, and these trends were reproducible in two separate subcellular 
fractionations. The decrease in Sod1 activity levels and the loss of COX activity suggest that 
in galactose, both major mitochondrial cuproprotein pools are lacking Cu. Because Sod1 has 
been suggested to play an essential role in glucose repression (Reddi & Culotta, 2013), these 
data suggest that the mitochondrial pool of Sod1 is likely important for this function. 
	
Figure 4.14 Sod1 protein and activity levels in glucose (Glc) and galactose (Gal)  
(A) Representative Sod1 Western blot (25 µg protein) and SOD activity gel (48 µg protein) using mitochondrial 
protein samples. SOD activity was measured in-gel using a well-established method (Beauchamp & Fridovich, 
1971). (B) Quantification of protein and activity levels relative to the no treatment control. Using the changes in 
Por1 levels (Figure 4.13) we defined significant changes in levels of Sod1. Quantification of protein and activity 
levels is from one subcellular fractionation. 
4.2.4	Effect	of	carbon	source	on	mitochondrial	function	during	Cu	deficiency	
The major difference we see after changing the primary carbon source from glucose 
to galactose is the loss of Sod1 protein and activity in the mitochondria after exposure to 500 
µM BCS. While we observed that retention of Sod1 activity did not have a major affect on 
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TCA cycle function or mitochondrial proteasomal activity in glucose grown cells, we assayed 
Lon, Sdh2, and Aco1 protein levels as well as Aco1 activity in galactose after treatment with 
BCS. While PIM1 transcript levels seem to be unaffected with BCS treatment in galactose 
(Appendix A), Lon protein levels increased with the treatment (Figure 4.15-A, 4.15-B). 
Increased Lon protein levels could explain the loss of Cox2 in galactose after BCS treatment. 
Our results regarding PIM1 transcript levels and Lon protein levels highlight the lack of 
congruence in transcript and protein levels, which has been reported previously (Dubinski et 
al, 2018).  
In glucose, Sdh2 and Aco1 protein levels were similar at 500 µM BCS compared to 
the no treatment control (Figure 4.15-A, 4.15-B), similar to our observations in Figure 4.9. 
However, after exposure to 500 µM BCS in galactose, both Sdh2 and Aco1 protein levels 
decreased compared to the untreated sample. Therefore, we concluded that the Sod1 protein 
levels behaved similarly to the Sdh2 and Aco1 protein levels. In glucose, protein levels were 
similar with and without BCS treatment, but in galactose, protein levels decreased after 
treatment with BCS. Analysis of Aco1 activity showed that in galactose, the decrease in 
protein levels of Aco1 from the no treatment control to the 500 µM BCS sample correlated 
with a decrease in Aco1 activity levels (Figure 4.15-C). Taken together, these data show a 
correlation between electron transport and TCA cycle activity in galactose in Cu deficient 
conditions, but display a disconnect between the two pathways in glucose when Cu is 
limiting. 
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Figure 4.15 TCA cycle analysis in glucose (Glc) and galactose (Gal)  
(A) Representative Western blots of mitochondrial protein samples (25 µg protein) using antibodies to proteins 
in the TCA cycle (Sdh2, Aco1). Blots were stained with Ponceau S prior to immunoblotting to ensure equal 
loading across all lanes of the gel. (B) Quantification of protein levels on Western blots relative to the no 
treatment control. Por1 (Figure 4.13) was used as the loading control. (C) Aconitase activity was assayed from 
mitochondrial fractions using citrate as the substrate. NADPH production was measured over 60 seconds at 340 
nm (Bulteau et al, 2003). Error bars represent ± range of duplicates from one subcellular fractionation. 
4.3	Summary	of	Results		
When extracellular Cu is limiting, cells are forced to prioritize Cu distribution 
between all cuproproteins. Our first indication that COX was not a priority during Cu 
deficiency was that we observed a decrease in COX4 transcript levels. We found that, after 
exposure to 500 µM BCS, Cu appeared to be preferentially donated to mtSod1. Interestingly, 
although we observed a loss of COX activity during Cu depletion, we observed an increase 
of mitochondrial Cox17 protein levels while the levels in the cytosol and in the whole cell 
remained constant. Furthermore, the increase in mitochondrial Cox17 protein levels was 
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accompanied by no change in Sco1 protein levels and a decrease in Cox11 protein levels, 
even though these proteins all work together in Cu delivery to COX. The patterns we 
observed in mitochondrial COX and Sod1 activities corresponded to minimal effects on the 
TCA cycle or proteasomal activity, and a decrease in mitochondrial oxidative damage. 
To check if glucose repression was affecting Cu distribution during depletion, we 
tested similar parameters using galactose as our primary carbon source. We showed that 
when cells are grown in galactose, they still physiologically respond to changes in 
extracellular Cu. Changing the carbon source to galactose did not affect the loss of COX 
activity we observed in glucose, but it did result in decreased levels of TCA cycle proteins 
and decreased Aco1 activity after cells were exposed to 500 µM BCS. Most importantly, the 
change of carbon source to galactose coincided with a loss of mtSod1 protein and activity 
levels, demonstrating that both mitochondrial cuproprotein pools are inactive with galactose 
and BCS treatment. 																										
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Chapter	5:	Cu	Availability	and	Cell	Cycle	Progression		
Our investigation of mitochondria under changing Cu conditions highlighted 
differences between Cu excess and deficiency. Preliminary results had shown that the Cox17 
KO, Sco1 KO, and Cox11 KO strains exhibited a generalized problem with cell cycle 
progression (Camasta, 2017). In contrast, other COX assembly mutants unrelated to Cu, the 
Cox15 KO and Cox4 KO, did not show the same problem. Therefore, we hypothesized that 
cell cycle delay we observed might be due to Cu imbalance in the cell. To support this, there 
are known cell cycle defects in the Sod1 mutant, which also has problems with Cu 
homeostasis (Carter et al, 2005). In this chapter, we explore the mechanism behind the cell 
cycle defect seen in certain COX assembly mutants, and investigate cell cycle progression in 
wild type yeast exposed to Cu excess or Cu deficient conditions. 
5.1	COX	Assembly	Mutants	and	Cell	Cycle		
Our initial analysis of cell cycle progression in mitochondrial mutants was undertaken 
because we saw abnormalities in budding indices during stationary phase in a subset of COX 
assembly mutants (Glerum lab, unpublished). We were interested to see if the anomalies in 
budding indices correlated with a cell cycle defect in COX assembly mutants. By using 
synchronized cultures and flow cytometry analysis, we found a cell cycle defect in our 
cuproprotein mutants (Cox17 KO, Sco1 KO, Cox11 KO), which we defined as a generalized 
cell cycle delay (Camasta, 2017).  
The cell cycle progression issue in the COX assembly mutants was thought to be 
associated with an increased oxidative stress baseline in those mutants, due to the fact that 
the respiratory chain is one of the major producers of ROS in the cell. In addition, oxidative 
stress has been reported to be associated with cell cycle defects (Shapira et al, 2004). 
Therefore, we were interested to test sensitivity of the mitochondrial mutants to hydroxyurea 
(HU), a DNA damaging agent that has recently been proposed to also cause oxidative stress 
(Singh & Xu, 2017). At first, we tested for growth defects at a concentration of 240 mM HU, 
where the wild type strain appeared to have a growth defect (Camasta, 2017). Results did 
show a differential response by the cuproprotein mutants, suggesting they are more sensitive 
to the HU insult (Camasta, 2017).  
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To get a better picture of the HU sensitivities of the wild type strain and the COX 
assembly mutants, we performed spot plate assays with lower concentrations of HU. We used 
the Rad53 Sml1 double KO as a control, as it is known to display a major growth defect 
when exposed to low concentrations of HU (Desany et al, 1998). At 50 mM and 100 mM 
HU, which we saw caused a major growth defect in the Rad53 Sml1 double KO strain, we 
saw no growth defect in either the wild type strain or the COX assembly mutants (Figure 5.1-
A). These results suggested that the cell cycle defect seen in the cuproprotein mutants was 
not as severe as the one in the Rad53 Sml1 double KO. Since HU is known to interfere with 
dNTP production and cause oxidative stress, doing these experiments in hypoxic conditions 
would allow for differentiation of the underlying cause of the growth defect. 
To mechanistically understand the cause of the cell cycle defect in the cuproprotein 
mutants, we compared protein levels of Rad53 in the wild type strain and the COX assembly 
mutants. Rad53 is essential for cell cycle control in yeast and has two major functions: 
halting cell cycle progression in the presence of DNA damage and initiating a pathway that 
leads to a spike in dNTP pool production (Barnum & O’Connell, 2014).  
Western blotting analysis of Rad53 in the COX assembly mutants revealed similar 
protein levels across the majority of the mutants (Figure 5.1-B, 5.1-C). One exception was in 
the Cox11 KO, where Rad53 protein levels decreased slightly compared to the Act1 loading 
control. Overall, the Rad53 protein levels are in agreement with our previous data (Camasta, 
2017). It is important to note that although the Rad53 protein levels are similar between the 
wild type strain and most of the mitochondrial mutants, they do not give an indication of 
activity, which is done using a phosphorylation assay. Preliminary data from collaborators 
indicates that the Cox11 KO also has a problem with Rad53 activity (Duncker lab, 
unpublished). The fact that Rad53 seems to have lower activity in the Cox11 KO should 
mean there is no delay in cell cycle since Rad53 halts the cell cycle and generates an 
imbalance in the dNTP pools. 
Because Rad53 also has an impact on dNTP pools, we performed Western blotting to 
detect protein levels of Rnr3 in the wild type strain and mitochondrial mutants (Figure 5.1-B, 
5.1-C). Rnr3 is one of the four RNR subunits and is thought to be a good marker for dNTP 
pools. Consistent with a decrease in Rad53 protein levels and activity, we found that Rnr3 
protein levels in the Cox11 KO are lower than protein levels seen in the wild type strain. In 
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contrast, the levels of Rnr3 in all other mitochondrial mutants were not different from the 
wild type strain or from each other. Overall, the cell cycle delay seen in the Cox17 and Sco1 
KO strains does not appear to be associated with changes in Rad53 or Rnr3 protein levels. 
However, the cell cycle defect in the Cox11 KO is correlated to decreased Rad53 and Rnr3 
protein levels, as well as decreased Rad53 activity. 
	
Figure 5.1 Analysis of cell cycle in COX assembly mutants  
(A) Spot plates of COX assembly mutants on YPD + hydroxyurea (HU). Plates were incubated at 30°C for 2 
days and imaged. (B) Western blots of cell lysate protein samples (60 µg) using antibodies against Rad53, Rnr3, 
and Act1. Blots were cropped from two separate gels. (C) Quantification of Western blots relative to the WT 
strain. Act1 was used as a loading control. These experiments were done on one protein isolation. Tyler Soule 
helped perform the Western blots in (B). 
5.2	Cu	Availability	and	Cell	Cycle	Progression		
The differences in Rad53 and Rnr3 protein levels in the Cox17, Sco1, and Cox11 KO 
strains suggested that the cell cycle defect in the Cox17 and Sco1 KO occurs by a different 
mechanism from that of the Cox11 KO. However, all three of these proteins are involved in 
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Cu delivery to COX, suggesting that they all have imbalanced cellular Cu levels. Therefore, 
we wanted to ask whether Cu imbalance affected cell cycle progression and if under these 
treatment conditions, we could reproduce the generalized cell cycle delay we saw in the 
cuproprotein mutants. 
Similar to our previous analyses with the mitochondrial mutants, cell cycle 
progression was tested with a flow cytometry approach. First, we incubated our cells for 18 
hours in the same concentrations of CuSO4 and BCS as used throughout this study and were 
optimized in section 3.1. Cells were then transferred to new media and exposed to the mating 
hormone α-factor, which arrests them in G1 phase. After this, cells were released into fresh 
YPD containing either excess or limiting Cu, allowing them to synchronously enter the cell 
cycle so progression could be monitored. Aliquots were collected at 0, 40, 80, and 120 
minutes after release and were stained with Sytox Green to measure DNA content. From the 
literature, the average yeast cell cycle should take 125 +/- 9 minutes, with the G1-S phase 
taking approximately 54 minutes (Shaw et al, 1998). Therefore, at the 120-minute time point, 
we should expect to see slight return of the 1N peak as some cells have completed 
cytokinesis. 
The results for cell cycle progression with excess Cu treatment are shown in Figure 
5.2. In the no treatment control, we observed that almost all cells had duplicated their DNA 
after 40 minutes, because of the absence of the G1 peak and the presence of the G2 peak. At 
the 120-minute time point in the WT, we started to see slight return of the G1 peak, as 
expected. The sample treated with 0.01% Cu looked similar to the no treatment control, 
indicating that this treatment has little effect on cell cycle progression. However, the sample 
treated with 0.1% Cu seemed to have a major cell cycle defect. Specifically, the G1 peak was 
present at all time points, suggesting that after treatment with 0.1% Cu some cells are stuck 
in G1 and cannot replicate their DNA. There is also a sub-G1 peak to the left of the G1 peak 
that represents cells containing less that 1N DNA. Reports in the literature suggest that these 
cells are apoptotic (Burhans et al, 2003), since high Cu concentrations cause oxidative stress, 
which likely leads to DNA damage and apoptosis. Taken together, these results show a cell 
cycle defect after treatment with 0.1% Cu, but not at the lower concentration of 0.01% Cu.		
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Figure 5.2 Cell cycle analysis after treatment with excess Cu  
Chromatograms representative of cell cycle progression. Cells were arrested in G1 by treatment with α-factor 
and then released into fresh media with excess Cu and collected at 40-minute intervals for 120 minutes. 
Subsequent staining with SyTOX Green and processing through flow cytometry resulted in the chromatograms 
shown here. The G1 peak denotes cells with 1N DNA and the G2 peak denotes cells with 2N DNA. The y-axis 
represents frequency and the x-axis represents fluorescence intensity. These experiments were repeated 3 times. 
Tyler Soule obtained these results. 	
Using the same flow cytometry approach, we also monitored cell cycle progression of 
wild type yeast after treatment with BCS. Exposure to BCS likely resembles problems in Cu 
concentration in the Cox17, Sco1, and Cox11 KO strains, as it has been shown that a Sco1 
KO mouse has Cu deficient tissues (Baker et al, 2017b). Because these KO strains are the 
ones in which we observed a cell cycle delay, identifying a defect in a generalized Cu 
deficiency could provide important clues to the mechanism causing the delay in the 
cuproprotein mutants.  
After exposure to BCS, cell cycle progression appeared to be similar between the 
BCS-treated samples and the control (Figure 5.3). At the 40-minute time point, the no 
treatment control and all the BCS treatment conditions had a prominent G2 peak, indicating 
that cells are all progressing through the cell cycle at a comparable pace. Similarly, at the 
120-minute time point, the G1 peak seems to be returning in all of the samples. Even though 
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we clearly showed that BCS treatment impacts mitochondrial function in Chapter 4, the cell 
cycle analysis shown here suggests that BCS treatment does not affect cell cycle progression. 		
	
Figure 5.3 Cell cycle analysis after treatment with BCS  
Chromatograms representative of cell cycle progression. Cells were arrested in G1 by treatment with α-factor 
and then released into fresh media with BCS and collected at 40-minute intervals for 120 minutes. Subsequent 
staining with SyTOX Green and processing through flow cytometry resulted in the chromatograms shown here. 
The G1 peak denotes cells with 1N DNA and the G2 peak denotes cells with 2N DNA. The y-axis represents 
frequency and the x-axis represents fluorescence intensity. These experiments were repeated 3 times. Tyler 
Soule obtained these results. 	
The fact that Cu excess conditions but not Cu deficiency affects cell cycle progression 
led us to ask whether there were any changes in Rad53 protein levels after changing Cu 
availability. Therefore, we performed Western blotting on whole cell lysates after treatment 
with either Cu or BCS. We found that after exposure to excess Cu, Rad53 protein levels were 
decreased in both treatment conditions compared to the control (Figure 5.4). This was 
unexpected, since we observed a defect in cell cycle progression only in the sample treated 
with 0.1% Cu. The decrease in Rad53 protein levels associating with cells stuck in the G1 
phase is contradictory, given that increased Rad53 activity is required to introduce a cell 
cycle delay. Alternatively, the decrease is Rad53 protein levels could suggest that dNTP 
pools are lower, which is why we saw cells that cannot progress through DNA replication 
	 81 
(Figure 5.2). As we expected, Rad53 protein levels are unaffected across BCS treatments 
(Figure 5.4), which is in agreement with the normal cell cycle progression we saw in these 
treatment conditions. 		
	
Figure 5.4 Rad53 protein levels with different Cu availability conditions  
(A) Western blots of cell lysate protein samples (60 µg) using antibodies against Rad53 and Act1. (B) 
Quantification of Rad53 protein levels relative to the no treatment control. Act1 was used as the loading control. 
These experiments were done on one protein isolation.  	
One major difference we observed in Section 4.2 when changing carbon source from 
glucose to galactose was the absence of mitochondrial Sod1 after treatment with 500 µM 
BCS. A previous study has reported that Sod1 plays a role in cell cycle progression through 
an interaction with Rad53 (Dong et al, 2013). The fact that a Sod1 KO yeast strain exhibits a 
cell cycle delay (Carter et al, 2005) further illustrates that the presence of Sod1 is likely 
necessary for normal cell cycle progression. This prompted us to test whether a strain grown 
in galactose with 500 µM BCS showed a cell cycle defect, since Sod1 is not present in either 
the mitochondria or cytosol under these conditions (Section 4.2).  
For this experiment, we used our glucose data as a control since we previously saw 
that BCS did not affect cell cycle progression when grown in glucose as a carbon source 
(Figure 5.3). Our results using glucose as the carbon source were extremely similar to those 
in Figure 5.3, demonstrating that the data are reproducible (Figure 5.5). When comparing our 
no treatment controls in the two different carbon sources, we saw that at the 120-minute time 
point the G1 peak return is much more noticeable when cells are grown in galactose, 
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suggesting that cells grown in these conditions have different cell cycle timing and may have 
a shorter G2/M phase. Cells exposed to 500 µM BCS displayed two minor differences when 
compared to the galactose no treatment control. First, at the 40-minute time point, there 
seemed to be more cells that have not progressed to the G2 phase in the BCS treated sample, 
suggesting a minor cell cycle delay. However, comparison of the chromatograms at 120 
minutes displayed a larger G1 peak in the BCS treated sample. Taken together, treatment 
with BCS using galactose as a carbon source may result in a delayed G1 phase, but an 
accelerated pathway through mitosis. 	
	
Figure 5.5 Cell cycle analysis with different carbon sources  
Chromatograms representative of cell cycle progression. Cells were arrested in G1 by treatment with α-factor 
and then released into fresh media with BCS and collected at 40-minute intervals for 120 minutes. Subsequent 
staining with SyTOX Green and processing through flow cytometry resulted in the chromatograms shown here. 
The y-axis represents frequency and the x-axis represents fluorescence intensity. The G1 peak denotes cells 
with 1N DNA and the G2 peak denotes cells with 2N DNA. These experiments were done once. 
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5.3	Summary	of	Results		
We began investigation of cell cycle by further analyzing mitochondrial cuproprotein 
mutants we previously showed to have a cell cycle defect. We found that at lower 
concentrations of HU, our mitochondrial mutants do not display a growth defect compared to 
the Rad53Sml1 double KO control. Because the Cox11 KO presents with lower Rad53 and 
Rnr3 protein levels compared to the wild type train, we propose that the Cox11 cell cycle 
delay is based on decreased dNTP production and therefore decreased replication rates. In 
contrast, the Cox17 and Sco1 KO strains have similar Rad53 and Rnr3 protein levels. 
Our analysis of cell cycle progression in generalized Cu problems revealed that with 
0.1% Cu, many cells are unable to progress past replication, and this is associated with a 
decrease in Rad53 protein levels. On the other hand, treatment with 0.01% Cu resulted in no 
obvious cell cycle defect but a decrease in Rad53 protein levels. Taken together, our results 
show that all BCS treatment conditions did not affect cell cycle progression or Rad53 protein 
levels.  
Lastly, we observed changes in cell cycle progression between carbon sources. Our 
preliminary results may suggest that BCS affects cell cycle progression in galactose, which 
would allow us to further investigate if and how mitochondrial Sod1 plays a role in cell 
replication. 
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Chapter	6:	Discussion		
The impacts of excess and limiting levels of Cu have been thoroughly studied at the 
system and organ levels in humans because of the debilitating clinical phenotypes seen in 
Wilson and Menkes diseases. Cu imbalance has also been observed in patients with 
mitochondrial defects and neurodegenerative disorders, highlighting the importance of Cu 
homeostasis in cells. However, the subcellular effects of exposure to changes in Cu 
concentrations are largely unexplored; as the locus for important cuproproteins and a storage 
space for Cu, mitochondria are considered to be central players in cellular Cu homeostasis. 
Additionally, recent reports have proposed a link between Cu homeostasis and cell cycle 
control. Therefore, our goal in this study was to analyze how excess or limiting levels of 
extracellular Cu impact mitochondrial function. 
6.1	Existence	of	a	Mitochondrial	Matrix	Cu	Pool	
In 2004, a non-proteinacious ligand (CuL) in the mitochondrial matrix was proposed 
to house the majority of mitochondrial Cu (Cobine et al, 2004). CuL exists as a soluble 
anionic complex and functions to store Cu, but the structure of CuL has not been clearly 
defined. Additionally, it has been suggested that CuL is the source of Cu for the 
mitochondrial cuproproteins COX and Sod1 (Cobine et al, 2006). The current understanding 
in the field is that the pool acts as a storage space for Cu, in the case that there is a problem 
with Cu concentrations in the surrounding environment (Horn & Barrientos, 2008). In Cu 
excess conditions, mitochondria could operate as a Cu sink to prevent toxicity of the metal in 
the cytosol, while in Cu deplete conditions the pool could provide a source of Cu to maintain 
functionality of cuproproteins (Dodani et al, 2011). Our data from this study provide insight 
into the behavior of the proposed matrix Cu pool with varying Cu availability. 
In Wilson disease models, which are defined to have excess Cu, mitochondria are Cu 
overloaded resulting in severe structural and functional defects (Zischka & Lichtmannegger, 
2014). One report suggested that there is an upper limit of Cu storage space in mitochondria, 
and that Cu transport to the CuL in the matrix is constitutive (Baker et al, 2017a). If the 
mitochondria are a main Cu storage location, we expect that cells will upregulate 
mitochondrial cuproproteins to compensate for the increased levels of Cu in the 
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mitochondria. However, our results show no change in transcript levels for COX17, SCO1, 
COX11, or COX4 under excess Cu conditions. On the other hand, we do observe that Cox2 
and Cox4 protein levels and COX activity are significantly increased at 0.01% and 0.1% Cu 
compared to the control, which suggests that COX is stabilized with higher levels of cellular 
Cu. COX activity values are 1359 nmol mg-1 min-1 and 1350 nmol mg-1 min-1 with 0.01% 
and 0.1% Cu, compared to 560 nmol mg-1 min-1 in the control. We do detect upregulation of 
CCS1 and SOD1 after treatment with excess Cu, which corresponds to higher mitochondrial 
Sod1 protein levels and a 1.6X increased SOD activity with 0.01% Cu and a 2.19X increase 
with 0.1% Cu. Finally, our results reveal higher levels of mitochondrial oxidative damage 
with 0.1% Cu, compared to a slight decrease in oxidative damage at the level of the whole 
cell. Overall, increases in activities of mitochondrial cuproproteins and more oxidative 
damage are consistent with the existence of a Cu pool located in the mitochondrial matrix 
that is responsible for Cu storage when the metal is in excess. 
During Cu deficiency, the CuL is proposed to serve as an important source of Cu to 
ensure function of cuproproteins. Therefore, as we increase the concentration of BCS, we 
expect a threshold of mitochondrial cuproprotein activity once the mitochondria are depleted 
of Cu. In limiting Cu conditions, we selectively lose function of cytosolic Sod1, but not 
mtSod1, which is in agreement with the existence of the CuL. This is also consistent with the 
Cu pool in the matrix being the storage for Cu when the metal is depleted. We also see an 
increase in transcript levels of CTR1 after BCS treatment, suggesting that some Cu is 
entering the cell through the plasma membrane. On the other hand, as we increase the 
concentration of BCS, the SOD activities in the mitochondria are 94%, 120%, and 70% with 
10 µM, 100 µM, and 500 µM BCS compared to the control. In contrast, COX activity 
gradually decreases from 470 nmol mg-1 min-1 to 71 nmol mg-1 min-1, the latter resembling 
auto-oxidation, as BCS concentration increases to 500 µM. The potential reasons for the 
retention of SOD activity in the face of decreasing COX activity at 500 µM BCS will be 
discussed in detail in section 6.4. However, the trends we observe with SOD and COX 
activities contradict the proposal that the CuL is the source of Cu for these enzymes. There is 
more SOD activity at 100 µM BCS than 10 µM BCS, when the 100 µM BCS treatment 
should negatively impact mitochondrial Cu concentrations. We also observe a gradual 
decrease in COX activity instead of a threshold, which we would expect if the mitochondrial 
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pool were to be completely depleted of Cu. We still do not understand the mechanism in 
which Cu is delivered to Sod1 and COX, and whether this delivery mechanism is constitutive 
or inducible would impact the activities of these proteins under Cu deficiency. 
The severe defect in mitochondrial cuproprotein function that is present with limiting 
Cu in galactose as the primary carbon source casts doubt on the existence of a mitochondrial 
Cu pool being the primary source of Cu for IMS residents. In the first description of the 
mitochondrial Cu pool, the authors found that carbon source does not influence the amount of 
mitochondrial Cu (Cobine et al, 2004). This indicates that if the CuL in the matrix were the 
primary source of Cu for Sod1 and COX, we would expect to see the same trends both in 
glucose or galactose. Our results reveal that in galactose, SOD activity is at 35% of control 
levels after exposure to 500 µM BCS, which is much lower than the activity we observe 
when glucose is the primary carbon source. The trends in COX activities between glucose 
and galactose with limiting Cu are consistent with each other. The divergent trends we 
observe between glucose and galactose do not fit with the current proposal that the CuL is 
unaffected by carbon source. Overall, our results do not contradict the existence of a Cu pool 
in the mitochondrial matrix, but do contradict the hypothesis that the CuL is the source of Cu 
for Sod1 and COX in the IMS. The system of regulation of mitochondrial cuproprotein pools 
is poorly understood and our data suggest the need to reconsider the current model.  
6.2	Cox17:	the	outlier	among	COX	assembly	factors	
Cox17 is dually localized between the mitochondria and the cytosol, with 60% 
existing in the mitochondria and 40% residing in the cytosol (Beers et al, 1997). Its accepted 
function is in the mitochondrial IMS for delivery of Cu to Sco1 and Cox11. However, there 
has yet to be a defined function for the cytosolic pool of Cox17. Fumarase is an example of a 
protein that is only known for its mitochondrial function, yet is dually localized to the 
mitochondria and the cytosol; this is known to arise from incomplete uptake of fumarase into 
the mitochondria (Maxfield et al, 2004). It has been proposed that this is also the case for 
Cox17 (Maxfield et al, 2004), although other results suggest that cytoplasmic pool of Cox17 
may have an alternate role. Surprisingly, site-directed mutagenesis of the Cox17 amino acid 
sequence revealed relatively few mutations that led to a detectable respiration defect (Punter 
& Glerum, 2003) suggesting that amino acid substitutions with no effect on COX activity 
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may, in fact, affect secondary pathways. In addition, it has been reported that a Cox17 KO 
has defective Mac1 activity in low Cu conditions, similar to the Sod1 KO, suggesting that 
both Cox17 and Sod1 are required for induction of Ctr1 (Wood & Thiele, 2009). This 
observation may be related to the fact that Cox17 has the ability to form poly-copper clusters, 
which consist of dimeric Cox17 in the cytosol or tetrameric Cox17 in the mitochondria 
(Heaton et al, 2001).  
In addition to published experiments, our observations from studying COX assembly 
mutants, which are unable to assemble functional COX and are therefore respiration 
deficient, similarly suggest that Cox17 participates in other pathways. Firstly, COX17 
transcript levels increase in several other COX assembly mutants when compared to a 
respiratory competent strain (Dubinski, unpublished). In comparison, the COX4 gene, which 
encodes a subunit of COX, has a decrease in transcript levels in the same COX assembly 
mutants when compared to a respiratory competent strain. Increased COX17 transcript levels 
in the face of decreased COX4 transcript levels in COX assembly mutants suggests that 
upregulation of the COX17 gene does not correlate with its role in COX assembly (Dubinski, 
unpublished). Additionally, bioinformatics analysis reveals that a subset of nematodes and 
trematodes that have a functional COX do not contain a COX17 gene, indicating that these 
organisms do not require Cox17 for respiration (Collington, unpublished). Taken together, 
our recent observations point to the existence of an alternate function for Cox17. For many 
years, we have been focused on defining a secondary function for the cytosolic pool of 
Cox17. Although a function for cytosolic Cox17 may exist, the results presented in this study 
strongly suggest a secondary function unrelated to COX assembly for the mitochondrial pool 
of Cox17. 
Our results in limiting Cu conditions reveal a 1.49X increase in Cox17 protein levels 
after exposure to 500 µM BCS. However, this increase is unrelated to the function of Cox17 
in COX assembly, since Cox2 and Cox4 protein levels decrease significantly and COX 
activity decreases to 71 nmol mg-1 min-1 in the same conditions. In galactose and Cu deplete 
conditions, Cox17 protein levels also increase in the mitochondria by 7.36X compared to the 
no treatment sample, which is more prominent compared to glucose. We think this is due to 
activity of Puf3, an RNA binding protein that binds to the 3’UTR of Cox17 and degrades it in 
glucose, but not galactose (Miller et al, 2014). Puf3 binding to Cox17 in galactose only is 
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also in agreement with our results that COX17 transcript levels are increased with 100 µM 
and 500 µM BCS in galactose (Appendix A). 
In excess Cu, Cox17 protein levels are also increased in the mitochondria. Since COX 
activity, Sco1 protein levels, and Cox11 protein levels are also increased, we could propose 
that Cox17 is present because it needs to help with the COX delivery pathway. However, 
there is direct evidence that does not support this hypothesis. When Cox17 was first 
described, it was shown that addition of 0.1% and 0.4% Cu recovered the COX defect seen in 
the Cox17 KO (Glerum et al, 1996a). Since Cox17 was absent in these experiments, they 
clearly demonstrate that there is an alternate pathway that can donate Cu to Sco1 and Cox11. 
Surprisingly, the increase of Cox17 protein levels in mitochondria is accompanied by a 
decrease in Cox17 protein levels in the whole cell. Cox17 is not downregulated in Cu excess 
conditions even though there is less protein present, which means that excess Cu affects 
Cox17 stability in the whole cell. Taken together, our data presented here demonstrate an 
increase in mitochondrial Cox17 protein levels during both Cu excess and depletion, 
suggesting that mitochondrial Cox17 may be serving an alternative function when Cu 
homeostasis has been disrupted.  
There has been one report of an alternate function for mitochondrial Cox17 in helping 
to maintain integrity of the mitochondrial contact site and cristae organizing system 
(MICOS) by interaction with Mic60 (Chojnacka et al, 2015). However, other than Cox17, 
there are no other connections between MICOS and Cu homeostasis. Although Cox17 likely 
does not shuttle Cu directly across the OMM, it still may have a role in mitochondrial Cu 
import.  One hypothesis is that Cox17 could be the starting point for Cu delivery for both 
mtSod1 and COX. Once GSH enters the mitochondria with Cu (see section 1.4.3), GSH 
donates Cu to Cox17, and Cox17 might then be responsible for trafficking Cu towards Sod1 
and COX.  
Imbalance in cellular Cu homeostasis may also activate the apoptotic pathway 
because of Cu toxicity or improper cuproprotein function, and in this scenario Cox17 may 
function as a pro-apoptotic protein. The yeast apoptosis inducing factor 1 (Aif1), a 
mitochondrial resident, is an important player in the caspase-independent yeast apoptotic 
pathway. Mechanistically, it translocates from mitochondria to nuclei during apoptotic 
induction and promotes DNA damage in preparation for apoptosis (Madeo et al, 2009). Aif1 
	 89 
shows similarities to Cox17 as it resides in the IMS and is imported into mitochondria via the 
Mia40/Erv1 pathway (Hangen et al, 2015). Our lab has shown that a Cox17 KO is unable to 
undergo apoptosis when induced with either hydrogen peroxide or ultraviolet light, an 
observation unique to the Cox17 KO but absent in other COX assembly mutants or the 
respiratory competent wild-type strain (Dubinski, unpublished), suggesting that Cox17 may 
have a role in apoptotic induction.  
Looking at the data presented in this thesis, apoptosis could occur during Cu excess 
conditions as we observe an increase in oxidative damage in both mitochondrial and 
cytosolic compartments, which suggests there is more DNA damage. During excess Cu, we 
also observe a decrease in Cox17 protein levels in WCL, but an increase in mitochondria. 
The decrease we observe in cytosolic Cox17 protein levels display disconnect with what we 
observed for whole cell protein levels, since the decrease in the whole cell is larger than the 
decrease in the cytosol. This suggests that Cox17 could exist in other cellular compartments, 
such as the nucleus. Preliminary evidence from nuclear isolations in steady state conditions 
reveals that Cox17 protein is not present in the nucleus (Dubinski, unpublished). However, 
Cox17 may translocate to the nucleus during apoptotic induction, and would not be present 
there during steady-state conditions. Additionally, Cox17 could potentially interact with 
XIAP in human cells, which presents another connection between Cox17 and apoptosis 
(Mufti et al, 2007). 
Lastly, the secondary function of Cox17 could be more important in quiescent cells. 
Until recently, research regarding COX assembly has been done in yeast cells growing 
exponentially. When glucose has been depleted, yeast cells enter the stationary phase, which 
is characterized by low transcript abundance, high levels of antioxidant defense, and elevated 
aerobic respiration (Werner-Washburne et al, 1993) (Allen et al, 2006). Analysis of ACT1 
transcript levels in a wild-type strain show a significant decrease from exponential to 
stationary phase. Contrary to expectations, COX17 transcript levels are not downregulated in 
yeast at stationary phase (Dubinski, unpublished). Since wild-type yeast have different 
mitochondrial physiology and a distinct oxidative damage profile at stationary phase when 
compared to exponential phase (Dubinski et al, 2018), the alternative role of Cox17 may be 
related to a pathway that is more prominent at stationary phase.  
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6.3	Comparison	of	behavior	of	Sco1	and	Cox11	
Sco1 and Cox11 are both IMM residents that function to deliver Cu to COX, and 
accept Cu from Cox17 (Horng et al, 2004). More recently, Sco1 and Cox11 have been 
proposed to play roles in redox metabolism. The Sco1 crystal structure reveals a thioredoxin-
like fold (Williams et al, 2005), and both the Sco1 and Cox11 KO strains display 
hypersensitivity to exogenous hydrogen peroxide (Banting & Glerum, 2006), suggesting that 
these proteins may have a role in responding to ROS. In 2011, an in depth study was 
performed comparing the Sco1 and Cox11 KO strains in yeast to further understand their 
peroxide sensitivity (Veniamin et al, 2011). The peroxide sensitivity in the Sco1 KO is 
recovered by overexpression of Sco2 or Cox11, but overexpressing Sco1 or Sco2 does not 
recover the peroxide sensitivity in the Cox11 KO. On the other hand, overexpression of Ctt1, 
the catalase in the mitochondrial matrix, recovers the peroxide sensitivity in both the Sco1 
and Cox11 KO. Interestingly, when Sco1 KO loses mtDNA, it is no longer hypersensitive to 
peroxide, but this is not the case in the Cox11 KO (Veniamin et al, 2011). This article 
highlights that the nature of the peroxide sensitivity differs between the Sco1 and Cox11 KO 
strains.  
In this study, we find that increasing or decreasing concentrations of extracellular Cu 
do not transcriptionally affect the SCO1 and COX11 genes. After treatment with 0.1% Cu, 
Sco1 protein levels increase slightly while Cox11 protein levels are unaffected. In 500 µM 
BCS, SCO1 and COX11 transcript levels are unaffected, but there is a slight decrease in Sco1 
protein levels while Cox11 protein is virtually absent. In lower concentrations of BCS, Sco1 
protein levels remain similar and Cox11 protein levels are lower. The similar Sco1 protein 
levels corresponding to a decrease in COX activity suggest that the role of mitochondrial 
Sco1 during Cu depletion could be associated with its role in redox metabolism or its recently 
identified role in Cu homeostasis, and highlights a difference between the roles of Sco1 and 
Cox11. 
Sco1 could be involved in breakdown of ROS in the mitochondria. Even though the Sco1 
KO is sensitive to peroxide, it displays no growth defect when exposed to paraquat (PQ), a 
superoxide generator, or menadione (MD), which also generates ROS (Banting & Glerum, 
2006) (Kocabey et al, 2018). However, a Sco1/Sod1 double KO drastically enhances the 
sensitivity to these chemicals that was seen in the Sod1 KO, suggesting that Sod1 and Sco1 
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may work together in the IMS to detoxify ROS. Together with our finding that cells maintain 
Sco1 protein levels in Cu depletion conditions, we propose that Sco1 and Sod1 can work 
together to break down superoxide in the mitochondria. This hypothesis is also consistent 
with the increase in Sco1 protein levels during Cu excess conditions, as we also observe an 
increase in Sod1 protein levels. 
Mutations in Sco1 are known to be associated with clinical presentation of 
mitochondrial disorders (Leary et al, 2007). Is it important to note that the yeast and human 
versions of Sco1 were thought to arise independently and therefore are considered paralogs. 
Another reason Sco1 protein levels might remain constant during Cu depletion is because of 
the role of Sco1 in Cu homeostasis in mammalian systems. Sco1 is thought to have a role in 
controlling Cu homeostasis since a Sco1 KO in mice results in a tissue and allele specific Cu 
deficiency, which is due to a change in Cu efflux (Leary et al, 2007). Cu deficiency in Sco1 
patient fibroblasts is rescued by KD of Atp7a, which verifies that differential regulation of 
Cu homeostasis in a Sco1 KO is due to increased Cu efflux by Atp7a (Leary et al, 2013). In 
the same article, the authors report that Cox19 was involved in signal transduction between 
Sco1 and Atp7a; they test COX assembly factors associated with Cu that are dually localized 
between the IMS and cytosol (Cox17, Cox19, Cox23).  
Further work done to analyze signal transduction from mitochondrial Sco1 has 
revealed that signaling is tissue-specific and various signaling mechanisms occur (Hlyaniuk 
et al, 2015) (Baker et al, 2017b). Taken together, these results suggest a general Cu 
deficiency in Sco1 KO tissues but tissue-specific variation exists for the underlying cause of 
the deficiency. In yeast, we suggest that maintenance of Sco1 levels during Cu deficiency 
could be related to a signaling pathway where cellular Cu influx is increased. 
We previously saw that both the Sco1 and Cox11 KO Strains have a cell cycle defect 
(Camasta, 2017). Here, we show that the cell cycle defect seen in the Cox11 KO is associated 
with decreased protein levels of Rad53 and Rnr3, while in the Sco1 KO these protein levels 
are similar to that seen in the wild type strain, distinguishing the two KO strains. Our studies 
with a subset of COX assembly mutants reveal that the Cox11 KO strain has the most severe 
growth defect and appears to have higher levels of oxidative stress compared to other 
mitochondrial mutants (Dubinski et al, 2018). In agreement with our findings, 
overexpression of Cox11 in wild type yeast leads to increased oxidative stress resistance 
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(Radin et al, 2018), suggesting that Cox11 is important for oxidative stress management. We 
suggest that the decreased Rad53 and Rnr3 protein levels are a result of increased oxidative 
stress in the Cox11 KO, and that this leads to a cell cycle defect. To support this, oxidative 
stress is known to cause cell cycle delays, as has been seen after exposure of cells to various 
ROS-generating agents (Shapira et al, 2004). The mechanistic explanation for the Sco1 KO 
cell cycle defect remains unknown. Although Sco1 and Cox11 have similar functions in 
COX assembly, our results regarding the mechanism behind the cell cycle delay seen in Sco1 
and Cox11 KO strains is another example of differential phenotypes associated with the loss 
of these proteins. 
6.4	Mitochondrial	Cu	Distribution	with	Limiting	Cu	
Our results with Cu depletion clearly demonstrate a preference for Cu to be delivered 
Sod1 over COX in the mitochondria (Figure 6.1). For function of Sod1 and COX, Cu is 
essential. Therefore, our observation that SOD activity is retained in 500 µM BCS while 
COX activity significantly decreases shows that Sod1 has obtained Cu but COX has not. 
From our Western blotting data, we show that protein levels of subunits of COX, Cox2 and 
Cox4, are significantly lower after exposure to 500 µM BCS. Therefore, the decrease in Cu is 
likely destabilizing the COX complex. When there are defects in COX assembly, we 
normally see absence of proteins that make up the catalytic core – Cox1, Cox2, and Cox3; 
however, nuclear-encoded subunits are still present (Glerum & Tzagoloff, 1998). In this 
study, we observe loss of both mitochondrial and nuclear encoded subunits, suggesting that 
the cell is not responding to defective COX assembly, but something else. Identification of 
mutated genes in the suppressor screen for growth on non-fermentable carbon sources with 
BCS will likely provide insight into the genes that are responsible for this process. 
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Figure 6.1 Model for Cells in Cu deficiency. 
Cu is preferentially donated to mtSod1 in Cu deficient conditions (modified from Baker et al, 2017) 
At 500 µM BCS, we are uncertain whether Cu is being directed towards COX via 
Cox17, but our results clearly demonstrate that Sod1 has Cu. Although we lack the antibody 
to detect Ccs1 protein levels in the mitochondria, the CCS1 gene is upregulated in Cu 
deficient conditions and therefore is likely favoring the Cu donation to Sod1 in the 
mitochondria. Our analysis with BCS also reveals a disconnect between Sod1 transcript and 
protein levels. Cytosolic Sod1 protein levels make up approximately 90% of cellular Sod1, 
and they are decreased to 3% of control levels after treatment with 500 µM BCS. However, 
transcript levels of the SOD1 gene remain constant after exposure to any BCS concentration, 
suggesting that protein stability of cytosolic Sod1 is greatly affected by BCS exposure. On 
the other hand, the mtSod1 pool is only slightly decreased after exposure to 500 µM BCS and 
therefore seems more stable during limiting Cu.  
We first need to address how the mitochondrial and cytosolic pools of Sod1 differ 
after exposure to BCS. Because they house the electron transport chain, mitochondria 
generate higher amounts of ROS than other organelles. Although we see slightly lower 
oxidative damage in mitochondria after exposure to 500 µM BCS, this may be because 
mtSod1 levels are maintained and therefore are able to break down ROS or simply because 
there is less Cu present. This is in agreement with the fact that oxidative damage levels are 
higher in the cytosol, when there is no Sod1 present. Cytosolic Sod1 is likely getting 
degraded because Sod1 protein levels are barely detectable and SOD1 transcript levels are 
maintained. However, if Sod1 enters mitochondria using the Mia40/Erv1 import pathway it is 
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known that Mia40 substrate take a longer time to enter mitochondria (Habich et al, 2019). 
Therefore, mitochondrial-target Sod1 must be protected in the cytosol so it does not get 
degraded like the cytosolic pool of Sod1. An exception to this could be if cytosolic Sod1 is 
not degraded until it is folded, because Sod1 targeted to mitochondria would be in an 
unfolded state. Previous work has illustrated that Sod1 can be modified by post-translation 
modifications, including phosphorylation and SUMOylation (Tsang et al, 2014) (Fei et al, 
2006). One of these modifications could activate the proteasomal pathway, which ends with 
degradation of the cytosolic pool of Sod1. Lastly, mtSod1 would have a disulfide bond 
formed, which increases its affinity for Cu (Culik et al, 2018). This would provide more 
evidence regarding why the mtSod1 pool exists during Cu depletion conditions and how that 
pool gets Cu.  
Once Cu goes to the IMS, it has two final destinations. Although COX is not 
assembled, both Cox17 and Sco1 are present during Cu deficient conditions. Therefore, Cu 
will be preferentially donated to one of the pathways. Since we observe 70% retention of 
SOD activity in the IMS during Cu depletion, we assume that Cu is first trafficked towards 
Sod1 before it goes towards COX via Cox17. Cmc1, a protein that has an as-yet defined role 
in COX assembly, was proposed to have a role in trafficking Cu towards one destination over 
the other (Horn et al, 2008). One possibility for the retention of Sod1 activity in mitochondria 
is because Sod1 is required for activation of Mac1, a Cu-responsive transcription factor that 
localizes to the nucleus (Wood & Thiele, 2009). As mentioned earlier, Mac1 is crucial for 
cell survival under low Cu conditions since its activation leads to increased production of 
Ctr1, a high affinity Cu transporter located on the plasma membrane. In conjunction with this 
finding, overexpression of Sod1, regardless of its Cu binding abilities, leads to an increase in 
cellular Cu levels (Tokuda et al, 2013). Sod1 localization and protein levels have also been 
associated with Cu dyshomeostasis in motor neuron cultures, further supporting the 
hypothesis that Sod1 functions in cellular copper homeostasis (Arciello et al, 2011) (Azzouz 
et al, 2000). 
We propose that the main reason for the preferential Cu donation is purely based on 
chemical properties, and depends on the affinity of the candidate protein for Cu. One study 
done in vitro stated that Ccs1 has a higher affinity for Cu than Cox17, which would explain 
why we observe retention in Sod1 activity but a loss of COX activity (Banci et al, 2010). To 
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our knowledge, our result is the first demonstration of preferential Cu donation in vivo that is 
in agreement with the chemical affinity gradient. Moreover, GSH has an even lower affinity 
for Cu, further supporting the possibility that GSH is the responsible molecule for Cu import 
into mitochondria as feasible. Although our results are consistent with the chemical affinity 
for Cu described in vitro, they directly contradict other studies of Cu distribution in the 
presence of limiting amounts of metal. 
The Culotta lab found that when depleting Cu in Candida albicans, a pathogenic 
fungus, cells downregulate Sod1 to maintain COX activity (Li et al, 2015) (Broxton & 
Culotta, 2016). These cells completely get rid of Sod1 in the mitochondria so there is no 
longer a competition between the Sod1 and COX pathways for Cu, which still supports the 
chemical affinity gradient (Banci et al, 2010). However, C. albicans also has a SOD3 gene, 
which is purely cytosolic and uses Mn as its catalytic metal (Li et al, 2015). In this model 
system, the mitochondria would likely possess more ROS since they do not have Sod1 
residing there. However, C. albicans also has an alternative oxidase (AOX), which acts as a 
final electron acceptor similar to COX. AOX has also been thought to reduce levels of 
oxidative stress in the mitochondria, which is further compensation for losing the 
mitochondrial pool of Sod1 (Ruy et al, 2006). Similar to this study, another study performed 
in the model organism Chlamydomonas shows that COX function is prioritized with limiting 
Cu, as other cuproproteins have more dispensable functions (Kropat et al, 2016). 
Chlamydomonas does not have a SOD enzyme that uses Cu, instead it contains Fe and Mn-
Sod, changing the parameters of Cu distribution in this model system (Merchant et al, 2006). 
Interestingly, limiting Fe in Chlamydomonas leads to upregulation of the MSD3 (Fe-Sod) 
gene, which leads to increased synthesis of the Mn-Sod gene (Page et al, 2012). In both C. 
albicans and Chlamydomonas, cells prioritize COX activity during Cu depletion, while in S. 
cerevisiae Cu is preferentially given to mtSod1. The differences we observe in Cu 
distribution in S. cerevisiae are likely associated with the presence of the AOX and the 
absence of Sod1 in C. albicans and Chlamydomonas.  
When we change the primary carbon source to galactose, we see a significant drop in 
active Sod1 in mitochondria, in addition to lower Sod1 protein levels. We also see that at 100 
µM BCS in galactose, the SOD1 gene is downregulated (Appendix A). We hypothesize that 
because of the role of Sod1 in glucose repression that is no longer necessary when galactose 
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is present (Reddi & Culotta, 2013). Sod1 is proposed to function in the cytosol to regulate 
glucose repression by interacting with Yck1 (Reddi & Culotta, 2013) and Pma1 (Baron et al, 
2015). Specifically, the interaction between Sod1 and the C-terminal of Yck1 requires 
oxygen and glucose, and Yck1 stabilization means it can repress respiratory genes. The 
finding regarding Sod1 having a role in nutrient sensing is expanding as Sod1 interacts with 
mTORC1 in yeast to regulate ROS levels depending on levels of nutrients in the surrounding 
environment (Tsang et al, 2018). Interestingly, our results also show Sod1 depletion in the 
cytosol after exposure to BCS (Dubinski, unpublished). Another possibility is that SOD1 is 
activated by glucose, a phenomenon that is seen with the TOM22 gene (Gerberth et al, 2013). 
It should also be noted that a Sod1 KO in S. cerevisiae cannot grow in galactose, but the 
reasons behind this are unclear (Glerum, unpublished). Overall, our work regarding galactose 
remains preliminary and more data are needed to understand how carbon source affects the 
mitochondrial pool of Sod1. 
6.5	Divergent	Cell	Cycle	Phenotypes	with	Cu	Availability	
Based on preliminary experiments showing a cell cycle delay in COX assembly 
mutants, our aim of the cell cycle progression analysis in Cu excess and Cu deplete 
conditions was to observe whether the cell cycle delay we saw in the mitochondrial 
cuproprotein mutants was reproducible with Cu imbalance. The cell cycle defects we observe 
in excess Cu conditions are different than what we observed in the mitochondrial mutants as 
they reveal a subset of cells stuck in G1 phase. At the 40-minute time point, where all of the 
cells in the no treatment sample have completed S phase, we see two similar peaks in the 
0.1% Cu sample representative of G1 and G2 phases. We also see that after treatment with 
0.1% Cu, Rad53 protein levels are significantly decreased to 57% of control levels. Because 
Rad53 is known to have roles in dNTP pool control (Jossen & Bermejo, 2013), the decrease 
in Rad53 protein levels likely corresponds to lower dNTP concentrations in the cell. Another 
reason cells would halt replication is if there are high levels of DNA damage, and cells are 
extremely prone to mutations (Desany et al, 1998). Oxidative stress has been associated with 
cell cycle defects, suggesting that increased levels of oxidative stress likely play a role in 
cells being stuck in G1 (Shapira et al, 2004). Although we see higher oxidative damage in the 
mitochondria and cytosol, a more thorough investigation of activation of phosphorylation 
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cascades in response to DNA damage is necessary. Therefore, from our preliminary data we 
conclude that cells trapped in G1 phase cannot undergo replication because of decreased 
dNTP levels. 
Another difference between the cell cycle traces in the samples with 0.1% Cu and the 
control is the presence of a sub-G1 peak in the samples with 0.1% Cu added. Sub-G1 peaks 
represent cells that have less than 1N DNA, and have been previously reported to be 
apoptotic cells (Burhans et al, 2003). Excess Cu can give rise to the Fenton reaction and 
causes oxidative stress, which is consistent with our observations that some cells are 
undergoing apoptosis. As we described in section 6.2, Cox17 may have a role in apoptosis 
during excess Cu conditions, and from the preliminary cell cycle analysis it appears that 
some of the cells in the population are apoptotic.  
Although our cell cycle results with excess Cu did not mimic the cell cycle defect 
seen in the COX assembly mutants, literature has proposed that Cu deficiency is more 
physiologically representative of cuproprotein mutants (Baker et al, 2017b) (Maxfield et al, 
2004). To our surprise, we observe no cell cycle defects between the no treatment sample and 
any sample treated with BCS. This suggests that the defects we see in the mitochondrial 
mutants are not associated with their lack of cuproproteins.  
Because we observed a near absence of mtSod1 protein levels in galactose compared 
to retention of these protein levels in glucose, we tested whether cell cycle defects are 
observed with BCS when galactose was the primary carbon source. Although our results are 
preliminary, they reveal two distinct differences between carbon sources. Firstly, it appears 
that cells stay in the G1 phase for a longer period of time, but they go through the G2 phase 
more quickly. We think that the reason for changes in cell cycle progression we see between 
galactose and glucose with BCS is because of the presence or absence of mtSod1. Sod1 is a 
non-essential gene in aerobic organisms but is also found in anaerobic organisms (Chung, 
2017), suggesting that it has roles unrelated to breaking down superoxide. Many novel roles 
of Sod1 unrelated to superoxide breakdown have been discovered in the model organism 
Saccharomyces cerevisiae, and several studies in mammalian systems support these findings. 
Yeast Sod1 is thought to act as a transcription factor in response to peroxide-induced 
oxidative stress after it rapidly translocates to the nucleus (Tsang et al, 2014). This 
translocation is dependent on phosphorylation of ySod1 by a cascade involving Dun1 and 
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Cds1, and Sod1 must be fully metallated and dimerized for this process to occur (Tsang et al, 
2014). Once in the nucleus, it is suggested that approximately 30% of Sod1 transcriptional 
targets are related to DNA damage stress and replication stress. It remains unclear whether 
Sod1 directly binds DNA or if this happens through interactions with other proteins. Because 
we know Sod1 is required for activation of Mac1, a well-defined transcription factor, one 
possibility could be that the upregulation of antioxidant genes during peroxide-induced stress 
is a result of an interaction involving Sod1 and Mac1. There is also more direct evidence that 
Sod1 helps regulate cell cycle and dNTP pools through its interactions with Rad53 (Dong et 
al, 2013) and Rnr (Das et al, 2018). In conjunction with this, wild type and mutant versions 
of Sod1 in humans have been found to affect apoptosis (Zhang et al, 2016), and this is likely 
through an interaction between Sod1 and Bcl-2, an anti-apoptotic protein (Pasinelli et al, 
2004). 
Our data suggest that the presence of mtSod1 could have a role in cell cycle 
regulation, as we observe no cell cycle defect when mtSod1 is present with glucose and BCS, 
but we do see abnormalities in galactose and BCS, where the major difference is the absence 
of mtSod1. Both the Ccs1 and Sod1 KO strains display a cell cycle defect (Carter et al, 
2005), in agreement with our hypothesis. The cell cycle defect seen in the Sod1 KO is likely 
of a similar severity to the one seen in the Rad53 Sml1 double KO because the strains have 
similar sensitivities to the DNA damaging agent HU (Carter et al, 2005). We also see 
increase Rad53 protein levels in the Sod1 KO, illustrating that an important protein involved 
in cell cycle control is affected by loss of Sod1 (Dubinski, unpublished). 
6.6	Conclusions	and	Future	directions	
In this study, we investigated mitochondrial function in Cu excess and limiting 
conditions. We hypothesized that changes in Cu availability would affect mitochondrial 
cuproprotein pools and lead to a cell cycle defect. Our results display significant changes to 
mitochondrial function with excess or limiting Cu, and we reveal a clear cell cycle defect 
after exposure to excess Cu. 
Although mitochondrial Cu import is fundamental, the pathways surrounding the 
mechanism by how this works are still under debate. Our results cast doubt on the CuL in the 
matrix being a main Cu source for IMS residents. Recently, Mrs3, a Fe transporter, was 
	 99 
described to participate in import of Cu to the mitochondrial matrix (Vest et al, 2016), which 
is another mechanism illustrating the well-known intersection between Cu and Fe regulation. 
Assaying mitochondrial cuproprotein function in excess or limiting Fe conditions would 
provide insight on subcellular cross-talk between the metals. Similarly, two of the proteins 
that were assayed, Sod1 and Cox4, also bind Zn. Studying cuproprotein function in 
mitochondria in the presence or absence of Zn would broaden our understanding of metal 
homeostasis in mitochondria. 
Because mutations in COX assembly factors lead to diverse clinical phenotypes, 
recent studies have been suggesting alternate functions of these proteins unrelated to COX 
assembly (Veniamin et al, 2011) (Chojnacka et al, 2015). We find that the mitochondrial 
pool of Cox17 is increased with both excess and limiting Cu, and propose that this finding is 
related to a secondary role of mitochondrial Cox17 in mitochondrial Cu import or apoptosis. 
To test the hypothesis that Cox17 plays a role in apoptosis, future work will focus on 
uncovering a relationship between Cox17 and Aif1 and performing immunofluorescence 
microscopy to track the location of Cox17 during apoptotic induction. This study also 
highlights divergence in Sco1 and Cox11 functions because of the differential behaviors we 
observe between these proteins with changing Cu. Our work supports the hypothesis that 
Sco1 and Sod1 work together to break down ROS in the mitochondria (Kocabey et al, 2018). 
In Cu deplete conditions our results reveal that COX activity significantly decreases 
while mitochondrial Sod1 activity is maintained. These data directly contradict studies done 
in the organisms Candida albicans and Chlamydomonas and we propose that this is because 
of the presence of an AOX in these systems and the absence of mtSod1 in Cu deficiency. 
Growing cells on a non-fermentable carbon source in the presence of BCS is lethal, 
indicating that cells cannot recover COX function for survival. We isolate four suppressors 
able to grow on EG + 500 µM BCS, which can now be sequenced and may provide insight 
on which genes are involved in regulating mitochondrial Cu distribution.  
Changing the primary carbon source to galactose results in loss of both COX and 
Sod1 function in the mitochondria in limiting Cu conditions. Although we find that exposure 
to BCS has no apparent cell cycle defect in glucose, we see a defect in Cu deplete conditions 
with galactose. We hypothesize that the mitochondrial pool of Sod1 is important for normal 
cell cycle progression, and that loss of this protein pool results in a cell cycle defect. Future 
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experiments will be aimed at further characterizing the cell cycle defect we see in galactose 
during Cu deficiency, which will be followed by trying to reproduce the defect in a Sod1 KO 
or in other carbon sources, such as raffinose. Ultimately, the interactions between Sod1 with 
Rad53 (Dong et al, 2013) and Rnr3 (Das et al, 2018) will be explored in detail and provide 
mechanistic insight towards the function of Sod1 in yeast cell cycle control. 
Studies of Cu homeostasis in Saccharomyces cerevisiae have provided essential 
contributions towards our understanding of Cu metabolism and cuproprotein functions in 
mammalian systems.  Continuation of studies regarding Cu homeostatic pathways in yeast, 
such as this one, is imperative to expand our knowledge of these basic biological mechanisms 
and for understanding how dysfunction of these pathways plays a role in disease. 
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Appendix	A:	qPCR	Data	with	Galactose	as	a	Carbon	Source		
This Appendix includes qPCR data for the COX17, SCO1, COX11, COX4, CCS1, SOD1, and 
PIM1 genes with galactose as a primary carbon source, and TDH2 qPCR data with both 
glucose and galactose as carbon sources.  
 
	
Figure A1.1 RT-qPCR of COX17, SCO1, COX11, and COX4 with galactose 
(A) Graphical representation of relative abundance of COX17, SCO1, COX11 and COX4. RNA was isolated 
from yeast cells grown for 18 hours in YPGal + BCS. PCR was performed using cDNA on both the gene of 
interest and ACT1 as a control. Values are representative of ΔΔCq values. Three biological replicates were 
performed for each concentration. A one-way ANOVA was performed to determine statistical significance: not 
significant = n.s, p < 0.05 = *, p < 0.01 = **. Error bars represent ± SEM. (B) Raw ΔΔCq values. 	
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Figure A1.2 RT-qPCR of CCS1, SOD1, and PIM1 with galactose 
(A) Graphical representation of relative abundance of CCS1, SOD1 and PIM1. RNA was isolated from yeast 
cells grown for 18 hours in YPGal + Cu or BCS. PCR was performed using cDNA on both the gene of interest 
and ACT1 as a control. Values are representative of ΔΔCq values. Three biological replicates were performed 
for each concentration. A one-way ANOVA was performed to determine statistical significance: not significant 
= n.s, p < 0.05 = *, p < 0.01 = **. Error bars represent ± SEM. (B) Raw ΔΔCq values. 
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Figure A1.3 TDH2 expression in glucose and galactose 
(A) Graphical representation of relative abundance of TDH2. RNA was isolated from yeast cells grown for 18 
hours in YPD or YPGal + Cu or BCS. PCR was performed using cDNA on both the gene of interest and ACT1 
as a control. Values are representative of ΔΔCq values. Three biological replicates were performed for each 
concentration. A one-way ANOVA was performed to determine statistical significance: not significant = n.s, p 
< 0.05 = *, p < 0.01 = **. Error bars represent ± SEM. (B) Raw ΔΔCq values. 		
TDH2 was originally our second qPCR control (ACT1 was the other) however expression 
was greatly varied with changing extracellular Cu concentrations, so using it as a control 
transcript would skew our results majorly. The differences in expression in glucose and 
galactose are not surprising, as TDH2 is the ortholog of glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) in mammalian cells. 	
	
	
